Studies on the effect of various topical agents on second ...
Transcript of Studies on the effect of various topical agents on second ...
![Page 1: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/1.jpg)
1
Studiesontheeffectofvarioustopicalagentsonsecondintentionwoundhealingoftheequinedistallimb.
VictoriaCMcIver
AthesissubmittedinfulfilmentoftheMastersofVeterinaryClinicalStudiessubmittedSeptember2020.
FacultyofScienceUniversityofSydneySydney,Australia
![Page 2: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/2.jpg)
2
StatementoforiginalityThisthesiscontainsmaterialpublishedinAustralianVeterinaryJournal,2020.ThisisthroughoutthethesisbutparticularlyChapters3and5.ThispaperpublishedtheresultsofPart1ofthetrial.MyinvolvementwasthatoffirstauthorandIwasinvolvedinstudydesign,implementation,obtainingandanalysingdataandauthoringofthepaper:
McIver,VC,Tsang,AS,Symonds,NE,Perkins,NR,Uquillas,E,Dart,CM,Jeffcott,LB,Dart,AJ(2020)Effectsoftopicaltreatmentofcannabidiolextractinauniquemanukafactor5manukahoneycarrieronsecondintentionwoundhealingonequinedistallimbwounds:apreliminarystudy.doi:10.1111/avj.12932Thisistocertifythattothebestofmyknowledge,thecontentofthisthesisismyownwork.Thisthesishasnotbeensubmittedforanydegreeorotherpurposes.
Icertifythattheintellectualcontentofthisthesisistheproductofmyownworkandthatalltheassistancereceivedinpreparingthisthesisandsourceshavebeenacknowledged.
VictoriaCMcIver
As supervisor for the candidature upon which this thesis is based, I can confirm that the authorship attribution statements above are correct.
Andrew Dart 16th September 2020
![Page 3: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/3.jpg)
3
TableofcontentsListoffigures………………………………………………………………………………………………….4Listofappendices…………………………………………………………………………………………...5Listofabbreviations………………………………………………………………………………………..6Chapter1:Abstract…….……………………………………………………………………………………6Chapter2:Literaturereview……………………………………………………………………………8 2.1Asummaryofwoundhealing..………………………………………………………...8 2.2Complicationsofwoundhealinginthehorse………………………………….13
2.3Asummaryoftopicalwoundtherapies…………………………………………..162.4Asummaryoftheuseofmedicalmarijuana…………………………………..212.5Asummaryofthetherapeuticuseofhoney…………………………………...242.6Modelsofwoundhealinginthehorse…………………………………………….28
Chapter3:Apilotstudyintotheeffectsoftopicaltreatmentofcannabidiolonsecondintentionhealingofequinedistallimbwounds…………………………………...31
3.1Introduction………………………………………………………………………………….31 3.2Materialsandmethods…………………………………………………………………..31 3.3Results…………………………………………………………………………………………33 3.4Discussion…………………………………………………………………………………….35Chapter 4: A study into the effect of incremental increases of UMF ratings ofmanukahoneyandMelaleucahoneyonsecondintentionhealingofwoundofthedistallimbofthehorse…………………………………………………………………………………..39 4.1Introduction………………………………………………………………………………….39 4.2Materialsandmethods…………………………………………………………………..40 4.3Results………………………………………………………………………………………….41 4.4Discussion…………………………………………………………………………………….42Chapter5:Conclusionsandfuturedirections…………………………………………………46Bibliography…………………………………………………………………………………………………47Appendices……………………………………………………………………………………………….......63
![Page 4: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/4.jpg)
4
LISTOFFIGURESFigure1:Plotofmeanwoundareaforeachgroupoverthe42daysofthestudy.Barsrepresent95%confidenceintervals.Figure2:Lineplotofrawwoundareameasurementsanddisplayingonelineperhorse.Thelineforhorse#4islabelled.Figure3:Plotofmeanwoundareaforeachgroupoverthe42daysofthestudy.Barsrepresent95%confidenceintervals.
![Page 5: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/5.jpg)
5
LISTOFAPPENDICESAppendix1:AnimalethicsAppendix2:AnaestheticmonitoringAppendix3:HorserecordsAppendix4:Post-operativemonitoring
![Page 6: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/6.jpg)
6
LISTOFABBREVIATIONSCannabidiol CBDCyclooxygenase COXInterferongamma IFN-ΥInterferonregulatoryfactor IRFInterleukin ILLipoxygenase LOXMethylglyoxyal MGOMetalloproteinase MMPMinimuminhibitoryconcentration MICMitogenactivatedkinases MAPMulti-drugresistantStaphylococcusaureus MRSANitricoxide NONon-peroxidaseactivity NPANon-steroidalanti-inflammatory NSAIDNuclearfactor NF-κβ,Plateletrichplasma PRPTissueinhibitorsofmetalloproteinase TIMPTetrahydrocannabinol THCToll-likereceptor TLRTransforminggrowthfactor-β TGF-βTumournecrosisfactorα TNF-αUniquemanukafactor UMFVascularendothelialgrowthfactor VEGF
![Page 7: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/7.jpg)
7
CHAPTER1:ABSTRACTTraumaticwoundsofthedistallimbarecommoninhorses.Thesewoundsareoftenlefttohealbysecondintentionbecauseofsubstantialtissueavulsionandcontamination.Inthehorsesecondintentionhealingisoftenproblematicandwoundsaresusceptibletotheproductionofexcessivegranulationtissue,whichinhibitstheprogressionofhealing.Therehavebeenmanyproductsrecommendedtoenhancesecondintentionwoundhealinginhorses,howevernoproducthasprovedtobeatreatmentpanacea.Marijuana(Cannabissativa)containsmorethan60biologicallyactivechemicalagentsthathavebeenshowntohavepotentantibacterialandanti-inflammatoryactivityaswellastheabilitytoimproveelementsofhealinginaratskinwoundhealingmodel.Thecurrentstudyaimedtoinvestigatetheeffectsofoneresin,cannabadiol,onsecondintentionwoundhealinginhorses.Thefirstpartofourstudywastodetermineifdailytopicalapplicationofcannabidiol,incombinationwithacarrierofmanukahoney,wouldimprovewoundhealingvariablesinanequinemodelofsecondintentionwoundhealing.Severalstudieshaveshownmanukahoneyenhancessecondintentionwouldhealinginhorsesinequinewoundhealingmodels.Astheuniquemanukafactor(UMF)increasessodoestheantimicrobialactivityofthemanukahoney.MoststudieshavefocusedonUMF20honeyincontaminatedanduncontaminatedequinewoundhealingmodels.ThesecondpartofourstudyexaminedtheeffectofdifferentUMFhoneyonsecondintentionwoundhealing,andcomparedthistotheuseofMelaleucahoney.OurhypothesiswasthatincreasingtheUMFratingwouldimprovewoundhealingandthatMelaleucahoneywouldnotenhancesecondintentionwouldhealinginthehorse.
![Page 8: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/8.jpg)
8
CHAPTER2:LITERATUREREVIEW2.1AsummaryofwoundhealingWoundspresentacommonchallengetoveterinariansandmedicalprofessionals.Inequinepracticethetreatmentofwoundscanquicklybecomeexpensiveduetobandagingcostsand,forperformancehorses,timelostfromtraining.Therefore,understandingtheprocessofwoundhealinganddevelopingtechniquesandtreatmentstooptimisetheprocessofwoundrepairisimperativeforequinepractitioners.Woundscanbeclassifiedasopenorclosed.Openwoundsarethosethatbreachtheskinbarrierduringtheinjuryprocess.Thesecanincludelacerations,abrasionsorsurgicallycreatedincisions.Incomparison,closedwoundsdonotbreachtheskinsurfaceandmayincludecrushinginjuries(1).Whenassessingthedegreeofbacterialcontamination,woundscanbecategorisedintoclean(surgicallycreated),clean-contaminated(surgicallycreatedwoundsenteringintotheurogenital,respiratoryorgastrointestinaltract),contaminated(eithersurgicallycreatedwoundswhereamajorbreachinaseptictechniquehasoccurred,oropen,traumaticwoundswithgrosscontamination),ordirtywounds(olderwounds,thosewithseveregrosscontamination,orthosewithnecrotictissuepresent)(1).Cleanorclean-contaminatedwoundshavelessthan1x105bacteriapergramoftissue,whilethosethataredirtyhavegreaterthan1x105bacteriapergramoftissue(2).Inhumanstimefrominjurytopresentationisusedtoclassifywoundsbecauseadelaytimetopresentationtypicallyequatestogreatercontamination(3).Inequinepractice,mostwoundsseenbyequinepractitionersareconsidereddirty.Insomecasesthisisduetothechronicityofthewounds,butmoretypicallyitisduetotheseverecontaminationpresent(1).Thisdegreeofcontaminationisdifficulttoavoidgiventheenvironmentthathorsesarehousedin.Duringwoundhealingthetissueundergoesaseriesofdifferentstagesincludinginflammation,proliferation,andfinally,remodelling(1).Thisprocessisacontinuumandeachstageoverlapsthenext.Regardlessoftheinitialclassificationofthewoundallopenwoundsfollowthisprocessduringhealing,howeverthebodyadaptstheprocessinanattempttomaximisethehealingoftheindividualwound.InflammatoryphaseTheinitialreactiontoawoundisinflammation.Theinflammatorystageinitiatestheprocessofhealingbyeradicatingcontaminantsandforeignmaterialsandprovidesthefoundationforthesubsequentstagesofhealing.(4).
![Page 9: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/9.jpg)
9
Initiallyhaemostasislimitsbloodlossthroughvasoconstriction.Theinjuredendothelialcellsreleasephospholipids,whicharetransformedintoarachidonicacid,beginninganinflammatorycascadeandreleasingendothelinandthromboxaneA2(4).Thiscausesplateletaggregationandmediatesthevasculartoneofthearea(4).Thislastsonlybriefly,approximately5-10minutes,beforevasodilationbeginsinthesmallvenules(4).Diapedesisofcells,fluidsandproteinsoutofthevesselsoccursandtheseaccumulatewithintheextravascularspace(4).Aplateletplugdevelopsthroughthecoagulationprocess(4)andsofttissueswellingalsoprovidessomevascularcompression,furtherfacilitatinghaemostasis(5)(6)(7).Thisplateletplugultimatelystabilisesthewoundsiteandbecomestheprovisionalwoundmatrix,whichwilllaterprovideaphysicalscaffoldduringhealing(4).Theplateletsthatareactivatedduringthisearlystageofhealingarepotentandpromoteinflammationandreleasechemoattractants.Thisprovisionalmatrixwilleventuallydesiccate,ifleftuncovered,andultimatelybecomesascab(1).Thisscabprovidesaprotected,moistenvironmentandlimitsmicrobialpenetrationintothewound.Intheearlyinflammatoryphaseactivatedplateletsandmastcellsandinjuredoractivatedmesenchymalcellsinitiatethecomplementcascadeandpromoteleukocytesfromnearbycirculatingpoolstomigrateintothewound(4).Thisinitiatesastep-by-stepprocessofactivation,tightadhesionandtransmigrationofleukocytesintotheareaviatheendothelium(4).Chemoattractantsstimulatethereleaseofenzymesfromneutrophils,whichimprovestheirpenetrationthroughvascularmembranes.Thevasodilationalsofacilitatescellmigration.Overalltheresultisamassiveinfluxofneutrophils,beginningwithinminutesofinjuryandpeakingontheseconddayafterinjury(4).Theroleoftheneutrophilsistwofold;toclearthewoundsiteofforeignmaterialandbacteria,andtoreleasechemoattractantsthatwillfurtherdrivetheinflammatoryphase(8).Neutrophilsacttodestroybacteriaandremoveforeignmaterialbyphagocytosisandenzymaticdegradationandtheproductionofoxygenradicals(4).Proteinasesarealsoreleasedtoremovedamagedcomponentsoftheextracellularmatrix,andtheseincludeprincipallyneutrophilspecificinterstitialcollagenase,neutrophilelastaseandcathepsinG.Theneutrophilsareconfinedwithintheclotandtheiractivityceasesoncetheareaisclearedofcontamination.Thisclotwilllaterslough.Anyremainingneutrophilswillbephagocytisedbymacrophagesormodifiedwoundfibroblasts(4).Neutrophilicinfluxintothewoundisshortlived,asaretheneutrophilsthemselves(4).Afterthesecondday,monocytesbegintoexitthevasculatureandenterthewound,transformingintotissuemacrophages.Theyadheretotheextracellularmatrixandtransformintoaphenotypethatallowsthemtoproducecytokinesthatbothsupporttheirownexistenceandstimulatethewoundrepairprocess.Theysecreteproteinases,includingelastase,collagenaseandplasminogenactivator(PA)(4)whichacttoclearthewoundofremainingdebrisbeforerepairbegins(4).Notonlydotheyclearthedebris,theyalsocontributeto
![Page 10: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/10.jpg)
10
recruitmentofothercellpopulations.Thesecellslateracttocreatenewbloodvessels(angiogenesis)andstimulatefibroplasiaandepithelialisation(4).Thewoundrepairprocessisorchestratedbycytokinesthatworkinunisontoguideandorganisethewoundrepairprocess(9).Whileamultitudeofcytokinesareinvolved,transforminggrowthfactor-β(TGF-β)hasthebroadestactivity(4).AwiderangeofcellsproducethreedistinctisoformsofTGF-B(TGF-B1,TGF-B2andTGF-B3),andexpressionofthetwomostrelevantisoforms(TGF-B1,TGF-B2)isparticularlyimportantduringearlythestagesofhealing(10).TGF-β1isfoundinmosttissues(4)andwhilethereisaninitialreleaseofthiscytokinefrominjuredtissues,continuedmodulationofit’sreleaseisdeterminedbyauniqueabilitytoregulateitsownsynthesisfrommonocytesandmacrophages(4).TheoutcomeofthisisaconstantsupplyofTGF-β1duringthewoundrepairprocess(4).Themajoreffectofthiscytokineistoactasachemoattractantformonocytesandmesenchymalcells,particularlyfibroblastslaterinthehealingprocess(4)(10).Whilstneutrophilsareconsideredbeneficialtowoundhealing,theyarenotstrictlyrequiredforhealingtoproceedinasepticwounds(11).Thismaybedifferentincontaminatedwounds.Incontrast,macrophagesareconsideredthemajorcellresponsiblefordebridementofwoundsand,comparedtoneutrophilswhoseroleisstrictlytoclearthewound,macrophagesalsohavearoleinstimulatingwoundrepair(12)(4).Withoutmacrophages,studieshavedemonstratedthatthereisaseverelimitationintheabilityofclearingdebrisandadelayintissuefibrosis(13).Inhorses,specifically,neutrophilicinfluxisslowerandoverallneutrophilnumbersremainhigherandforaprolongedperiodresultinginchronicinflammation(14).Incontrast,thisisnotseeninponies.Theleukocytesofponiesproducegreatervolumesofcytokines,chemoattractantsandgrowthfactors.Overallhorseshavebeenshowntohaveaprolongedandsub-optimalinflammatoryresponsewhencomparedtoponies.Experimentalstudiesexaminingwoundhealingonthemetatarsusandbuttockshavedemonstratedthatbothprimaryandsecondaryintentionwoundhealingisprolongedinthehorsewhileponieshadasignificantlystrongerandfasterinflammatoryresponse.Thisexplainswhyhorsestypicallyhavepoorerwoundhealingthantheirsmallercounterparts(1).TissueproliferationphaseThesecondphaseofwoundhealingistermedthetissueproliferationphase(1).Thisbeginswiththedevelopmentofnewbloodvesselsformingfrompre-existingones.Thisprocessistermedangiogenesis,andthesevesselssupplythenewtissuewithfactorsandoxygen(1).Thereisaconcurrentfibroblasticproliferationasthebodylaysdownnewtissuestofillthedefect(4).Thisstageoccursastheinflammatorystagedownregulates(4)andtheoutcomeisthecreationofgranulationtissue.FibroblastsmigrateintothewoundundertheguidanceofTGF-B1(4)tohelpformgranulationtissuealongwithmigratingmacrophagesandnewcapillarynetworks.Fibroblastsmigrateintotheareabytheseconddayafterwoundingandpredominatebydayfour(16),(17)withnumberspeakingsevento
![Page 11: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/11.jpg)
11
fourteendaysafterinjury(16)(18).Fibroblastsmigratefromtheadjacentuninjuredtissueofthedermisandsubcutisbehindtheadvancingfrontofmacrophageswhichprovideapathclearedofcontaminants(4).Behindthefibroblastscomesnewcapillarynetworks(1)(4).Fibroblastsarestimulatedtoexpressintegrinreceptorstoassistmigrationintothetraumatisedarea(4).Integriniscriticaltocellmigratorypatterns(4).Fibroblastsalsosecreteproteasesthatacttoremovethefibrinclotandenhancecellmigration(4).Newcomponentsofextracellularmatrixdepositedduringfibroblastmigrationresultinarapidincreaseintissuevolume,althoughthisnewtissuelackssignificantstrength(4).ThisnewmatrixisreplacedbyaType1collagenrichsubstrateofglycosaminoglycans,fibronectinandhyaluron(4).Atthisstage,TGF-β1actsasapro-fibroticagenttolimittheturnoverofthenewstromabydownregulatingmetallomatrixproteinases(MMPS)andincreasingtheexpressionoftissueinhibitorsofmetalloproteinases(TIMPs)(4).Theresultingtissueactsasabarriertoinfectionandprovidesasurfaceacrosswhichnewepithelialcellsmaylatermigrate(4).Thedevelopmentofnewbloodvesselsisinitiatedbyanenvironmentthatisoxygenpoor,withhighlactatelevelsandlowpH(7).Pre-existingvesselsdevelopincreaseinwallpermeabilityandproteinasesfromactivatedendothelialcellsdegradethelocalbasementmembrane,whichallowsamigrationofendothelialcellsintotheinterstitialspace.Thisbeginswiththeextensionoftheircytoplasmicpseudopodiainitially,beforetheendothelialcellitselfcanfollow(4).Theremainingendothelialcellsthatdonotmigrateinsteadproliferate,providingasourceofnewcells(4).Thesenewsproutsofvesselsthenjointheneighbouringsprouts,fusingintoanarcade(4)andformingaprimitivecanalthaterythrocytescanpassthrough.Thesethenmature,becomingacapillary(4).Thisprocessbeginsontheseconddayafterinjury.Itreliesontheconcurrentformationofnewextracellularmatrixtoactasascaffoldforthesefragilevessels(4).Thesedelicatevesselscontinuetogrowinthepresenceofthecytokinesreleasedwithinthewound,inparticularTGF-β1.(4).Growthofthesevesselsceasesoncethetissueisadequatelyperfused(8).Atthisstage,stimuliaredownregulatedandthenewnetworkofcapillariesisreduced(4).Thisoccursthroughtheactionofmatrixmetalloproteinases(MMPs)(14)andapoptosisoftheendothelialcells(4).Clinicallythismanifestsasachangeintherichredcolourofgranulationtissuetothatofapalertissue(4).Afterthefirst10-14days,collagensynthesisslows(4).Capillariesregressandthegranulationtissuebeginstobereplacedbyalessvascularscartissue.Fibroblastsundergoeitherapoptosisortheyacquiresmoothmusclecharacteristicsandparticipateinwoundcontraction(4).Duringthisstage,TGF-β3becomesimportantbydown-regulatingtheinflammatorydrive,reducingaccumulationofextracellularmatrixandlimitingfibroplasia(19).Thisultimatelylimitsscarring(20).Thebarrierepitheliumprovidesgivesprotectionfromtheoutsideworldsore-epithelialisationofthewoundcommencesquickly.Indirtyorinfectedwoundshowever,epithelialisationcannotoccuruntilahealthyunderlyinggranulation
![Page 12: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/12.jpg)
12
tissuebedhasbeencreated.Amoistenvironmenttypicallyspeedsmigrationanddissolutionofthescabisnotrequired(21)(22).Theprocessbeginswithin24-48hourswiththecentripetalmigrationofexistingcellsfromthesurroundingrimofskin(4)(23)(24).Insuperficialwounds,epithelialcellsareavailablefromwoundedgesaswellasthebasementmembraneandappendagepopulations(forexamplehairfollicles,sebaceousandsweatglands)(25),(26)acrossthewound.Thisacceleratestheprocessdramatically.Epithelialisationinitiallydoesnotinitiallyrequireproliferationofepithelialcells.Initiallyitreliesonexistingpopulationsofcellsmigrating(4).Indeed,TGF-βisthoughttoinitiallyinhibitproliferation,insteadencouragingmigrationofexistingpopulations(27)(4).Priortomigrating,basalepidermalcellsatthewoundedgesalterthemselvestoimprovemobilityandphagocyticabilities(4).Thereisanincreaseinproteinaseactivityincellsoftheadvancingfrontthatallowsthecellstodegradeanyexistingclotandtoclearremainingdebris(4).Thecellsthenmigrate,withtheaidofintegrinreceptorsandundertheinfluenceofTGF-β.Eventuallyproliferationbeginsandthecellsbegintoleapfrogoveroneanotherasthemigratingfrontadvances(4).Thesecellsformanadherentmonolayer.Thismonolayermaturesintoamorenormalmultilayeredepidermis(4).Oncethecellshavecoveredtheentirewound,expressionoflamininintheextracellularmatrixleadstocontactinhibitionandmigrationceases(4)(16).AnewbasementmembraneformsandnewcellularlayersattachtothebasementmembranethroughType4collagenfibrilsandhemidesmosomes(4).Thispartoftheprocesstakessignificanttime,andcontinuestooccurlongaftergrosshealinghasoccurred(4).Strengthslowlyincreasesinthewound(4).Woundhealingbyepithelisationalonewouldbeslowsowoundsundergocontractiontoenhancethehealingprocess.Afterinjurythereisaninitialphaseofretraction,duringwhichtimewoundareaincreases.Thislastsfor5-10daysafterwoundingandrepresentsthetimepriortopeakfibroblastinvasionfollowedbyaperiodofrapidcontraction(4).Duringthecontractionphase,thedermisandepidermisaroundafullthicknesswoundmovecentripetallyoverthewoundbed(4).Thisbeginsinthesecondweekafterwounding(4)anddecreasesthetotalareathatmustbeepithelialised.Contractiondependsheavilyonfibroblastandmyofibroblastpopulationswithinthewound(16).ThesepopulationsareabundantwithingranulationtissueandareinfluencedbyTGF-β(4).Myofibroblastshaveasmoothmuscleactinsystemalongthelongaxisofthecellthatisrelatetotheextracellularmatrixthroughintegrins,andthecellsthemselvesarealignedalonglinesoftensionwithinthewound.Eachcellisconnectedtotheneighbouringpopulationsbygapjunctionsandhemidesmosomes(4).Thisgivestheentirecellpopulationameanscontract,decreasingthesizeofthewound.Followingaperiodofrapidcontraction,itslowsdramaticallyandfinallyceasesoncethewoundedgesmeetortensioninthesurroundingtissuesbecomestoogreat(28)(17).Attheconclusionofcontraction,myofibroblastnumbersdecreasethroughapoptosisorreversiontoaquiescentfibroblast(4).Ultimatelythisprocesscanreducethesurfaceareaofthewoundbybetween40-80%(29).Inareasofloosetissue,contractioncanoccuratarateof0.75mmperday(30).Thisisreducedinareas
![Page 13: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/13.jpg)
13
oftension.Fibroblastscontinuetoproducecollagentostrengthenthewound(17)(18)andthisoccursalonglinesoftension(28),furtherincreasingtissuestrength.TissueremodellingphaseRemodellingbeginsinthesecondweekofhealingbuthasapoorlydefinedend,onetotwoyearsafterinjury.Tissueisneverregeneratedtopre-injurystatus,insteadscartissueforms.Thisscartissuewillalwaysbe15-20%weakerthantheoriginaltissue(31).Remodellingseestheprovisionalextracellularmatrixconvertedintoscartissue.Itbeginsashyaluronintheprovisionalmatrixisreplacedbyproteoglycansintheextracellularmatrix.Fibroblastproliferationceasesovertime,asdoesmigration(17)(18).Thecollagencontentgraduallyincreases.Atthesametime,cellularcontentsdecreaseduetoreductionsincytokineproduction,signallingandneovascularisation(32).Collagenfibres,whichwereinitiallylaiddownrandomlyandprovidedminimaltissuestrength,begintoorientateinanorganisedmanner.Theyreforminbundlesalonglinesofstressandthisgivestrengthtothenewtissue(4).Collagen,nowinbundles,thencross-links(32)andintegratesintopre-existingbundles(4).Thereissimultaneousandequaldestructionandgenerationofcollagenduringthisphase,resultinginnonetgain.Type3collagenisremovedandreplacedbyType1collagenuntilthepre-injuryratioof1:4isreached(4).Degradationoccursviaproteolyticenzymes,mostlytheMMPcollagenase,stromelysinandmetallogelatinase,andthereisasimultaneousbalanceinhibitorslikealpha2-macroglobulinandalpha1-antiprotease,tissueinhibitorsofmetalloproteinases(TIMPs)(4).TIMPsmayalsostimulatepartsofwoundhealing(4).Theprocessofremodellingcantakeanywhereuptotwoyears(4).Tissuestrengthgraduallyincreasesfrom20%ofnormaltissueat3weeksto50%at12weeks.Finaltissuestrengthnevermatchesthatofuninjuredtissues,insteadreachingamaximumof80%oftheinitialstrength(32).2.2ComplicationsofwoundhealinginthehorseAlthoughallwoundsessentiallyundergothesamephasesofhealing,equinepractitionersmustbeawarethatwoundhealinginhorsesisproblematic,withhigherreportedratesofdehiscenceandothercomplicationssuchasexuberantgranulationtissue(33).Woundsonthelowerlimbsofhorsesarealsonotoriousforslowertimesofhealing(34)(35)(36).Experimentallycreatedwoundsoverthemetatarsusormetacarpushealnoticeablyslowerthananequivalentwoundonthebodyofthehorse.Thisisattributedtodevelopmentofexcessivegranulationtissue,or“proudflesh”,onthelowerlimbs(34)andslowerreepithelialisationandcontraction(34)(35)(36).Thisformerislinkedtothesuboptimalinflammatoryresponsethathorsesdisplayduringwoundhealing(37).Exuberantgranulationtissuemanifestsclinicallyasa
![Page 14: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/14.jpg)
14
mushroomingbedofgranulationtissuerisingabovethesurroundingskinedgesthatlimitstheabilityofthebodytocontractandepithelisethewound(1),resultinginapoorlyornon-healingwound.TheTGF-βcytokinefamilyplaysacriticalpartofregulatingwoundrepair.TGF-B1isconsideredtobethepro-fibroticisoformanditsmainroleistoattractandguidefibroblastsduringtheproliferativestageofwoundhealing.Itpeaksearlyinwoundhealing.Inthedistallimbofthehorse,TGF-B1hasbeenshowntohaveanextendedperiodofexpression(19)andmaybeassociatedwiththeprofibroticandpro-inflammatorythatunderpinthedevelopmentofexcessivegranulationtissueinthehorse(31).DifferencesinthespatialandtemporalexpressionofTGF-B1andTGF-B3betweenbodyanddistallimbwoundsmayalsoinfluencehealingpatterns(31).TGF-B3isexpressedearlierandinhigherconcentrationsinwoundsofthetrunkthanthoseofthelowerlimbsandmayhelpexplainwhywoundsofthebodyhealinamoreefficientlythanthoseofthelowerlimbs(19).Bandagingoflowerlimbwoundsmayfurthercontributetoapro-inflammatorystatebytrappinginflammatorymediatorsagainstthetissuesofthewound(1).Tissuehypoxiamayalsocontributetodysregulatedhealing.Tissuehypoxiaisanormaloccurrenceduringtheearlystagesafterwounding,associatedwithdamagetothelocalvasculatureandtheimmediatevasoconstrictionthatoccursinanattempttolimithaemorrhage(36).Arelativehypoxiafollowsdespitevasodilationandsubsequentangiogenesisduetotheincreasedmetabolicdemandsofhighlyactivecells(36).Complicatinghypoxiainthehorseistheinherentlylowerbloodflowofthelowerlimb,eveninareaswithoutinjury(36).Occlusionofthemicrovasculaturehasbeenshowntooccurmorecommonlyindistallimbwoundscomparedtowoundsoftheupperbodyonthehorse(38).MicrovasculatureocclusionmayupregulateTGF-B1,encouragingaprofibroticstateandexplainingwhydistallimbwoundsarepronetothiscomplication.Hypoxiainherentlyincreasesangiogenesisandproliferationoffibroblasts–thetwomaincomponentsofgranulationtissue(38).Experimentalstudieshavealsodemonstrateddecreasedoxygensaturationandanincreaseinglucoseutilisationandlactateaccumulationinthedistallimbofhorseswithwoundsthatdevelopexuberantgranulationtissue(36).Theauthorsconcludedthatthiswasnotsimplyassociatedwithhypoperfusion,insteadtheysuggestedthatoxygendiffusionoraerobicglycolysiswasimpaired(36).Thesestudiesdemonstratedincreasedurea-adjustedlactatelevelsinexuberantgranulationtissue,whencomparedtohealthybedsofgranulationtissue.(36).Tissueoedemaorfibrosiswasproposedtobetheunderlyingcause(39).Whilerapidcellulargrowthandoxidativeburstsofwhitebloodcellscanleadtointermittentincreasesinlactateproduction(40),thelactateconcentrationsinbodywoundsconsistentlyremainedintherangeof3mmol/L,whilelactateconcentrationinlowerlimbwoundswasconsistentlyelevatedbetween4-6mmol/Lforthe38dayperiodofthestudy(36).Systemicplasmalactatelevelsremainednormal,whichconfirmedtheabnormallactateofthelowerlimbwoundswasduetolocalproductionoflactate(36).Elevatedlactatelevelsofthelowerlimbinhorseswithexuberantgranulationtissuehasbeenimplicatedasthedrivingforceforthedevelopment
![Page 15: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/15.jpg)
15
ofexuberantgranulationtissue(36).Lactatehasadirectupregulatingeffectonvascularendothelialgrowthfactor(VEGF)possiblyduetothedamagingeffectsoncellsthatareresponsiblefortheirproduction(41).Italsoupregulatesgrowthfactorsandfibroblastsleadingtoangiogenesis(42)andcollagendeposition(43).Clinically,hypoxiainthelowerlimbofthehorsecanbeexacerbatedbytheroutinepracticeofbandagingthelowerlimbafterwounding.Bandagesarecommonlyappliedtolowerlimbwoundstolimitenvironmentalcontaminationandfurthertraumaandtorestrictmovementandprovidetheareawithwarmthandmoisture(44).However,bandaginghasalsobeenlinkedtothedevelopmentofexuberantgranulationtissue(44)(19),(45)(46).Experimentalstudiesusinguncontaminatedwoundmodelsofhealinginthehorseshowedthatbandagedwoundsofthelowerlimbretractmoreandaremorelikelytodevelopexuberantgranulationtissue.(44).Howeverifbandagesareremovedonceahealthybedofgranulationtissuedevelopsthetendencytodevelopexcessivegranulationtissueislimited.(1).Thediscoveryofbiofilmsinthe1970’shasdramaticallychangedtheunderstandingofwoundmanagement,particularlyinchronicwounds.Inhumanmedicineitisestimateduptohalfofchronicwoundshaveabiofilm(47).Therehasbeensubstantialresearchintobiofilmsinhumanwounds,butcurrentlythereisstillashortageofequineresearch.Abiofilmisproducedwhenbacteriabecomeencasedinalayerofextracellularmatrix,termedaglycocalyx(1).Althoughtypicallyconsideredapathogeniccondition,initialworkinthe1970’sindicatedbiofilmsmayoccurinhealthywounds,andthisworkdemonstratedtheymightactuallylimitthepenetrationofpathogenicbacteriadeeperintowounds(47).Itisimportanttonotethatawoundmaybevisiblyhealthyoruninfected,andyetstillhaveabiofilmpresent.Inapathogenicbiofilm,apolymicrobialfilmcoatswoundsorimplantsandbecomeproblematic.Biofilmslimittheaccessofantibioticstothebacterialcolonies.ExperimentalstudieshavedemonstratedthatbiofilmsofS.aureuscanbeuptoonehundredtimesmoreresistanttoantimicrobialscomparedtouncontainedbacteria.Furthermore,biofilmsincreasetheriskofanegativewoundculture,whichisclinicallyrelevanttothepractitioner(48).Theyalsotrapaconstantsourceofinflammatorymediatorsinthearea(49),leadingtoalow-gradepersistentinflammatorystate(50).Thisresultsinwoundsthatareproblematictotreat,increasingmorbidityandmortality.Inhumanmedicine,thepresenceofabiofilminwoundsisclinicallymanifestedasanimpairmentofgranulationandepithelialisation(50).Itislikelytobesimilarinahorse,howevertherearelimitedexperimentalstudiesavailable.Onestudyexaminedunbandagedwoundsoftheshoulderaswellasbandagedandunbandagedwoundsofthelowerlimbsofthehorseforbiofilms(51).Thewoundsweresurgicallycreatedandthenunderwentserialexaminationsforbiofilmformation.Theauthorsfoundthatshoulderwoundshealeduneventfullywithoutevidenceofbiofilmformation.Incomparison,alllowerlegwoundsthatwerebandagedbegantodevelopabiofilmatday7-10andbyday10-14thesebiofilmswerewellestablished.Thesewoundsweremore
![Page 16: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/16.jpg)
16
pronetothedevelopmentofexuberantgranulationtissue.Incontrastonly57%ofunbandagedlowerlimbwoundsdevelopedabiofilmandnounbandagedlowerlimbwoundsdevelopedexuberantgranulationtissue.Thebiofilmsinunbandagedlowerlimbwoundswerelessdeveloped.Mostsuperficialbiofilmsthroughoutthestudyculturedcocci,withonebiofilmfromdeeperwithinthewoundculturingrods(51)buttheauthorsdidnotfurthertypetheisolates.AsimilarstudyfoundthatsuperficialbiofilmstypicallyconsistedofS.aureus,whilstthoseofdeeperareastypicallygrewP.aeruginosa(52).Itwouldbereasonabletospeculateisolateswereconsistentinthetwostudies.Whybiofilmsdevelopedinthelowerlimbsandnotinbodywoundswasnotexplainedbythisstudy,howevermanyofthefactorsthatareknowntocontributetobiofilmformationalsofavourthatofexuberantgranulationtissue.Persistentinflammation,hypoxiaandhypoperfusionarefoundinbothpathologicalstates(51).Itispossiblethattheinherentsuboptimalinflammatoryresponseofthelowerlimbofthehorsefailstoproperlyclearthewoundofbacteria,allowingcolonisationandthedevelopmentofabiofilm.Itisalsopossiblethatthelowerlimbissimplyexposedtomorecontaminationatthetimeofwounding(51).Bandagingoflowerlimbsmaylenditselftobiofilmformationbecausethiscreatesamoist,warmenvironment(51).Regardless,onceabiofilmdevelopsitimpairshealing.Thebiofilmitselfdampenstheabilityofleukocytestodestroybacteria(53)andcontributestoahypoxicstatewithahighdemandforoxygen(54).Furtherstudiesareneededinthisarea.2.3AsummaryofwoundtherapiesInclinicalpracticewoundsarecommonlytreatedwithsystemic,regionalortopicaldrugs.Theprinciplesofemergencywoundmanagementaretooptimisethewoundbedtoenhancehealingwhilstminimisingcomplications,namelyinfection.Thereareexhaustivelistsoftherapiesavailableduringthewoundhealingprocess,anddiscussionofmanyofthemisbeyondthescopeofthisthesis.Drugsadministeredsystemicallyaretypicallygivenviaintravenous,intramuscularororalroutestargetingthebodyasawhole.(1).Regionallyadministeredagentsmaybegivenasaregionallimbperfusionorasanintraosseousinjectionandtargettheaffectedanatomicalregion(1).Topicalagentsareextremelyfocusedintheirareaofactionandusuallyhaveamuchmorelimitedpenetration(55).Thismeanstheyhavelimitedsystemicsideeffects.Thereareexceptions,butthesewillnotbediscussedfurther.Becausetopicalmedicationstargettheiractionstotheareatheyareappliedto,theymaybemorecosteffective,particularinlargeanimalpractice.Further,theyareusuallypracticaltoapplybyboththepractitionerandowner.Topicalagentscanhaveawiderangeofeffects.Someagentsmayhaveextremelylimitedroles,forexamplesomeagentsmayactasasimplebarrierfromtheoutsideworld,limitingpenetrationofmicrobesandpreventingtraumatothewoundbedduringdressingchanges(56).Othertopicalagentsmayhaveamoregeneralisedspectrumofactioncomparedtopharmaceuticaldrugs.Manukahoney,forexample,hasbothantimicrobialandanti-
![Page 17: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/17.jpg)
17
inflammatoryeffectswhenappliedtowounds(57)(58).Selecttopicalagentscanalsobeusedtodebridethewoundorpromotecertainstepsinthehealingprocess.Topicalagentscanthereforehavemultipleeffectsonwounds,andoftenhaveeffectsthatextendbeyondthesimplepharmaceuticaleffectsthatdrugssuchasNSAIDorantibioticsoffer.(59).Itisnotjustpuretopicalmedicinalagentsthathavebeenshowntoalterwoundhealing.Inthedevelopmentofequinecontaminatedwoundmodelsthetopicalapplicationoftopicalfreshfaecestoasurgicallycreateddistallimbwoundfor24hourswasfoundtoleadtogreaterretractionofthewoundandfasterhealingwhencomparedtouncontaminatedwounds.Thisislikelytobeassociatedwithupregulationoftheinitialinflammatoryresponsethatisoftensuboptimalinequinedistallimbwounds(60).Thisdemonstratesthevariedwaysinwhichtopicalagentscanhaveaneffectonopenwounds.Topicalagentsincludecreams,ointmentsanddustingpowders.Theseformulationscarrythechosenactiveingredientthroughtheskinbarrierorwoundsoboththeformulationandactiveingredientmustbeappropriateforpenetrationtooccurtothedesireddepth(61).Someagentsmaylimittheireffecttothestratumcorneum,whereasothersmaypenetrateintothedeeperlocaltissues.Regardless,theaimistohaveatargetedeffectontheareaofconcern(55).Despitethepositives,unfortunatelymanyoftheavailabletopicalagentssimplyfailtoperformtoexpectations,or,evenworse,inhibitwoundhealing.Muchworkhasbeendonetofindtheultimatetopicalwoundtherapeuticagentbuttodatethereisnotreatmentpanacea.Anti-inflammatoryandanalgesicagentsOneofthemainstaytreatmentsofequinewoundmanagementisprovisionofanti-inflammatorymedications.This,ofcourse,reducesinflammationbutalsopatientdiscomfort.Inequinepractice,non-steroidalanti-inflammatoriesaretypicallythedrugofchoiceforwoundtherapiesandtheyaretypicallyadministeredsystemically(1)(59).Otheragentssuchasopioidsareavailableforseverecases,butroutineusageisuncommon(1).NSAIDareusedforreductionofinflammationandpainandrepresentrelativelylowcostandeffectivemedicationsthatownerscaneasilyadministerthemselves.Whenusedappropriately,thesemedicationsaregenerallyconsideredrelativelysafe(1).Examplesincludephenylbutazone(1).However,therearesituationswheretheseNSAIDshouldbeavoided,suchasinanimalswithcompromisedrenalhealth(1)orcompetitionanimalsundergoingdrugscreening.Inthesesituations,othermodesofapplicationoralternativetherapiesmaybeconsidered.Whenfacedwithawound,practitionerstypicallyuselocalanaestheticsfordesensitisationoftheareaforthepurposesofdebridementorwoundrepair(1).Howevertopicallocalanaestheticshavealsobeenusedinhumanmedicineforthepurposesofpost-operativeanalgesia,withtheaimofreducingopioidusage(62).However,thelong-termeffectoflocalanaestheticsonwoundhealingisunclear(59).Whilesomestudiesshownonegativeeffectsofjudicioususeoflocalanaestheticsforulcerdebridementinhumans(63),animalmodelshaveshownhigherconcentrationsoflignocaineinhibits
![Page 18: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/18.jpg)
18
epithelialisation(64).Giventhepotentialdownsides,localanaestheticsmaybebestlimitedtoacutepainmanagement.Unfortunatelytopicalformulationsofnon-steroidalanti-inflammatorieshavelimitedavailabilityandtheirformulations,suchasdiclofenac,arenotrecommendedbymanufacturersforuseonopenwounds(65).Topicalcorticosteroidsmaybeutilisedjudiciouslythetreatmentofexuberantgranulationtissue.Inthiscase,topicalcorticosteroidsmaybeappliedandresultindownregulationofthepro-fibroticTGF-β1,ultimatelylimitinglocalinflammationandfibroplasia(4).Whilebothfactorsareimportantinthedevelopmentofexuberantgranulationtissue(4),evidencesuggestscorticosteroidsmayinhibitangiogenesisandepithelialisation(66).Thereforejudicioususeandappropriatetimingisrequired.GiventhelimitedNSAIDsorviablelong-termalternativesavailablefortopicalusemorenovelagentssuchasCBDhavebeentrialled.Inpart,theaimhasbeentoreduceopioiddependenceinhumanmedicine.Thesehaveshownanti-inflammatoryeffectswithpromisingresults(67).Topicalagentsalsoworktoindirectlyreducepatientdiscomfortassociatedwithwoundmanagement.Muchofthediscomfortassociatedwithwoundscomesfrombandagechanges.Minimisingthiscanbeachievedbycreatingamoistwoundenvironment.Thisisalsobeneficialtowoundhealing(1)butimportantlycreatesanon-stickenvironmentandreducestraumatotissuesduringdressingchanges(68).Agentsthatcreateosmoticgradientsinwounds,suchasmanukahoneyachievethisgoal(69)(70).Thereforetheyhavesignificantvalueforthispurpose.AntimicrobialagentsOneoftheprinciplesofwoundmanagementistopreventorreducebacterialloadorresolveinfection.Theefficacyofanytreatmentisreflectedbyareductionincolonyformingunits(CFUs)(59).Mechanicalwounddebridementisencouragedasafirstlinestep,butalonethisisnotalwayseffective(1).Thereforeothermeansshouldbeused,andthismayincludetheuseofsystemic,regionalortopicalantibioticuse.Thedecisiontousesystemicantibioticsismultifactorial.Inhumanmedicine,thetimefromwoundingtopresentationislinkedtoinfectionrates.Intheequinefield,timingisrarelycriticalastheenvironmentandmanagementofhorsestypicallyprecludestheaccidentalcreationofacleanorclean-contaminatedwound(1).Instead,themechanismofwoundingandnatureofthelesionshouldbeconsidered.Forexample,aheavilytraumatisedwoundcreatedwithajagged,soiledobjectorthroughananimalbiteismoreconcerningthanasimplelacerationorsuperficialwoundwithminimalsurroundingtrauma(71).Incaseswithsignificantclinicalconcernexistsorthosewithacurrentinfection,antibioticsareoftenused(1).Thelocationofthewoundalsobecomesimportant.Systemicantibioticsarecommonlyutilisedinwoundsinvolving(orsuspectedtoinvolve)anormallysterilearea,suchassynovialstructuresorbodycavities,ascomplicationsintheseareasoutweigh
![Page 19: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/19.jpg)
19
anydownsidesofsystemicantibioticuse(71).Conversely,anatomicaldifferencesinbloodflowbecomeimportant,asareasthataretraditionallylesswellperfusedmaynotreceiveadequatedosesofsystemicmedications,renderingthemlesseffective(72).Thesystemichealthoftheanimalshouldalsobeconsidered,andanimalswithcompromisedimmunestatusesorseriousunderlyingmedicalissuesmayalsobecandidatesforsystemicantibioticsastheirabilitytohealnormallymaybecompromised(71).Inessence,wherethereisseriousclinicalconcernsystemicallyantibioticsaremorecommonlychosen.Wherepossiblehowever,systemicuseofantibioticsshouldbelimitedinlinewithantibioticstewardshipguidelines.Ifsystemicdeliveryofantibioticdrugsisdeclined,regionaltherapiesmaybeelected.Theobjectofregionallimbperfusionsistodeliverhighlevelsofantibioticstoafocusedregionofconcerntoreducebacterialpopulations.Thisminimisessystemicexposureofthepatienttothedrug(73).Intravenousregionalperfusionsworkontheprinciplethatatourniquetplacedabove,andpossiblybelow,theaffectedareawillisolateitfromsystemiccirculation.Injectionofthechosendrugoccurswithintheisolatedsectionofthelimb,andthistheoreticallyprovideshighlevelsofthedrugtotheaffectedareawhilstlimitingsystemicexposure(73).However,regionallimbperfusionshavedownsides:theproceduretypicallyrequiressedationoranaestheticofthepatientandmayberelativelyexpensivetoperform,especiallywhensystemicdosagesorfrequentperfusionsareutilised(73).Furthermore,arecentreviewofthetechniquedemonstratedaninabilitytoconsistentlyachieveappropriatelevelswithintheareacutofffromthesystemiccirculation,andconverselyaninabilitytoguaranteethepreventionofsystemicexposure(73).Giventhecostandneedforaveterinariantoperformthistechnique,thismethodistypicallyreservedforthetreatmentofsynovialsepsisorforcomplicatedwoundsofthedistallimbs.Ithasimmensevalueinthesesituations.Therearelimitedintra-operativeprophylacticusesforregionallimbperfusionsofantibiotics,whichwillnotbediscussedfurther.(73).Thethirdoptionavailabletoequinepractitionersistheuseoftopicalagents.Inmanycases,systemicorregionalmedicationsaresimplyoverkill.Thereareamyriadoftopicalantimicrobialtreatmentsandlistsoftheseproductsareexhaustive(4).Evidencerelatingtotheuseoftopicalantibioticsisvariedandattimescontradictory.Onestudyfoundthatinfectedlegulcersinhumanmedicinereceivednobenefitfromtopicalantibiotics(74),whereasotherstudieshaveconsideredtheiruseiscritical(75).ArecentCochranereviewinhumanmedicinesuggeststhatthetopicaluseofantibioticsinincisionshealingviaprimaryintentionprobablyreducestheriskofsurgicalsiteinfectionafterwoundrepair,buttheevidenceismoderate(76).Thedownsidesoftopicalantibioticsincludedelayedhypersensitivityreactions(77)but,perhapsmorecritically,thedevelopmentofantibioticresistance(78).Studieshavedemonstratedthatantibioticsthathavebothsystemicandtopicalusesareparticularlypronetothis,andoneexampleofthisinequinepracticeisgentamicin(79).Withantimicrobialstewardshipbecomingincreasinglycriticalandtheevidencefortheirefficacyastopicalagentsbeinglow,topicalantibioticsshouldbereservedforselectedcases.Instead,otheragentswith
![Page 20: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/20.jpg)
20
antimicrobialeffectscanbeused.Thenaturalinclinationistoturntoantisepticssuchasiodineorchlorhexidine.However,availableevidencesuggeststhatinordertoreducebacterialloads,cytotoxicconcentrationsofantisepticagentmustbeused,damaginghealthytissuesduringthisprocess(80).Hydrogenperoxideisanothercommonlycitedagents.Thishasdirectandindirecteffectsonmicrobes.ItdecreaseslocalpH,creatinganenvironmentthatisnotconducivetomicrobialsurvival,butitalsoworksdirectlybyreleasingenzymesthatdirectlydamagethemicrobe(81)(58)(82).However,hydrogenperoxidealsohascytotoxiceffectswithinwoundsbedsandretardswoundhealing(83).Itisthereforenolongerroutinelyrecommendedforwoundmanagementasaresult.Newrecommendationsthereforeadviseagainsttheuseoftheseagentsonwounds(1).Asseen,manycommonagentshavethepotentialtocausesignificantharmtofragiletissues.Thishasledtoinvestigationintoamultitudeofotheragents,suchasmanukahoney(84)ornovelagentssuchascannabidiol(85).Thesetherapeuticsaregenerallylesslikelytodevelopproblemswithresistance,givingthemaddedadvantages(86)(87).Furthermore,topicalagentsoftenhavemultipleothersimultaneousbenefitssuchascreationofamoistwoundbedoranti-inflammatoryeffects(57)(58)(88).OthergoalsThereareamultitudeofagentsavailabletothepractitionerthathavevalueoutsideofthetraditionalanti-inflammatory/analgesicorantimicrobialeffects.Theseactionsmayincluderolestargetingspecificphasesofwoundhealing,ormayhaveplacesinwounddebridement,forexample.Agentsrangefrombiologicalagentssuchasequineamnionorplateletrichplasma,ornaturalagentsorextractssuchascannabidiol,honeytosyntheticagents(89).Topicalagentscanhavefunctionsinwounddebridement.Althoughmechanicaldebridementincommonplaceinequinepractice,itcannotbeentirelyreliedupon.Enzymaticdebridementisavalidadjunctivetherapy.Enzymaticagentsincludestreptokinase,collagenase,ortrypsin.Tobeusedproperly,sharpdebridementmustbeperformedfirstastheenzymaticagentsareincapableofremovaloflargevolumesofnecrotictissue(1).Intheequinesetting,availablyandpracticalityoftheseagentslimittheiruseandasaresulttheywillnotbediscussedfurther.Otheragentssuchasgrowthfactorshavebeenusedtopicallyduringwoundhealingwithspecificgoalsinmind.Listsincludegrowthfactorssuchasplateletrichplasma,TGF-β(89)orVEGF(90).Thesemaytargetspecificphaseswithintheprocessofwoundhealing,andacttoenhancethem.Forexample,inhumandiabeticpatientsVEGFisreduced,andthisreducesangiogenesis.Clinically,thisresultsinimpairedwoundhealing.Giventhis,topicalVEGFhasbeentrialledtocorrectthisdeficiency.Andhasshownpromisingresults(90).Althoughthisisoneofmanyagentsavailable,itdemonstratesthetargetedactionofsomeagents.
![Page 21: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/21.jpg)
21
ConclusionOverall,theaimofanytopicalagentistopromotewoundhealingwithnoorlimitedsideeffects,eitherlocallyorsystemically,andtolimitcomplications.Howeverthereisnotreatmentpanaceaandtherearehundredsoftopicalagentsthathavebeenutilisedinwoundhealing.Thefactthatsomanyoptionsexistsuggestsnoneareperfectineverysituation,anddemonstratestheneedforfurtherresearch.Acompletereviewoftheseagentsisbeyondthescopeofthisthesis,andassuchonlythetwomainagentsofinterest–honeyandcannabidiol-willbediscussedindetail.2.4AsummaryoftheuseofmedicalmarijuanaMarijuana(Cannabissativa),aleafyplantcommonlyutilisedasanillicitdrug,haslongbeenknowntohavetherapeuticbenefits(91).Recentlythepopularpresshasfocusedattentiononitsnumerouspotentialmedicalbenefits.Cannabiscontainsagroupofcompoundsincludingthecannabinoids,theterpenesandthephenoliccompounds(92)(93).Ofparticularinterestarecannabinoids.Thisgroupincludestetrahydrocannabinol(THC)andcannabidiol(CBD).However,over90cannabinoidsaredocumented(94).Thesecompounds,despitesimilarbiochemicalstructures,havedifferentphysiologicaleffects(94).THCmakesupthelargestproportionofcannabinoidcomponentoftheplantandhassocietalassociationsasanillicitdrug.Thisisduetoitspsychoactiveproperties,butitdoesalsohavevalidmedicinalproperties(94).CBDisthesecondlargestcomponentofCannabissativaandthemajorcomponentofhemp(94).Itisnotpsychoactive,anddoesnot,onitsown,affectmotorfunctionormemory(94).In2017,theWorldHealthOrganisationannouncedthatCBDhasnopotentialforabuseordependency(95).InterestinthetherapeuticbenefitsofCBD,whileavoidingthesideeffectsofTHC,hasincreased.Today,mostmedicalmarijuanaapprovalsareforchronicpainconditionsorformusclespasmsufferers(93).ThereisincreasinguseinneurodegenerativeconditionssuchasAlzheimer’s,multiplesclerosis,arthritisorforuseasanadjunctiveanti-nauseatreatmentduringchemotherapyadministration(93)(94).Interestingly,cannabidiolshavealsobeenshowntoexertanti-bacterialeffectsandthereforemayhavearoleininfectioncontrolasantibioticresistancecontinuestoincrease(85).Cannabinoids:MechanismsofactionTheendocannabinoidsystemisacriticalneuromodulatorypathwayfoundinmammals.Itisresponsibleforavarietyofeffectswithinthebody.Thissystemreliesonendogenouscannabinoids.Thisisasystemofenzymesproducedwithinthebodythatareresponsibleforproductionanddegradationofthesecannabinoidsandavarietyofreceptors,primarilyCB1andCB2receptors,onwhichtheyexerttheireffects.Exogenouscannabinoids,suchasthosefoundwithinCannabissativa,exerttheireffectbyinteractionswiththeseCB1andCB2receptors(96).
![Page 22: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/22.jpg)
22
CB1receptorsarefoundpredominantlyinneuronaltissues,includingthebasalganglia,cerebellum,neocortex,hypothalamusandlimbiccortex(91)andalsoincentralandperipheralneurons.CB1receptorsarealsodistributedinthedorsalhornofthespinalcordandwithinimmunecellstoalesserdegree.CB2receptorsareprimarilyfoundintheperipheryofthebodyandinimmunecellsandtissues.Theyexertimmunosuppressiveandinflammatoryactivity.Toalesserextenttheyarealsofoundinthebrain(97).THCisapartialagonistoftheCB1andCB2receptorsalthoughitpreferentiallybindsCB1receptors(98).CBD,incomparison,exhibitsaloweraffinityforthesereceptorsthanTHC.CBDactsasanon-competitiveCB1andCB2receptorantagonist(99).ThisallowsittoactasanentouragemoleculetoTHC.ThisimprovesthesafetyofTHCbycounteractingsomeoftheTHCsideeffects(100)(101)(102)(103)(94).ThisisparticularlyapparentwhentheratioofCBD:THCis8:1orgreater(102)(102).InadditiontothebenefitsCBDhasinthepresenceofTHC,ithasitsownindividualmerits.Firstly,CBDhasanti-inflammatoryeffects.CBDhasaninverseagonisteffectontheCB2receptor(99),andthisresultsinananti-inflammatoryeffectbyinhibitingimmunecellmigration(104).Secondarily,itdirectlyinhibitslipoxygenase(LOX)andcyclooxygenase(COX)(105).LOXandCOXarewellknownmeditatorsoftheinflammatorycascade.CBD’santi-inflammatoryeffectsareclinicallyaremorepotentthanaspirin(106)(107,22).CBDhasalsobeenfoundtoactonglycinereceptors(108).Glycineactsasaninhibitorypostsynapticneurotransmitterofthedorsalhornofthespinalcord,andassuchCBDmayhaveaneffectinchronicpainthathasresultedfrominflammatorystatesorneuropathies.Furthermore,CBDactsasamureceptorligandandhasapositiveallostericmodulatoreffectonmuanddeltaopioidreceptors,suggestingsomeabilitytoenhanceopioideffects(98).CBDhaswidespreadandvariedpositiveeffects:anticonvulsant,antipsychotic,anxiolytic,anti-nausea,neuroprotectiveandanticancereffects(109)(110)(111).CBDandwoundhealingThereisaplethoraoftopicalagentsavailableforthetreatmentofwounds.Thesearealladvertisedasimprovingwoundhealing,eitherdirectlyorthroughindirecteffectssuchasanalgesiceffects,orbytreatinglocalinfections.GiventhehighsafetyprofileofCBD,ithasrecentlybeeninvestigatedandshowspotentialasanexcitingalternativetoothercommerciallyavailabletopicalwoundmedications.SeveralstudieshaveattemptedtodemonstratetheeffectCBDhasonwoundhealing.Thisincludesastudythatexaminedtheeffectofsystemic(specificallyintra-peritoneal)CBDonamiceoralmucosalwoundingmodel(112).Thisgroupdemonstratedasignificantreductioningrossandhistologicalinflammatoryscoresduringtheearlyphasesoftreatment.TheyconcludedthatthetopicalCBDhasapositiveeffectonearlywoundhealing,butthiseffectwaslimitedtotheearlystagesofwoundhealing.Theysuggestedfurtherresearch
![Page 23: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/23.jpg)
23
wasrequiredtoproperlydeterminetheeffectCBDhad,butconcludedthetreatmentwasbothsafeandpromising(112).Theanti-inflammatoryeffectsofCBDonwoundsmayhaveapplicationtoequinepracticebecauseequinedistallimbwoundsarepronetochronicinflammationassociatedwithdysregulatedhealinginthehorse.CBDhasbeenshowntodecreaseinflammationandfibrogenesisaswellaspromotingskinre-epithelialisationinamousemodel(113).InPartCBDdecreasesinflammationdecreasingneutrophilcontent,butmoreimportantlybyhalvingmacrophagecontent.Bydecreasingmacrophagenumbers,thereisadecreaseinpro-inflammatorymediatorsreleasedsuchasinterleukin1(IL-1),interleukin6(IL-6)andtumournecrosisfactoralpha(TNF-α).Overall,inflammationdecreased.Pro-angiogenesisfactorVEGF-αisalsodecreasedwhichreducesgranulationtissuewithinthewoundwithoutalteringneovasculardensity(113).Interferongamma(IFN-Υ)activitywasincreased,andthisfactorispartiallyresponsibleforactivationofmacrophages,promotingphagocytosisandcytokineproduction.Thismayexplainwhy,despiteanoveralldecreaseinwhitecellsnumber,effectivemacrophageactivitywasabletocontinue(113).Keratinocytemigrationwasalsoimproved.(104)Otherstudieshavedemonstratedreductioninfibrosisinmicewoundingstudies(114).TheseresultsfurthersupportapotentialforCBDuseinequinewoundtherapieswherethegoalistoreduceinflammationandfibrosis.CBDalsohasapotentialantimicrobialeffectthatwouldbeusefulasawoundtherapy.RecentstudieshaveexaminedtheeffectofTHCandCBDonmulti-drugresistantstrainsofStaphylococcusaureus,orMRSA(85).Thisgroupfoundexceptionalactivityagainstsomestrainsofbacterialisolates,whichwerecomparabletoorexceedingthatofastandardprescribedantibiotic.(85).Recently,mediaoutletshavereportedsuccessbyanAustralianbasedcompanyinthetreatmentof“superbugs”andbiofilmswiththeuseofCBDimpregnatedproducts.Theseproductswereusedtopically.Accesstoresultsiscurrentlyunavailable.Itisexpectedthatthisareaofresearchwilldramaticallyincreaseinthenearfuturegiventhedevelopmentofantibioticresistance.Inhumanmedicine,painassociatedwithsignificantskinwoundshastraditionallybeenmanagedwiththeuseoftopicalorsystemicopioids.Intheveterinaryindustry,systemicopioiduseiscommon.However,therearesignificantconcernswiththeprolongeduseofopioids.Thereisawell-establishedriskofdependencyorundesirablesideeffectsinthesecases.ThishasgivenrisetotrialswithtopicalCannabidiolasanalternativemeansofmanagingpainassociatedwithskinwounds,suchasthosecausedbyPyodermagangrenosum.Althoughasmallstudy,onetrialdemonstratedclinicallysignificantreductionsinpainscoresintwooutofthreepatientswithpositiveopioidsparingeffects(67).Aclinicallysignificantreductionisgenerallyconsideredtobea30%orgreaterreductioninpainscore,asperinternationalguidelines(115).Marijuanaextractsmayhavevalueinwoundhealing,butclinicalbenefitsarelargelyunknown.CBDinveterinarypractice
![Page 24: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/24.jpg)
24
Todate,literatureregardingtheuseofCBDinanimalsituationshasfocussedonexperimentalanimalmodels.ThereisextremelylimiteddataonCBDuseinveterinaryclinicalcases,withtheexceptionofthoseexaminingaccidentaltoxicity(116)(117)(118).However,thereissomereporteduseofCBDinthemanagementofglaucoma(119)(120)aswellasinthefelinedermatologyspecialtyinthemanagementofeosinophilicgranulomas(121).PublicationontheuseofCBDinthepalliativemanagementofdogsundergoingoncologicaltreatmentisalsoavailable(122),whichisnotsurprisinggiventhewell-describeduseofCBDinhumanoncologicalpatients.NopublicationsarecurrentlyavailablefortheuseofmedicalMarijuanainhorses.2.5AsummaryofthetherapeuticuseofhoneyThetherapeuticuseofhoneyasawounddressingdatesbacktothetimeoftheancientEgyptians.Ithasbeendocumentedinastaggering5000of9000recordedtherapies,suggestingaheavyrelianceontheproductthroughouthistory(123)(124).TherearealsoreportsofhoneybeingutilisedformedicinalpurposesinChinese(123),Greek(125)(126)andIslamiccultures(124)(123).Theuseofhoneythenwanedwiththeproductionofantiseptics.Theincreaseinresistancetoantimicrobialdrugshasledtoarenewedinterestinhoneyandrigorousscientificresearchhassupporteditsplaceinmodernmedicine.Recentresearchhaslargelyfocusedontheantimicrobialpropertiesofhoneyhoweverthereisanemergingbodyofevidencethatsuggestshoneymaydirectlymodulatethehealingprocess(127).Thisnewresearchalsoindicatesthatnotallhoneyvarietalsbehaveequallyandtheprofilesofthehoney’sbioactivecomponentschangethisbehaviour(128).Thereareamultitudeofvarietalsavailablefromgenerictablehoney,tothemorespecifichoneysproducedfrommanukaorMelaleucaplantspecies.CommonpropertiesofallhoneysAllhoneysarecomposedtoamixtureofsugars,aminoacidsandothersubstances.Theytypicallyhavealowwatercontent(129).ThepHofmosthoneysrangesfrom3.2to4.5,butcanextendoutto3.2to6.1(129)(58)Thisacidityisduetothegluconicacidpresentandwillcontributetotheantimicrobialeffectsofhoney(130).AlowpHenvironmentcandirectlychangetheshapeofbacterialcells(58).Thishasbeenshown,underscanningmicroscopy,tocausecelldisruptionandthelysisofPseudomonasaeruginosa(131).Furthertothis,bacterialproteaseactivityisreducedinlowpHenvironments(132).Proteasesplayrolesinthedestructionofcytokines,growthfactorsandextracellularmatrixandtheiractivityincreasestissuetraumaandretardshealing.Thisprovidesantimicrobialpropertiesbycreatinganosmoticgradientandsubsequentbacterialdehydrationandosmoticstress(127).Anosmoticgradientisalsocreatedinthewoundbed,asthereisafluidshiftfromsurroundingtissuesandvasculature.Thiscreatesamoistwoundenvironmentandsuppliesnutrientstothewound,promotingautolyticdebridementandenhancinghealing(69)(70).Currentrecommendationspromotemoistwoundenvironmentsforthesereasons(1),butalsobecausetheyminimisetraumatodelicatenewtissuesduringbandagechangesby
![Page 25: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/25.jpg)
25
creatinganon-sticksurface(68).Clinicallythismayalsoreducepainanddiscomfortexperiencedbythepatientduringdressingchanges.Mosthoneysalsocontainglucoseoxidaseinlowconcentrations(129).Glucoseoxidaseactstoconverttheglucosewithinthehoneyintogluconicacidthatcausesasubsequentreleaseofhydrogenperoxide.Hydrogenperoxideisawell-knownantimicrobialsubstance(58).IthasadirectactiononmicrobesbutalsoanindirectactionthroughadecreaseinpHinhibitsmicrobesandassociateddamagingenzymes(81)(58).Thiscreatesanenvironmentthatisnotconducivetobacterialsurvival(82).Baselevelsofhydrogenperoxideactivityvarytremendouslybetweenstrainsofhoneybasedonenvironmental,plantandinsectfactors(133).Levelsaretypicallybelowdetectablelimitsinundilutedhoney(134)(135).However,whenhoneyisdilutedtheactivityofglucoseoxidaseincreasesandthisresultsinincreasinglevelsofhydrogenperoxide.Dilutionisunavoidablethroughtheadditionofawoundexudatefluid,andatdilutionsof30-50%,antimicrobialactivityisoptimised(135).Unfortunately,processingandstorage,pollenandsomebacteriamayinactivatehydrogenperoxideandthereforetheantimicrobialactionofhoneyduetohydrogenperoxideis,atbest,variable(136)(133)(137)(138).Generichoneysalsoofferanti-inflammatoryproperties.Thisoccursthroughareductionintheactivityofimportantcytokinesandfactorswithinawound.Thereisareductioninsomeofthemajorpro-inflammatorycytokines,includingTNF-aandinterleukin8(IL-8)(86)aswellasaninhibitionofMMPproduction(139)andreductioninCOXactivitythroughflavonoids,includingchrysin(140).Furthermoremacrophageproductionofnitricoxide(NO),apotentinflammatoryagent,isreduced(82)(141).Honeyhasbeenshowntobetterregulatetheinflammatoryresponsewithinthewoundaswell,byimprovingtheinflammatoryresponseofleukocytesthatproducethecytokinesthatregulateangiogenesisandfibroblastproliferation(142)(143).Inhorseswithaweakandsuboptimalinflammatoryresponse,thismayproveclinicallyrelevant.Honeyhasalsorecentlybeenusedforpreventionofbiofilmsinwounds.Topicalapplicationofgenerichoneyhasbeenshowntoeffectivelypenetrateintothebiofilm,largelyduetothesugarcomponent,whichlimitsthe“swarming”abilityofbacterialcolonies(144).Thisinturndisruptstheabilityofthecolonytoformabiofilm(145).Biofilmslimitantimicrobialpenetrationandreducethesuccessoftreatinginfections,aswellastrappinginflammatorymediatorsintheregion(49).Theabilitytotreatbiofilmsisbecomingevenmoreimportantwiththedevelopmentofantimicrobialresistance.Thereisnodocumentedantimicrobialresistancetohoney.Thisislikelyduetothemultiplepathwaysinwhichhoneyhaseffectsonbacteria(146).Ingeneralmicrobesthataresporeformingoryeastsaretheoreticallymorelikelytoberesistanttohoneybutstudieshavedemonstratedefficacyofmosthoneysagainstbacteriaisolatedfromwoundsinhorsesinvitro(146).Honeyhasbeenshowntobeeffectiveatstoppingmicrobialgrowthinvivoatconcentrationsof16%orless,evendownto4%insomecases(146).Otherpublisheddatahasdemonstratedinvitrominimuminhibitoryconcentrations(MIC)ofhoney
![Page 26: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/26.jpg)
26
againstPseudomonassppat15.7%andStaphaureusat2.8%(87).Thisislowerthantheexpectedhoneyconcentrationsinawoundinvivo,eveninhighlyexudativewounds(146).Furtherstudieshaveconfirmedthatselectingforhoneyresistantmicrobialpopulationsistheoreticallypossible,butunlikely(86)(87).Thisgroupconcludedthat,inpractice,highconcentrationsofhoney(over80%)areutilised,andthereforetheyconsideredclinicalfailureofhoneyandtheemergenceofresistanceunlikely(87).Dailydressingchangesmaybeonewaytoovercomepotentialproblemsinhighlyexudativewounds.ManukahoneyTheLeptospermumspeciesofplants,morecommonlyknownasthemanukafamily,isfoundprimarilyinAustraliaandNewZealand.Mosthoneyvarietalsstudiedhavebeenproducedfromthemanukabush(L.scoparium)ofNewZealand.Honeyfromtheseplantshasadditionalbeneficialproperties,inparticulargreaterantimicrobialactivity,comparedwithgenericcounterparts(147,148).Manukahoneyalsohastheabilitytomodulatewoundhealingdirectly(57).Thesepropertieshaveledtoacommercialisationoftheproductfortherapeuticuse.Manukahoney,incontrasttogenerichoney,displaysminimalhydrogenperoxideactivityandyethasexceptionalantimicrobialproperties(58)(88).Further,hydrogenperoxidecontentdoesnotincreasewithdilution(149).Forsometimethereasonbehindthisexceptionalantimicrobialactivitywasunknownsowastermedthenon-peroxidaseactivity,orNPA,ofmanukahoney.In2008laboratoryanalysisidentifiedthepresenceofmethylglyoxal(MGO)inhoneyproducedfromLeptospernumspecies(150)(88)(58).MGOispresentinhighconcentrationsintheflowerofthemanukabush,andisproducedfromdihydroacetate(138).MGOhasbeenshowntohaveantimicrobialeffectsmediatedthroughthedownregulationofautolysin,anenzymeimportantforcellulardivisionandcellwallregulationingrampositivebacteria.Alterationsinthecellwallregulationcauseafailureofcelldivisionanddysregulationofthecellwall(151).Ingram-negativebacteria,MGOseemstoaffecttheexpressionofgenesthatregulatecellwallstability.Theoutcomeiscelllysis(152)(153).Duringstorage,concentrationsofdihydroxyacetateslowlydecreasewhilstconcentrationsofMGOincrease.Thisactivityisusedtodeterminetheuniquemanukafactor,orUMF,ofthehoney(88)andaimstoaccuratelyreflecttheantimicrobialactivityofthespecificbatchofhoney(154).Theratingcomparestheantimicrobialactivityofabatchofhoneyagainstthatofastandardantisepticagent(phenol)againstStaphylococcusaureus(88)(155)(156).UMF-4hasminimalantimicrobialeffect,UMF5-9hasasmallantimicrobialeffectbutnotatlevelsthatareconsideredtherapeuticwhilstUMF-10-15isconsideredclinicallyuseful,andUMF16-30hasexcellentantimicrobialefficacy(157).However,manukahoney’santimicrobialeffectsarenotsimplyduetothepresenceofMGO.ThereisnotalinearcorrelationbetweenMGOconcentrationsandantibacterialeffects(154).Thereislikelytobeotherundiscoveredbioactiveagentscontributingtotheantimicrobialactivityofmanukahoney,anditislikelythatthesecompoundsactsynergisticallytocreateasuperiorproduct.(158)(159).Itisimportanttonote
![Page 27: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/27.jpg)
27
theUMFratingonlyreflectstheantimicrobialactionsofmanukahoneybearsnoreflectiononitspotentanti-inflammatoryproperties.Biofilmsinequinewoundsarecommonandhavesimilarbacterialdiversitytothosefoundinchronichumanwounds(160).Experimentalmodelshavesuggestedthisisparticularlyaprobleminthedistallimbofthehorse(51).Manukahoneyhasbeenshowntobemoreeffectivethangenerichoney,inpreventingandeliminatingbiofilmsproducedbyStaphylococcusaureus(161).IthasbeenshowntonotonlyimpairPseudomonassppbiofilms,buttocompletelyeliminateinfectionswhenappliedatconcentrationsof64%and80%honey.Honeyistypicallyappliedatconcentrationsof100%,butclinicallywoundexudatewilldilutethehoneytolowerconcentrationsinthewound(162).Itwouldappearthatconcentrationsofmanukahoneytoeliminateestablishedbiofilmsarehigherthanthatrequiredtopreventbiofilms(161).Furthermore,studieshaveshownmethylglyoxal,isolatedfrommanukahoneyandusedaloneatconcentrationsequivalenttothatfoundinmanukahoneyisineffectiveagainstPseudomonassppbiofilms(145).Thishighlightsthatmethylglyoxalactssynergisticallywithotherbioactivecomponentsinmanukahoneytodeliverantibacterialandanti-biofilmeffects(145)(161)..Manukahoneyalsohastheabilitytomodulatewoundhealingdirectlyandhasbothantiandpro-inflammatoryeffects(57)deliveredbyregulatingtheinflammatoryresponseinthewoundandenhancingtheproductionofcytokinesthatregulatethetissueproliferationphaseofhealing(57).Ithasbeenspeculatedthatmanukahoneydoesnotsimplyjustupordownregulateinflammation,butratherenhancestheinflammatoryresponseintimesofalow-gradeinflammatorystate.Converselyduringahigh-gradeinflammatoryresponse,suchasduringanactiveinfection,itcanbedownregulated(149).Toll-likereceptor4(TLR-4)isanintegralpartofthisprocess.TLRshaveimportantrolesinthesignallingandultimateoutcomeoftheinnateimmunesystemastheyformagroupofpatternrecognitionreceptors(PRRs).Theyrecognisemicrobialmolecularpatternsandthensignal,vianuclearfactorκβ(NF-κβ),interferonregulatoryfactor(IRF)ormitogenactivatedprotein(MAP)kinases,toguidetheimmuneresponse(163).Activatedmonocytes,viatheNF-κβpathway,produceanarrayofcytokines(149).TheseincludeIL-1β,IL-6andTNF-α,allofwhichareimportantpro-inflammatorycytokines(164)andhavebeendemonstratedtobecriticalinresolvingwoundinfectionsandstimulatingrepair(142).Previousstudieshavespeculatedthathoneycontaminatedwithmicrobesmaybepro-inflammatory(165),asthepresenceofmicrobesandtheirendotoxinshaveastimulatoryeffect.Contaminationisplausibleviathehoneybeeitselforrawnectar(166).However,amorerecentstudyhasdemonstratedthatthereisaspecificbioactiveisolatecontainedwithinhoneythathasdirectstimulatoryeffectsontheTLR-4receptor.Thiscomponenthasbeenisolatedbasedonmolecularweight,andisa5.8kDamoiety(166).Furtherstudiesarecontinuingtocharacterizethisisolate.Importantly,thisstudyfoundnoassociationbetweenUMFandtheinflammationmodulatingeffectofmanukahoney(166).OtherstudieshavefoundchangesinIL-8production,amajoranti-inflammatorycytokine(1),invitro(167)(168)Furthertothese
![Page 28: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/28.jpg)
28
recentdiscoveries,manukahoneyhasbeenfoundtoinhibittheexpressionofCOX-2andalsoreducetheproductionoffreeoxygenradicals(169)(170).Additionalresearchisrequiredinthisareatocompletelyclarifytheanti-inflammatorymechanismsofmanukahoney.TeaTree(Melaleuca)honeyRecently,researchersinAustraliahavediscoveredthathoneyderivedfromtheTeaTreehashealingproperties.TheAustralianTeaTree,orMelaleucaalternifolia,isusedtoproduceTeaTreeoilandisfoundonthenortheastcoastofNewSouthWales(171).TeaTreeoilhasawell-establishedscientificbackgroundforuseasamedicinalagent(172)(173).However,verylittlepublishedresearchontheuseofhoneyfromtheAustralianTeaTreeasamedicinalagent.OneprojectcommissionedbyaninvestmentgroupandconductedbyresearchersatSouthernCrossUniversityhasindicatedthatMelaleucahoneyhasstrongandimmediateanti-oxidantandanti-microbialproperties.Thisprojectconcludedthattheantimicrobialeffectswereimmediateanddidnotoccurinthepost-harveststage,asitdoeswithmanukahoney.Limitedspecificdetailsofthefindingsarecurrentlyavailable(174)andthisconfirmsfurtherresearchiswarranted.2.6ModelsofwoundhealinginthehorseModelsofwoundhealinginthehorsehavehistoricallyinvolvedsurgicallycreatedfullthicknesswoundsonthedorsomedialaspectofthemetacarpusormetatarsus.Thesestudieshavecreatedwounds,varyingbetween2cmx2cm,2.5cmx1.5cmand2.5cmx2.5cminsize,undershort-termintravenousanaesthesia.Thesemodelshaveevolvedovertimewiththeunderstandingofwoundhealinginthehorse.Initiallylimbswerekeptbandaged,forthepurposesofcontinuingcontactwithtopicalagents,whichresultedonaprotractedbandagingperiod(175).Overtime,withexpandingknowledgeofwoundhealing,bandagingbecameactivelydiscouragedpastday12afterwounding(44).Thislatterstudythatdemonstratedthebenefitsoflimitingbandagingusedanon-contaminatedwoundmodelwheresurgicallycreated2.5cmx2.5cmwoundsonthelowerlimbwereeitherbandagedorleftunbandaged.Bandagedlimbswerechangedregularlyuntilhealingwascompleted.Unbandagedlimbshadalightbandageplacedforthefirst24hoursforthepurposesofhaemostasis,butwerethenleftunbandagedforthedurationofthestudy.Itwasfoundthatbandagingthewoundssignificantlyprolongedthephaseofretraction,andthatabandagedwoundrequiredregularinterventionforthecontrolofexuberantgranulationtissue.Incomparison,unbandagedwoundshealeduneventfullywithnointervention.Totaldaystohealingremainedcomparablebetweenthetwogroups,butitisvalidtoassumethattherepeatedinterventionfortheexuberantgranulationtissueinbandagedlimbshastenedthehealingprocessandaddedanotherleveloftreatment.Hadnointerventionoccurred,itislikelythathealingwouldhavebeendelayed(44).Followingthesefindings,modelschangedtolimitbandagingtotheearlyphasesofthetrialsanddiscouragedbandagedbeyondday12,approximatelythepointatwhichgranulationtissuebedsstarttobecomeexuberant(44)(176).
![Page 29: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/29.jpg)
29
Initialmodelsalsocreatedwoundsasepticallyundersurgicalconditions(44)(177).However,theclinicalrelevanceofthesemodelswasdebatableastheyfailedtoreplicatethetypicalclinicalsituationofgrosscontaminationoflowerlimbwounds.Thisledtothedevelopmentofcontaminatedwoundmodels,wherefreshfaeceswereappliedtothesurgicallycreatedwoundsforthefirst24hoursafterwounding(176).Instudiesutilisingcontaminatedmodels,thewoundsexperiencedatransientincreaseinbothaerobicandanaerobicbacterialcounts.Thisincreaseinbacterialcountdidnotresultinaclinicalinfection.Further,thesestudieschangedthepatternofhealingcomparedtoanuncontaminatedwound.Contaminatedwoundscontractedmoreandhealedfasterthanuncontaminatedwounds.Theauthorsspeculatedthatcontaminationofawoundimprovesandstimulatesthequalityoftheearlyinflammatoryphasethatistypicallysuboptimalinwoundsofthedistallimbofthehorse.Manukahoneyhasbeenwellstudiedinsecondintentionhealingofwoundsofthedistallimbofthehorse,usingcontaminatedanduncontaminatedwoundmodels.Incontaminatedmodels,manukahoneyhasbeendemonstratedtolimittheinitialphaseofwoundretraction,althoughsimilarbutlesspronouncedeffectsareseeninuncontaminatedmodels(176)(15).WhileUMF20manukahoneyhaswellestablishedantibacterialproperties,severalstudiesinthehorsehavebeenunabletodemonstrateadirecteffectonbacterialcounts.However,moststudiessuggesttheprimarymodeofactionofmanukahoneyonwoundhealingisthroughitsantibacterialproperties(20).ManukahoneyisalsoreportedtohavedirectinflammatorymodulatingeffectsmediatedthroughtheactionofToll-likereceptor4onneutrophils(20).Ultimately,theoveralltheactionofUMF20manukahoneyappearstopromoteavisiblyandhistologically,morematurebedofgranulationtissueearlierinthehealingprocess.Itwouldappearthebeneficialeffectsofmanukahoneyoccurintheinitial21daysfollowingwounding(176).FurtherstudiescomparedthewoundhealingpropertiesofUMF20manukahoneywitha66%UMF20manukahoneygelcomposite,andcontrolwoundsincontaminatedanduncontaminatedmodels.TheUMF20gelwasmadebycombiningthehoneywithawaterbasedgellingagenttoimprovecontactwiththewound..Theresultsshowedthat66%UMF20manukahoneygelwasaseffectiveaspureUMF20manukahoneyinpromotingsecondintentionwoundhealing(60).Consistentwithpreviousstudies,thisstudyconcludedthatmostofthebenefitsofmanukahoneywerefoundinlimitingwoundretractionintheinitialperiodafterwounding,buttherewasasmallbeneficialeffectonwoundstreatedwithmanukahoneygelthroughouthealing.Theauthorssuggestedtheremaybeclinicallybeneficialeffectsofapplying66%UMF20gelthroughouthealinginlarge,heavilytraumatisedwoundsthatoftenconfrontpractitionersinthefield.Dilutinghoneywithawater-basedgelreducestheneedforbandagestomaintaincontactbetweentheactivetopicalagentandthewound,reduceswastageandtheriskofexuberantgranulationtissuefromprolongedbandaging.Further,theabilitytodilutethehigherratedUMFmanukahoneymayreducethecostoftreatmenttotheclient.
![Page 30: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/30.jpg)
30
Thenextstageofinvestigationwentontoquantifyantibacterialeffectsandimprovementsinsecondintentionwoundhealingfollowingapplicationofmanukahoney(20).A66%compositegelofUMF20manukahoneywasused,basedontheprevioustrials.Thisstudyfailedtodemonstrateasignificantreductioninbacterialcountsafterapplicationofhoneybutdidconfirmthatcontaminationwithfaecesresultedinhigherinflammatoryscores.Theauthorssuggestedtheshort-termapplicationoffaecesasawoundhealingmodelisinsufficienttocreatecontaminationandprovidesamodelmorerepresentativeofaclinicalsituationandsuggestedthatthecomplexityofthestudydesignmayhavelimiteddetectionofanti-bacterialeffects.Bothwoundstreatedwithhoneyandthosecontaminatedwithbacteriademonstratedareductionininflammatoryscores,andcontaminatedwoundshadlowerinflammatoryscoresthanuncontaminatedwounds.Histologicallytherewasimprovedangiogenesis,fibrosisandcollagenorganisationinmanukahoneytreatedwounds(20).However,manukahoneyhadnoeffectonthetemporalexpressionofTGF-B1orTGF-B3(20)(19).MoststudieshaveinvestigateddilutedorpureUMF20manukahoneybasedontheknowledgethathigherUMFratedhoneyhadmorepotentantibacterialpropertiesandthiswaslikelytobeassociatedwithimprovedwoundhealing.However,UMF20isexpensivecomparedtolowerUMFmanukahoneyandgenerichoney(178).FurthermoreitislikelythatthepotentantibacterialpropertiesofhigherUMFmanukahoneyisnotalwaysnecessaryinthetreatmentofsomewoundswherethemoregenericpropertiesofhoneymaybesufficient.Onthisbasis,astudyusinganuncontaminatedequinedistallimbwoundhealingmodelwasperformedcomparingUMF20manukahoneytoUMF5manukahoneyandastoreboughttablehoney.Thisstudyelectedtouseanon-contaminatedmodeltoreducetheantibacterialeffectsofUMF20ofmanukahoneyandevaluatethemoregenericeffectsofhoneyandthereportedinflammatorymodulatingeffectsofmanukahoney.InthisstudyUMF20manukahoneyshowedonlymodestimprovementsinoveralltimetohealing.Whencomparedtotheeffectsfoundincontaminatedmodelsofequinewoundhealing,thisimprovementwassmallsuggestingthattheantibacterialeffectsofmanukahoneyareimportantinwoundhealing.(20).Therewerenosignificantdifferencesinwoundhealingvariablesbetweengenerichoney,UMF5andsalinetreatedcontrolwounds.Mostgenericstoreboughthoneyundergoesheattreatmentduringprocessingwhichreducestheactivityofglucoseoxidase.Furthermore,prolongedstoragealsoseesareductioninglucoseoxidase(137).Basedontheresultsofthisstudygenericstoreboughthoneycannotberelieduponasatherapeuticinsecondintentionhealing.WhilethetherewasnosignificantdifferencesinwoundhealingvariablesbetweenwoundstreatedwithUMF5manukahoneyandthosetreatedwithgenerichoneyorsalinetreatedcontrolstherewasatrendtowardsimprovedhealing.UMF5manukahoneyissuggestedtohavelittleornoantibacterialactivitybutmanukahoneydoeshavetheabilitytomodulatetheinflammatoryresponseandwhiletheantibacterialactivityofmanukahoneyisratedastheUMF,theanti-inflammatoryactivityisnotrated.ItispossiblethetrendtowardsimprovedwoundhealingvariablesseenbetweenUMF5manukahoneyandthoseof
![Page 31: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/31.jpg)
31
generichoneyandsalinetreatedcontrols,atleastinpart,reflecttheanti-inflammatorypropertiesofmanukahoney.WhilethestudyconcludedthatUMF20showedimprovementinwoundhealingtheauthorsconcludedthathistologywouldbehelpfultodistinguishwhetheranydifferencesinwoundhealingbetweentreatmentgroupsinthisstudyandcomparethesetopreviousstudies.Inallthesestudieswoundswerephotographeddigitallyonceweekly.Animageanalysissoftwareprogram(ImageJ)wasutilisedtoanalysethephotographsbeforestatisticalanalysisoccurred.Thisprovedtobeareliablemeansofmonitoringwoundhealing.(20)(176)(60)(178).Thecontaminatedwoundmodel,withlimitedbandaging,hasprovedtobeareliableproducerofstatisticallysignificantresults.
![Page 32: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/32.jpg)
32
CHAPTER3:APILOTSTUDYINTOTHEEFFECTSOFTOPICALTREATMENTOFCANNABIDOLONSECONDINTENTIONHEALINGOFEQUINEDISTALLIMBWOUNDS3.1IntroductionThepurposeofthisstudywastoinvestigatethepotentialforCBDextracttomodulatesecondintentionhealingofdistallimbwoundsinhorses.Specifically,theaimwastodetermineifa1%CBDextractcombinedwithUMF5manukahoneyasacarrierwoulddeliverabeneficialeffectonsecondintentionwoundhealinginacontaminated,distallimb,woundmodelinhorses.UsingUMF5manukahoneyasthecarrierintheCBDpreparationwasattractivetoinvestigatethepossibilityofanysynergismbetweenmanukahoneyandcannabidiolthatwouldofferanovelnaturalproductforuseinequinedistallimbwounds.ThehypothesiswasthatthecombinationofUMF5manukahoneyandcannabidiolwouldimprovesecondintentionwoundhealingvariablesincontaminated,equinedistallimbwounds
3.2Materialsandmethods
SixadultStandardbredhorses(3geldings,3maresagedbetween3and10years)withoutevidenceofwoundsorscarsontheirforelimbswereusedinthestudy.Theinstitution’sAnimalCareandEthicsCommitteeapprovedthestudy.
Oneweekpriortothesurgerythehorseswereweighed,identifiedwithanumberedcollarandtreatedwithananthelmintic.Theywerehousedinpairsingrassyardsforthedurationofthestudy.Lucernehaywasfedat2.5%bodyweightindividedfeedsdailyandfreeaccesstowaterwasavailablethroughoutthestudy.WoundcreationEachhorseunderwentaclinicalexaminationonthemorningofsurgery.Thedorsalaspectsofbothmetacarpiinallhorseswereclipped.A14Gcatheterwasplacedintheleftjugularvein,themorningofsurgery,afterasepticpreparationandlocalanaesthesiaofthesite.Eachhorsereceivedasingledoseofphenylbutazone(2.2mg/kgIV)andtetanusprophylaxispriortosurgery.Horsesweresedatedwithxylazinehydrochloride(1.1mg/kgIV)andanaesthesiawasinducedwithdiazepam(0.1mg/kgIV)andketamine(2.2mg/kg).Anaesthesiawasmaintainedusingtotalintravenousanaestheticagents(TripleDrip).
Allwoundswerecreatedonthesameday.Theskinoverthemetacarpiwasnotasepticallyprepared.Atotaloffivefullthicknessskinwounds(2.5cmx2.5cm)werecreatedonthelimbtoreceivethethreewoundswasrandomlyassignedbyblindlypullingthehorsenumberandthetreatmentprotocoloutofahat.Thewoundsweremademedialtotheextensortendonsandwereevenlyspacedbetweenthecarpusandthefetlock.Woundswerecreatedbymakingafullthicknessskinincisionaroundastandard,flexibletemplateusingascalpel,andtheskinwasremovedwithsurgicalscissors.Twogramsoffreshfaeces
![Page 33: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/33.jpg)
33
collectedfromahorsethatwasnotincludedinthestudywasplacedoneachwound,andeachwoundwasindividuallybandaged.Thebandageconsistedofalowadherent,absorbentdressingcuttosizetopreventcrosscontamination(Melolin,SmithandNephewMedicalLtd,HullEngland)coveredwithasoftgauzeroll(EasifixK,BSNMedical,Hamburg,Germany)andcompressedunderanelasticadhesivetape(TensoplastVet,BSNMedical,Hamburg,Germany).Thehorseswereallowedtorecoverunassisted.
WoundtreatmentsBandageswereremoved24hafterwoundcreationandthefaecesrinsedoffthewoundsusingsterilesaline.Thewoundsonthelegwithtwowoundsweretreateddailywitheither2mlofUMF5manukahoney(carrier),(ComvitaAustraliaPtyLtd,Brisbane,Australia)or1mlof1%CBDextract(equivalentof10mgCBD)in2mlofUMF5manukahoney(CBD).Thewoundsonthelegwith3woundsweretreatedwith2mlof0.9%sterilesaline(saline),2mlofUMF20manukahoney(UMF20),(ComvitaAustraliaPtyLtd,Brisbane,Australia),or2mlUMF5manukahoney.The1%CBDextractwasmixedwithacarrier(UMF5manukahoney)toprovideasimilartreatmentvolumetooptimisecontactwiththewound.Thetreatmentallocationoneachlegwaspredeterminedsothattreatmentsoneachlegwereevenlydistributedacrossallwoundsandallhorses.Treatmentswererandomlyassignedbypullingthehorseidentificationandtheassignedtreatmentprotocolforeachlegrandomlyoutofahat.Aftertreatment,woundswereindividuallybandaged,asdescribed,topreventmixingoftreatments.Woundswerebandagedafterwoundcreationandforatotalof13daysandbandagedwerereplaceddaily.Treatmentwasapplieddailyfor12daysunderabandage.Onday13bandageswereremovedandwoundswereleftopenandtreateddailyforatotalof42days.WoundmeasurementsDigitalphotographsofthewoundwereobtainedondays1,7,14,21,28,35,and42afterwoundcreationandwoundsweremeasuredusinganimageanalysissoftware(ImageJ,USNationalInstitutesofHealth,Bethesda,USA).A2.5x2.5cmtemplate(6.25cm2)wasplacednexttothewoundasastandardreference.Theareaofthewoundswasmeasuredthreetimesandtheaveragecalculatedtoproduceasinglemeasureforeachwoundforeachmeasurementday.Theareaofthegranulationtissue,notincludingtheadvancingedgeofepitheliumoneachsideofthegranulationbed,wasmeasured.Overalltimetocompletehealingwasrecorded.Woundswereconsideredcompletelyhealedwhengranulationtissuewasnolongervisible.Overallrateofwoundhealing(cm2/day)wasdeterminedbydividingthewoundareaonday1bythetotaldaystocompletehealing.StatisticalanalysisAgenerallinearmodelwasusedtoanalysethedata,witheachhorsehavingmultiplemeasurementsovertimeafterwoundcreation.Themodelincludedfixedeffectsoftreatment(saline,carrier,UMF20,CBD),day(1,7,14,21,28,35,42),leg(left,right),positiononleg(top,middle,bottom)andtheinteractioninvolvingtreatmentandday.Arandomeffectwasenteredforeachhorseto
![Page 34: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/34.jpg)
34
accountforcorrelationsbetweenmeasurementsmadeinthesamehorse.Residualsfromthefinalmodelwereinspectedtocheckmodelassumptions.Summaryoutcomemeasureswerederivedatthelevelofeachwoundforeachhorsetorepresenttotaldaystocompletehealing,andoverallhealingrate(changeinwoundareaperdayfromday1tocompletehealing).Separategenerallinearmodelswereusedtoanalysetheseoutcomesusingthesameapproachasdescribedabove.Significanteffectsinthemainmodelwerethensubjectedtopairwisecomparisonsofestimatedmarginalmeansasfollow-uptests,usingstandarderrortermsderivedfromthegenerallinearmodel.Allfollowuptestsassociatedwithsignificantunadjustedp-valueswerethenadjustedusingtheFalseDiscoveryRateapproachtocorrectforriskofelevatedtype1errorduetomultiplecomparisons.Theanalysiswasfirstrunwithwoundstreatedwiththecarrier(UMF5manukahoney)onseparatelegsincludedasseparatetreatments.Initiallythiswasrunwiththewoundstreatedwiththecarrieridentifiedasleftorright.TheanalysiswasthensubsequentlyrunwithwoundstreatedbythecarrierbeingidentifiedasipsilateralorcontralateraltothewoundtreatedwithCBD.TheseanalyseswereruntodetermineiftherewasanylocaleffectofCBDonhealing.Theseanalysesshowednodifferenceinmeanwoundareaonanytreatmentdaybetweenanyofthetreatmentgroupssothemeanwoundareasofallthecarrierwoundswerecombinedforthefinalanalysis.AnalysiswereperformedinSTATA(StataDataAnalysisandStatisticalSoftware,StateCorp,LP,CollegeStation,TX,US)usinganalphathresholdof0.05.3.2ResultsAllhorseswereclinicallyhealthythroughoutthetrial.Therewasnoevidenceoflamenessorswellingandnowoundsdevelopedexuberantgranulationtissue.Horse#4wasobservedtointerferewiththebandagecoveringonewoundandthewoundinquestionappearedsubjectivelylarger.Therewasnodifferenceinwoundareabetweenanyofthewoundonday1followingwoundcreationbeforetreatmentcommenced.Thegeneralpatternsofhealingweresimilaracrossalltreatmentgroups(Figure1).Therewasnodifferenceinthedailymeanwoundareabetweenanyofthetreatmentsonanyofthetreatmentdays.
![Page 35: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/35.jpg)
35
Figure1:Plotofmeanwoundareaforeachgroupoverthe42daysofthestudy.Barsrepresent95%confidenceintervals.Therewasnochangeinwoundareaforanyofthewounds,irrespectiveoftreatment,betweendays1and7.Afterday7,thereweresignificantdifferencesinmeanwoundareaovertimewithineachtreatmentgroup.Thedailymeanwoundareasfordays14to42weresignificantlysmallerthanday1and7meansinalltreatmentgroups(P<0.05).Inalltreatmentgroups,dailymeanwoundareafordays21to42weresmallerthantheday14mean(P<0.05).Dailymeanwoundareafordays14to42weresignificantlysmallerthanthemeanwoundareaonday7(P<0.05)foralltreatmentgroups.Beyondday21therateofreductioninwoundareaappearedtoslowandcomparisonsofmeanwoundareawithinanyonetreatmentgroupproducedsignificantresultsinsometreatmentgroupsandnon-significantresultsinothertreatmentgroups.Therewasnodifferenceinthemean(±SE)overallhealingrate(cm2/day)betweenanyofthetreatmentgroups(saline:0.108±6.5;carrier:0.113±0.006;UMF20:0.100±0.008;CBD:0.111±0.008).Therewasnodifferenceinthemean(±SE)totaldaystohealingbetweenanyofthetreatmentgroups(saline:84.9±0.008;carrier:83.2±5.0;UMF20:88.5±6.8;CBD:84.4±6.7).Woundareawithhorse#4omittedHorse#4wasobservedtohaveinterferedwiththebandagecoveringonewoundandthewoundareameasurementsappearedtobeimpacted(Figure2).
0
1
2
3
4
5
6
7
8
9
10
11
12
Area
(cm
²)
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44Day
Saline CarrierUMF20 CBD
![Page 36: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/36.jpg)
36
Figure2:Lineplotofrawwoundareameasurementsanddisplayingonelineperhorse.Thelineforhorse=#4islabelled.Woundareameasurementswereinspectedforstatisticalevidenceofoutliermeasurements.Therewasnoevidencetosupportidentificationofanymeasurementsinanygroupasbeingoutliers,includingthemeasurementsfromthehorsethatinterferedwiththebandages(Horse#4).Consequentlytheanalysiswiththefulldatasetwasconsideredthemostappropriateanalysis.Althoughpreviousstudynumbersweresimilartothisstudy,aretrospectivepoweranalysiswasperformedandthisconfirmedthatthesamplesizeofsixhorsesdidnotimpactontheresults.Increasingthesamplesizeto8or10orevenabovethatwouldnothavechangedtheresults–assumingthatadditionalhorsesandwoundsbehavedthesamewayasthe6horsesthatwereincludedinthestudy.3.4DiscussionTherehavebeenmanyproductsrecommendedtoenhancesecondintentionwoundhealinginhorses,buttherearelimitedoptionsavailablethathavebeenshowntoreliablyenhancehealing.Thisstudyaimedtoinvestigatetheeffectsoftopicalcannabadiol(CBD),withacarrierofmanukahoney,onsecondintentionwoundhealing.CBDisanovelagentwithanti-inflammatoryandanti-fibroticeffects(113)(114)showingearlypromiseasatreatmentforsecondintentionwoundhealing.Thesepropertiesaresimilartotheinflammatorymodulatingeffectsofmanukahoney.Bothproductshaveantimicrobialpropertiesandarenaturalcompoundssothecombinationwasconsideredacommerciallyattractiveandinnovativecombinationofproducts.Theactivecomponents,thetherapeuticeffectsandtheinteractionbetweensuchcomponentsinbothproductsarestillbeingdeterminedbutpotentialsynergismexistsbetweenvarioustherapeuticcompoundswithinthe
Horse= #4
05
1015
0 10 20 30 40
TreatmentCarrier
Wou
nd a
rea
(cm
2 )
Day
Wound area
![Page 37: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/37.jpg)
37
marijuanaplanthasbeendescribed,suggestingthatcompoundslikeCBDandTHCtogetherexertastrongereffectthantheindividualcomponentsusedalone(179)(180)(181).Thisistermedtheentourageeffect.ItisalsospeculatedthatCBDmayhaveanentourageeffectwithterpenesorterpenoids,howeverthereislittlepublisheddataavailable(182).Infact,somestudieshaveattemptedbutfailedtoestablishthiseffect(182).Regardlessterpenesarefoundinhoneys(183),and,ifthereisanentourageeffect,wehypothesisedtheremaybepotentialforasynergisticeffectbetweenhoneyandCBD.Asdiscussed,wehypothesizedthenovelcombinationofmanukahoneyandCBDwouldenhancehealingofwoundsbymodulatingtheearlyinflammatorystageofhealing.Therewerenodifferencesbetweenthemeasuredwoundhealingvariablesfromwoundstreatedwiththedifferenttreatmentregimensinthisstudy.ThiswasunexpectedbecauseaseriesofrecentstudieshaveshownUMF20manukahoneyconsistentlyimprovesmeasuredwoundhealingvariableswhenapplied,daily,tocontaminatedoruncontaminated,surgicallycreated,experimental,distallimbwoundslefttohealbysecondintentioninhorses,whencomparedtocontrolwounds(20)(60)(176)(178).Inthesestudies,woundstreatedwithUMF20manukahoneyconsistentlyretractedlessthanuntreatedwounds(176)(60).Theauthorsproposedthatthepresenceandefficiencyofmyofibroblastsinamaturegranulationbedinthefirst7daysafterwoundcreationintreatedwounds,limitswoundretractionwhencomparedtountreatedwounds(176)(60).WhilethemostobviousbenefitofapplicationofUMF20manukahoneyisseeninthefirst7daysafterwoundcreation,improvedoverallhealingtimeshavealsobeenreported(60)(178).Unfortunately,UMF20manukahoneyisexpensive,whichledustoconsiderthelowergradeUMF5manukahoneyasacarrier.PreviousreportssuggestUMF5manukahoneyisgenerallynotrecommendedfortherapeuticuseasanantibacterialagentbecausetheknownactiveconstituentMGOisfoundinsuchlowconcentrations(178)(57)(157).Nevertheless,UMF5manukahoneywasconsideredanattractivecarrierfortheCBDinthispreliminarystudybecausedifferentvarietalsofhoneycontainmanyunidentifiedbioactivecomponentsthat,whencombined,contributetotherapeuticbenefitsofthespecificvarietal,andevenbatch,ofaspecifichoneyvarietal(178)(157).Trademarkedmanukahoneyistheonlyhoneywherethereisanattempttoprovideareliablemeasureofbioactivitybutthisissolelywithrespecttothehoney’santimicrobialproperties(178)WhilemostofthebeneficialeffectsofmanukahoneyonwoundhealingarecurrentlyattributedtoMGO,evidencewouldsuggestthattheanti-microbialefficacyofMGOappearstorelyonthepresenceofotherknown,andmanyunknown,antimicrobialandanti-inflammatoryconstituentswithinthehoney,toreachoptimalefficacy(57)(161).Giventhis,wehypothesisedthat,intheabsenceofaregionaleffect,thehealingvariablesinwoundstreatedwith1%CBDinacarrierofUMF5manukahoneywouldhavebeenexpectedtobeimprovedwhencomparedtothewoundstreatedwithUMF5manukahoneyaloneinthatsameleg.Topicallyapplied1%CBDcombinedinacarrierofUMF5manukahoneywasexpectedtohaveresultedinanimprovementinwoundhealingvariableswhencomparedtoUMF5manukahoneyaloneorsalinegroups.ComparisoncouldthenbemadetothewoundstreatedwiththemoreexpensiveUMF20manukahoney.Thesamecontaminatedwoundhealingmodelwasused(176)(60).Themean
![Page 38: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/38.jpg)
38
woundareaonday1beforetreatmentcommencedwasconsistentacrossalltreatmentgroups.Thiswasanticipatedandconsistentwiththeresultsofpreviousstudies(176)(60)(178).Themeanwoundareainalltreatmentgroupswasthenexpectedtoincreasebetweendays1today7(176)(60)(178).However,therewasnochangeinthemeanwoundareairrespectiveoftreatment.Specifically,woundstreatedwithsalinewereexpectedtoretractmorethanwoundstreatedwithUMF20manukahoney,(176)(60)buttheresultsofthecurrentstudyshowedthatthepatternthroughouthealingwasthesameforalltreatmentgroupswithnoapparenteffectoftreatment.Therearefewlikelyexplanationsfortheunexpectedpatternofhealing(20)(176)(60)(178).OnepossibilityisthattherewasasystemiceffectofthetopicalCBD.CBDissuggestedtohavepotentialanti-inflammatory,(184)(185)antioxidant(94)andanalgesicproperties(186)aswellaspotentantibacterialeffects(184)(85).ItwouldappearthattheactivationofCB2receptorsincellssuchaslymphocytes,monocytes,macrophages,fibroblastsandkeratinocytes,amongstothers,(187)(188)(189)(190)suppressinflammationbyreducingexpressionofvariouscytokinesincludingtrans-forminggrowthfactorβ(TGF-β),transforminggrowthfactorα,interleukin-1andinsulin-likegrowthfactor-1(191)Inmostspecies,TGF-βhasthebroadestspectrumofactivityinwoundhealingandisdirectlyassociatedwiththeregulationofthefibroticresponse.(192)(193).Inhorses,thedifferentisoformsofTGF-βinteracttoplayapivotalroleinorchestratingwoundhealing.(19)(194)(195).TGF-β1peakssoonafterwoundingwhileTGF-β3peaks7–9dayslaterandmodulatesthefibroticresponse(19)(194)(195).Whiletheprocessofsecond-intentionwoundhealinginthehorseiscomplexandnotcompletelyunderstood,theconcentrationsandtemporalexpressionpatternsofthesetwocytokineswithinthewoundappeartobeessentialforthenormalprogressionofwoundhealing,particularlyinwoundsonthedistallimb(19)(194)(195).Itisbelievedinhorses,andinparticularindistallimbwounds,animbalanceintheexpressionofTGFβ1and3cancauseaweakandprolongedinflammatoryresponsethatleadstodelayedwoundhealing(31).IfthereweresystemiceffectsofCBDinthisstudy,itwouldhavebeenexpectedtohaveasimilarinfluenceontheprogressofwoundhealinginallwounds.BasedonthereportedpropertiesofCBD,thepotentialeffectsoftopicalapplicationinacontaminatedequinewoundhealingmodelwouldbeexpectedtobeassociatedwithitsantimicrobialandanti-inflammatoryeffects.Thewoundhealingmodelusedinthecurrentstudywasoriginallydevelopedtotryandeffectivelyreplicatenaturallyoccurringwoundsratherthantheaseptic,surgicalmodelsusedinearlierstudies(176)(60)(196)(178).Thepurposeofapplyingfaeceswastoreplicatewoundcontamination.However,whilethishasbeenshowntoincreaseaerobicandanaerobiccountsonthewounds,bacterialcountsonlyremainelevatedfor24h(20).Nevertheless,theapplicationoffaecesfor24hhasbeenshowntobesufficienttoaffectthepatternofhealingcomparedtonon-contaminatedwounds(60).Woundstreatedwithfaecesretractfurther,buthealfasterthanuncontaminatedwounds(60).Thissuggeststhattheapplicationoffaecesfor24hmaystimulatetheinitialinflammatoryresponseinequinedistallimbwoundsandenhancethewoundhealingprocesswithoutthenegativeeffectsofpersistentoroverwhelminginfectionoftenassociatedwithnaturallyoccurringdistallimbwounds(60).IfCBDwastohaveasystemiceffectinthismodel,itisverylikelythereportedanti-inflammatoryandantimicrobialpropertieswouldhavereducedwoundretractioninallwoundsinthefirst7daysafterhealing,
![Page 39: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/39.jpg)
39
whichisconsistentwiththeresultsreportedinthecurrentstudy.Whendesigningistrial,itwasconsideredtherecouldbesystemicandregionaleffectsofCBDfollowingtopicalapplication.ItisdifficulttocomparethisprotocoltootheranimalmodelsastheavailablemicestudieshavegenerallyutilisedsystemicdosesofCBD,withoutcombinationwithotherproducts.Forexample,onestudyuseddosesofbetween5mg/kgand10mg/kgviaintra-peritonealinjectioninrodents(112).Experimentsutilisingthesetopicalagentsarerare,andnonearecurrentlyavailableusingequinemodels.However,availableevidencesuggestedanysystemiceffectwaslikelytohavebeenverysmallandunlikelytoaffectwoundhealing.OnestudyinvestigatingthetransdermaleffectsofCBDappliedtopicallyfortreatmentofpainandinflammationinarodent,adjuvant-induced,monoarthritismodelin260–280gratsfounddailydosesof6.2and62.3mgCBDappliedtopicallyfor4dayswereeffective,whilelowerdoseswerenot(197).Whiledailydosesof0.6and3.1mgwerenottherapeuticallyeffective,theywereabsorbedsystemicallyandrevealedadoserelated,linear,pharmacokineticcorrelationwhenthe6.2mgdosewasincluded(197).Whenthehigherdoseof62.3mgwasincludedinthepharmokineticcorrelation,itdidnotfollowthislinearrelationship(197)Theauthorsproposedthattransdermalabsorptioncouldbecomesaturatedwhenhigherdosesandhighervolumesofmedicationwereapplied,particularlyifthesedoseswereappliedtoaconfinedarea(197).TheauthorsalsopostulatedthatapplicationofCBDtotheskinoverlyingtheaffectedjointwouldpotentiallyincreasethelocalCBDconcentrationsandenhancelocalefficacywithoutsystemicinvolvement(197).Inthecurrentequinewoundstudy,woundstreatedwithCBDreceived10mgofCBDtopicallydaily.Thiswasconsideredamodestdosethatwouldhavelocaleffectswithouttherapeutic,systemiceffects.However,thecurrentstudyappliedtheCBDtoopenwoundsratherthantransdermally,soitispossiblethatsystemicabsorptionoftheCBDthroughanopenwoundmayhavebeenhigherandlessrestrictedbyareainthisstudycomparedtotransdermalapplicationintherat.Nevertheless,givendosesof0.6and3.1mgin260–280gratsappliedtopicallytotheskinwereabsorbedsystemicallybutnottherapeuticallyeffective(197),itwasconsideredadoseof10mgina500kghorsewasunlikelytodeliversystemicconcentrationsthatwouldbetherapeuticallyeffectiveinthecurrentstudy.TherehavebeennostudiesinvestigatingCBDinhorsessoitispossibletheeffectsofCBDorthesensitivityofCBDreceptorsaredifferentinhorsesthanrodents(197).Whilethecurrentstudydesigndidnotanticipateasystemiceffect,thestudydesigndidtakeintoaccountthepossibilityoflocaleffectsofCBD,foranypotentialeffectsofUMF5asthecarrier,andforanyinteractionbetweenCBDandUMF5manukahoney.Alone,UMF5manukahoneywasconsideredunlikelytohaveanyeffectonwoundhealingbasedonapreviousstudythatshowedUMF5manukahoneyhadnoeffectonwoundhealingvariablesinanuncontaminatedwoundhealingmodelinhorses(178).Althoughpreviousstudynumbersweresimilartothisstudy,aretrospectivepoweranalysiswasperformedandthisconfirmedthatthesamplesizeofsixhorsesdidnotimpactontheresults.Increasingthesamplesizeto8or10orevenabovethatwouldnothavechangedtheresults–assumingthatadditionalhorsesandwoundsbehavedthesamewayasthe6horsesthatwereincludedinthestudy.Giventhis,weremainconfidentthatthecauseofthe
![Page 40: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/40.jpg)
40
lackofresultsismostlikelyasystemiceffectofCBD.
![Page 41: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/41.jpg)
41
CHAPTER4:ASTUDYINTOTHEEFFECTOFINCREMENTALINCREASESOFUMFRATINGSOFMANUKAHONEYANDMELALEUCAHONEYONSECONDINTENTIONHEALINGOFWOUNDSOFTHEDISTALLIMBOFTHEHORSE4.1IntroductionUMF20Manukahoneyhasbeenshowntohavepositiveeffectsonsecondintentionwoundhealinginthedistallimbofhorsescomparedtountreatedcontrolwounds,woundstreatedwithgenericstoreboughthoneyandwoundstreatedwithUMF5manukahoney(179).TheantimicrobialeffectsofManukahoneymaycontributetotheimprovementinwoundhealingvariableshoweverManukahoneyalsohasbeenshowntomodulatetheinitialinflammatoryresponsethroughactivationofToll-likereceptor4onwhitecells(157).ThehighertheUMFofmanukahoneythemorepotentaretheantimicrobialeffects(157).UMF5and10haveminimalantimicrobialactivitywhileUMF15and20havesuperiorantimicrobialeffects(57).Whileantimicrobialactivityofmanukahoneyisquantifiedagainsttheantisepticphenol,theanti-inflammatoryeffectsofanybatchofmanukahoneyisnotrated(147).Furthermoretheremaybeotherbioactiveconstituentsofmanukahoneythatarecurrentlyunknown.ThecostofManukahoneyincreaseswiththeincreasingUMFfactor.WhileahighUMFfactormaybemoreappropriateinheavilycontaminatedwoundsorwoundswithestablishedbiofilms,lowerUMFandlessexpensiveManukahoneymaybeeffectiveinenhancinghealinginlesscontaminatedwoundsthroughthegenericfeaturesofhoneyandthespecificanti-inflammatoryeffectsofmanukahoneymediatedthroughToll-likereceptor4orotherunknownbioactiveconstituents.MorerecentlyMelaleucahoney(TeaTree)hasbeenproposedtohaveantimicrobialeffectshoweverthetherapeuticeffectshavenotbeenquantifiedorstandardisedlikeManukahoneyandanybenefitsonwoundhealinghavenotbeenestablished.ThepurposeofthisstudywastoinvestigatewhethertherewereanydetectabledifferencesonthewoundhealingvariablesbetweenManukahoneywithdifferentUMFsinacontaminatedwoundhealingmodelofthedistallimbofhorses.FurthermorewewantedtocomparetheeffectofMelaleucahoneyonsecondintentionwoundhealingagainstManukahoneyusingthesamewoundmodel.WehypothesisedthatusingthiscontaminatedwoundhealingmodelthatthewoundhealingvariablesofwoundstreatedwithUMF15andUMF20ManukahoneywouldbesuperiortothosewoundstreatedwithUMF5andUMF10manukahoneyandthatthewoundhealingvariablesofwoundstreatedwithUMF5andUMF10Manukahoneywouldnotbedifferenttosalinetreatedcontrolwounds.Further,wehypothesisedthatMelaleucahoneywouldnotimprovethewoundhealingvariablesinthiswoundhealingmodelwhencomparedtosalinetreatedcontrolwounds.
![Page 42: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/42.jpg)
42
4.1Materialsandmethods
NineadultmixedsexStandardbredhorseswithoutevidenceofwoundsorscarsontheirforelimbswereusedinthestudy.ThestudywasapprovedbytheinstitutionsAnimalCareandEthicsCommittee.
Oneweekpriortothesurgerythehorseswereweighed,identifiedwithanumberedcollarandtreatedwithananthelmintic.Theywerehousedinpairsingrassyardsforthedurationofthestudy.Lucernehaywasfedat2.5%bodyweightindividedfeedsdailyandfreeaccesstowaterwasavailablethroughoutthestudy.WoundcreationEachhorseunderwentaclinicalexaminationonthemorningofsurgery.Thedorsalaspectsofbothmetacarpiinallhorseswereclipped.A14Gcatheterwasplacedintheleftjugularvein,themorningofsurgery,afterasepticpreparationandlocalanaesthesiaofthesite.Eachhorsereceivedasingledoseofphenylbutazone(2.2mg/kgIV)andtetanusprophylaxispriortosurgery.Horsesweresedatedwithxylazinehydrochloride(1.1mg/kgIV)andanaesthesiawasinducedwithdiazepam(0.1mg/kgIV)andketamine(2.2mg/kg).Anaesthesiawasmaintainedusingtotalintravenousanaestheticagents(TripleDrip).
Allwoundswerecreatedonthesameday.Theskinoverthemetacarpiwasnotasepticallyprepared.Atotalofsixfullthicknessskinwounds(2.5cmx2.5cm).Thewoundsweremademedialtotheextensortendonsandwereevenlyspacedbetweenthecarpusandthefetlock.Woundswerecreatedbymakingafullthicknessskinincisionaroundastandard,flexibletemplateusingascalpel,andtheskinwasremovedwithsurgicalscissors.Twogramsoffreshfaecescollectedfromahorsethatwasnotincludedinthestudywasplacedoneachwound,andeachwoundwasindividuallybandaged.Thebandageconsistedofalowadherent,absorbentdressingcuttosizetopreventcrosscontamination(Melolin,SmithandNephewMedicalLtd,HullEngland)coveredwithasoftgauzeroll(EasifixK,BSNMedical,Hamburg,Germany)andcompressedunderanelasticadhesivetape(TensoplastVet,BSNMedical,Hamburg,Germany).Thehorseswereallowedtorecoverunassisted.
WoundtreatmentsBandageswereremoved24hafterwoundcreationandthefaecesrinsedoffthewoundsusingsterilesaline.Treatmentswere2mlofUMF5manukahoney,UMF10manukahoney,UMF15manukahoneyorUMF20manukahoney(ComvitaAustraliaPtyLtd,Brisbane,Australia),2mlteatreehoneyor2mlsterile0.9%sodiumchloride(saline).Thetreatmentallocationoneachlegwaspredeterminedsothattreatmentsoneachlegwereevenlydistributedacrossallwoundsandallhorses.Treatmentswererandomlyassignedbypullingthehorseidentificationandtheassignedtreatmentprotocolforeachlegrandomlyoutofahat.Aftertreatment,woundswereindividuallybandaged,asdescribed,
![Page 43: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/43.jpg)
43
topreventmixingoftreatments.Woundswerebandagedafterwoundcreationandforatotalof13daysandbandagedwerereplaceddaily.Treatmentwasapplieddailyfor12daysunderabandage.Onday13bandageswereremovedandwoundswereleftopenandtreateddailyforatotalof42days.WoundmeasurementsDigitalphotographsofthewoundwereobtainedondays1,7,14,21,28,35,and42afterwoundcreationandwoundsweremeasuredusinganimageanalysissoftware(ImageJ,USNationalInstitutesofHealth,Bethesda,USA).A2.5x2.5cmtemplate(6.25cm2)wasplacednexttothewoundasastandardreference.Theareaofthewoundswasmeasuredthreetimesandtheaveragecalculatedtoproduceasinglemeasureforeachwoundforeachmeasurementday.Theareaofthegranulationtissue,notincludingtheadvancingedgeofepitheliumoneachsideofthegranulationbed,wasmeasured.Overalltimetocompletehealingwasrecorded.Woundswereconsideredcompletelyhealedwhengranulationtissuewasnolongervisible.Overallrateofwoundhealing(cm2/day)wasdeterminedbydividingthewoundareaonday1bythetotaldaystocompletehealing.4.2ResultsAllhorseswereclinicallyhealthythroughoutthetrial.Therewasnoevidenceoflamenessorswellingandnowoundsdevelopedexuberantgranulationtissue.Therewasnodifferenceinwoundareabetweenanyofthewoundsonday1followingwoundcreationbeforetreatmentcommenced.Thegeneralpatternsofhealingweresimilaracrossalltreatmentgroups(Figure3).Therewasnodifferenceinthedailymeanwoundareabetweenanyofthetreatmentsonanyofthetreatmentdays.
![Page 44: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/44.jpg)
44
Figure3:Plotofmeanwoundareaforeachgroupoverthe42daysofthestudy.Barsrepresent95%confidenceintervals.Therewassignificantincreaseinwoundareaforallofthewounds,irrespectiveoftreatment,betweendays1and8.Therewasthenasignificantreductioninwoundareafromday8today15inallgroups.Woundareacontinuedtosignificantlyreduceateachsuccessivemeasurementdayinallgroupsthroughtoday28(p<0.05).Beyondthistherewasacontinuedreductioninwoundareathroughtotheendofthestudy(day42)butcomparisonswerenotallsignificant.Fromday28today35,woundareasignificantlyreducedintheUMF5grouponly(p=0.04)andinallothergroupsthechangefromday28today35wasnotsignificant(p>0.05).Fromday35to42thechangeinwoundareawasnotsignificantinanygroup(p>0.05).Therewasnosignificantdifferencebetweentreatmentgroupsforoverallhealingrateordaystocompletehealing.4.4DiscussionTheresultsofthisstudywerecompletelyunexpected.Usinganestablishedcontaminated,equinedistallimbwoundhealingmodel,therewerenodifferencesinthemeasuredwoundhealingvariablesbetweenanyofthetreatmentsevaluated,orbetweenanyofthetreatmentsandcontrolwounds.Infact,thegeneralpatternsofhealingweresimilaracrossalltreatmentgroups.Woundsallwentthroughaninitialperiodofretractionfollowedbyaprogressiveperiodofwoundcontractionthatischaracteristicofthiswoundhealingmodel(20)(60)(176)(178).Incontrast,previousstudiesusingthiswoundmodelhaveconsistentlyshownwoundstreatedwithUMF20manukahoneyretractlessandshowbettergrossandhistologicalhealingwhen
![Page 45: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/45.jpg)
45
comparedtosalinetreatedcontrols(60)(176)(178).Beneficialeffectsonwoundhealinghavebeenshowninbothcontaminatedanduncontaminatedequinedistallimbwoundmodels,althoughtheeffectsaremoremodestusinganuncontaminatedmodel(20)(60)(176)(178).Acontaminatedwoundhealingmodelwasusedinthecurrentstudytobetteralignthemodeltoanaturallyoccurringwoundwherecontaminationiscommon,andtopotentiateanydifferencesinwoundhealingvariablesasaresultoftheantibacterialeffectsofdifferentUMFgradesofmanukahoney(176)(60)(196)(178).Inacontaminatedwoundmodel,freshhorsefaecesareappliedtoeachwound,underabandage,for24hoursafterwoundcreation.Thismodelhasbeenshowntoleadtoatransientincreaseinbacterialcountswithoutcausingovertclinicalsignsofwoundinfectionbut,atthesametime,itprovidessufficientcontaminationtoalterthepatternofhealingcomparedtosalinetreated,controlwounds(20).TheeffectsofUMF20manukahoneyonwoundhealingusingthismodelbeenattributedtotheenhancedcontractileactivityofmyofibroblastsinamorematurebedofgranulationtissue,particularlyinthefirstweekafterwounding(176)(60).WhilestudiesdemonstratemostofthebeneficialeffectsoftreatmentwithUMF20manukahoneyoccurinthefirst3weeksafterwoundcreation,therearealsoimprovementsintheoveralltimestohealing(60)(178).BasedontheconsistentbeneficialeffectsofUMF20manukahoneyonamodelofsecondintentionhealingofdistallimbwoundsinhorsesshowninpreviousstudies,itislikelythatacompromisedstudydesignwasresponsibleforthefailuretodemonstrateaneffectofanyofthetreatmentsinthecurrentstudy(20)(176)(60)(178).Giventhesimilaritiesinstudydesignbetweenpreviousstudiesandthecurrentstudy,therearelikelytoonlybeafewpossiblereasonsforthefailuretodemonstratetreatmenteffects.Broadlyspeaking,itispossible,aloneorinsomecombination,establishinganytreatmenteffectwaslimitedbythesizeofthewounds,thenumberofwoundsandthenumberofdifferenttreatmentsoneachlimb.Thesizeandproximityofwoundstooneanotherinthecurrentstudydesignmayhavehadeffectsontheforcesresponsibleforretractionandcontractionofadjacentwounds.Inpreviousstudiesusingasimilarmodel,woundnumbersweregenerallylimitedtooneortwowoundsperlimbofsimilarsizeusedinthecurrentstudy(176)(60).Intwostudiesthatusedalargernumberofwounds,woundsizewasmuchsmallerthanthecurrentstudyandwoundswereoffsetratherthancreatedinaverticallinearrow(20)(196).Inoneofthesestudiesonlygrowthfactorsandhistologicalscoresweremeasuredandwoundhealingvariableswerenotanalyzed(20).Inthesecondstudy,woundhealingvariablesweremeasuredandtheseweresignificantlyimprovedinwoundstreatedwithUMF20manukahoneyora66%UMF20manukahoneygel,whencomparedtocontrolwoundstreatedwithsalineorthewaterbasedgellingagent(196).However,whilethenumberandsizeofthewoundsweresimilartothecurrentstudy,thedifferencewasthattherewerefewertreatmentsbeingevaluatedintheearlierstudy(196).Only2treatments,UMF20manukahoneyanda66%manukahoneygelwereevaluatedandthesetreatmentswereappliedfortwodifferenttimeperiods(12daysorthroughouthealing).Socomparedtothecurrentstudy,thisearlierstudy
![Page 46: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/46.jpg)
46
hadalesscomplexdesign,itwascomparingfewertreatmentsandthetreatmentswerebothbasedonaUMF20manukahoneyandshowntohavethesamebeneficialtreatmenteffectswhencomparedtocontrolwounds.Thestudydesigninthecurrentstudyevaluatedalargernumberoftreatmentsandthesetreatmentswerelikelytohavesubtledifferencesintherapeuticactivity.Thesefactors,combinedwiththecloseproximityofthewoundstoeachother,mayhavelimitedtheexpressionanydifferencesbetweentreatmentsonwoundhealingvariables.Specifically,thetherapeuticbenefitsofthedifferentUMFmanukahoneysmayhavebeeninsufficienttoovercomeanyforcesaffectingtheretractionandcontractionofadjacentwounds.Whileitisalsopossibleovertcrosscontaminationofwoundsduringtreatmentcouldhaveoccurred,thiswasnotafeatureinpreviousstudiesusingthesamemodelandwasunlikelytohavebeenafactorinthisstudy.Itismorelikelythatdifferencesintreatmentonadjacentwounds,particularlywithUMFmanukahoneywithsimilartherapeuticactivity,wasnotdetectedinamorecomplexandambitiousstudydesignwithtoomanydifferenttreatments.Astudydesignusinglesswoundsandlesstreatmentsmayhavebeenmoreappropriate.Manukahoneyistheonlyhoneyvarietalwherethereisanattempttoprovideareliableandrepeatablemeasureofbioactivity.TheantibacterialactivityofeachbatchoftrademarkedmanukahoneyisstandardisedagainsttheantisepticphenoltoproduceaUMF.WhiletheUMFofmanukahoneyhasbeenlargelyattributedtothebioactivityofMGO,andtheconcentrationsofMGOinanybatchofhoneyhavebeenbroadlycorrelatedwiththeUMF,reportshavesuggestedthatothertherearemanyotherknownandunknownbioactiveagentsinmanukahoneywhichcontribute,asawhole,toitsefficacy(57)(161).So,whileitappearstheantibacterialpropertiesofmanukahoneycontributetothebeneficialeffectsonwoundhealing,theprecisemodeofactionofmanukahoneyonsecondintentionwoundhealinginthehorseremainsunclear.CurrentlythereislittlepublishedresearchaboutwhetherdifferentUMFmanukahoney,andconsequentlydifferentantibacterialefficacy,isdirectlycorrelatedwithwoundhealing.ArecentstudyusinganuncontaminateddistallimbwoundhealingmodelinhorsesshowedwoundstreatedwithUMF20honeyshowedsuperiorhealingtowoundstreatedwithUMF5manukahoneyorgenericstore-boughthoneybutthisstudydidnotestablishwhetherthisdifferencewasrelatedtotheantibacterialeffectsofmanukahoney,otherfactors,oracombinationofboth(178).ManukahoneywithaUMFfactorof5or10isreportedtohavelittleornoantibacterialactivityandisnotrecommendedfortherapeuticuseasanantimicrobialagent,whiletheefficacyofmanukahoneyagainstmanyoftheantibioticresistantbacteria,andestablishedbiofilms,increaseswithanincreasingUMF(157)(158)(198).TheaimofthecurrentstudywastoinvestigatewhethertheantibacterialefficacyofdifferentUMFmanukahoneywouldaffectwoundhealingvariablesdifferently.OurhypothesiswasthattherewouldbenoeffectofUMF5andUMF10manukahoneywhileUMF15andUMF20wouldimprovewoundhealingvariables.However,theresultsofthestudyfailedtoshowanyeffectoftreatment.ItispossiblethatthebacterialloadanddiversitycreatedusingthismodelwasnotsufficienttodemonstratesubtledifferencesbetweentheantimicrobialspectrumofthedifferentUMFfactors.However,previousstudiesthathavedemonstratedclearandconsistentimprovementsinwoundhealingvariablesbetweenwoundstreatedwithUMF20andsalinetreatedcontrolswouldsuggestthatthetransientand
![Page 47: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/47.jpg)
47
modestbacterialcontaminationcharacteristicofthiscontaminatewoundmodelisunlikelytohave,alone,contributedtothefailuretoestablishdifferences.Otherfactorsthatmayhaveimpactedonthecurrentstudyarelesslikelytohavebeenresponsibleforthefailuretodemonstrateanytreatmenteffects.Thebrandofmanukahoneyusedinthecurrentstudywasdifferenttothebrandusedinpreviousstudies,soitispossiblethetwobrandshaddifferenteffectsonwoundhealing.However,themanufacturersproducingeachbrandoftrademarked,manukahoneyverifytheUMFoftheirhoneythroughinhouseandindependenttesting.Nevertheless,thereislittleresearchpublishedthatspecificallyaddressesfactorsthatmightreducethebioactivityofmanukahoney.Forexample,generichoneyisoftenheattreatedandstoredforlongperiodsthatisknowntoreduceitsbioactivity(137)(178)(57).IncontrasttheconversionofdihydroxyacetoneintoMGOinmanukahoneyincreasestoapproximately30%followingstorage.Nevertheless,itispossiblethatthebatchesofhoneyusedinthisexperimentwerecompromisedinsomewayPreviousstudiesusingthismodelhaveusedadultStandardbredgeldingsandmaresofmixedages.Welimitedtheupperageofthestudygroupto11yearstominimizeanysuggestedageeffectsordiseasessuchasCushing’sdisease,onhealing(199)(200).NoneofthehorsesinthestudyhadclinicalsignsofCushing’sdiseaseandtheagesofthehorsesweresimilartopreviousstudiessoitisunlikelyagefactoredintotheresultsofthisstudy.TheadditionofMelaleucahoneytothisstudyaddedanotherlayerofcomplexitytothestudydesign.However,Melaleucaalternifolia(AustralianTeatree)andLeptospermumscoparium(Manukabush)aredifferentspeciesoftheMyrtaceae(Myrtle)family.TeatreeoiliswellestablishedasatherapeuticagentbutthereiscurrentlylimitedevidencesupportingtheuseofTeatreeoilorhoneyforwoundhealing(172).Melaleucahoneyissuggestedtohavehighconcentrationsofanti-oxidantsaswellasantimicrobialactivity(174).Antioxidantspreventfreeradicalformation,scavengefreeradicalsorpromotethebreakdownandmayplayaroleinwoundhealingbypreventingfreeradicaldamage(201).Lowlevelsofantioxidantsinwoundshavebeenlinkedwithdelayedhealinginanimalmodels(202).ThestudylentitselftoevaluateMelaleucahoneybycomparingitwiththeknowneffectsofUMF20manukahoneyonwoundhealingonandtothepotentialeffectsofdifferentUMFmanukahoney.ThefailuretodemonstrateanytreatmenteffectsinthecurrentstudywouldsuggestfurtherstudieswillberequiredtoproperlyevaluateanypotentialeffectsofMelaleucahoneyonwoundhealing.Wedonotbelieveitispossibletodrawanyreliableconclusionsfromthecurrentstudy.Previousandsimilarstudydesignsusing6-9horseshavebeenshowntocapturestatisticaldifferencesbetweentreatmentgroups.Thefailuretodemonstratedifferencesinthecurrentstudy,inparticularestablishedeffectsofUMF20manukahoney,onsecondintentionwoundhealingvariables,wouldsuggestaflawinthecurrentstudydesignratherthatalackoftreatmenteffect.Wewouldconsiderthatitislikelythestudydesignbecametoocomplicated.Inthisstudyweinvestigated5treatments,4ofwhichwereevaluatedtoinvestigatesubtledifferencesintheeffectsofantimicrobialefficacyalongtheUMFgrading
![Page 48: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/48.jpg)
48
scale.Thecontaminatedwoundhealingmodelonlycreatesatransientincreaseinbacterialcountsand,incombinationwith6largewoundsperhorse,mayhavemadeitdifficulttoestablishanydifferencesbetweentreatments.Inretrospect,thestudywastooambitiousandsetouttoevaluatetoomanytreatmenteffects.Infuturestudies,keepingthedesignsimpleandlimitingthenumberoftreatmentsiswarranted.TheadditionofMelaleucahoneytothestudyaddedtothecomplexityandmayhavebeenbetterlefttoaseparatetrial.
![Page 49: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/49.jpg)
49
CHAPTER5:CONCLUSIONSANDFUTUREDIRECTIONSEquinedistallimbwoundsthatarelefttohealbysecondaryintentioncontinuetoposeachallengeforownersandveterinarians.Thetaskcontinuestofindaproductthatwillconsistentlyenhancethehealingofsuchwounds.Inthispilotstudy,wewereunabletodemonstrateaneffectofthenovelcombinationof1%CBDinacarrierofUMF5manukahoneyappliedtopicallyfor42daysonwoundhealingvariablesinasecondintentionhealingcontaminatedequinedistallimbwoundmodel.Despitepotentialissueswithstudydesign,thelackofanystatisticaldifferencesbetweenanytreatmentgroupswassurprisingtotheresearchersgiventhepreviousreliabilityofsimilarmodelsinproducingstatisticallysignificantresults.Althoughthispilotstudyintothecombinationofmanukahoneyandcannabidiolonthesecondintentionhealingofequinedistallimbwoundsdidnotproduceaneffect,wedonotnecessarilyconsiderthisafailureofthecannabidiolresin.Tothecontrary,whileitispossibletheremayhavebeenotherunknownfactorsresponsiblefortheunexpectedresultsinthisstudy,asystemiceffectofCBDseemsmostlikelygiventhedeviationawayfromthenormalretractionphaseafterwounding.MorestudiesintotheeffectsofCBDonequinewoundhealingthataccommodatespotentialsystemiceffectsofCBDwouldneedtobedevelopedtovalidatethisassumption.However,anyfurtherstudieswouldbecomplicatedbytheinabilitytouseeachhorseasitsowncontrol,soanystudywouldneedalargerstudypopulationtoaccountfordifferencesinwoundhealingbetweenhorsesandwouldaddanotherlayerofcomplexityandcosttotheexperimentalmodel.Thecombinationofmanukahoneyandcannabidiolstillremainsapotentiallyattractiveoptionandmay,infuturestudieswithrefinedmethodologies,provetoabetreatmentpanaceaforsecondintentionwoundhealingofthedistallimbofthehorse.Furthermore,althoughwefailedtoestablishdifferencesinhealingwithvaryingUniqueManukaFactorhoneygrades,previousstudieshavesuggestedthatusageofUMF20manukahoneyisstillencouragedoverotheroptions,includingUMF5manukahoneyandgenerichoney(178).OursuspicionremainsthattherecouldbeincreasingimprovementinhealingpatternsastheuniquemanukafactorincreasesincrementallybetweenUMF5andUMF20andevenabove.Thisparticularstudymayhavecreateditsowndownfallinattemptingtoresolvemultiplequestionsinonetrial.Wehypothesisethatthenumberofwoundsofthedistallimbmayhave,initself,createdaregionaleffectandobscuredanymeaningfuldata,reducinganydifferencesbetweenvaryingUMFtreatmentgroupstobelowstatisticallydetectablethresholds.Alternatively,issuessuchascrosscontaminationbetweengroupsmayhaveoccurredandchangedourresults,butweconsiderthesepotentialissuesunlikelygiventhereliablesuccessofthismodelinpreviousstudies.Regardless,addingintheTeaTreehoneyasatreatmentgroupmayhavecomplicatedthisstudyunnecessarily.Assuchtheresearchgroupfeelsthereisastrongneedforfurthertargetedresearchinthesefields,butwerecommendasimplermodelwithmorelimitedtreatmentgroups.WeremainencouragedtocontinueinvestigatingtheoutcomesofvaryingUniqueManukaFactorhoneysonsecondintentionhealingofwoundsofthedistallimbofthehorse
![Page 50: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/50.jpg)
50
Bibliography[1]Auer,J,Stick,A.Equinesurgery.4thed.St.Louis:ElsevierSaunders,2012.[2]Robson,R.Infectioninthesurgicalpatient:animbalance:animbalanceinthenormalequilibrium.ClininPlasSurg(1979);6(4):493-503
[3]Brown,P.Thepreventionofinfectioninopenwounds.ClinOrthRelRes(1973);96:42-50
[4]Theoret,T,Stashak,C.Equinewoundmanagement.Ames:Wiley-Blackwell,2008.[5]Prakash,H,Sinno,S.Complementsandwoundhealingcascade:anupdatedreview.
PlastSurgInt(2013);146764[6]Saito,H.Disordersofhaemostasis.Philadelphia:Saunders;1996.Chapternormal
haemostaticmechanisms.[7]Demidova-Rice,TN,Hamblin,MR,Herman,IM.Acuteandimpairedwoundhealing:
pathophysiologyandcurrentmethodsfordrugdelivery.Part1:normalandchronic wounds:biology,causesandapprochaestocare.AdvSkinWoundCare;25(7):7
[8]Theoret,CL.Equinewoundmanagement.Ames:Wiley-Blackwell.Chapterphysiologyofwoundhealing,2008.
[9]Roberts,A.Transforminggrowthfactor-B:activityandefficiacyinanimalsmodelsofwoundhealing.WoundRepairRegen.1995;3(4):408-418
[10]O'Kane,S,Ferguson,M.TransforminggrowthfactorBsandwoundhealing.IntJBiochemCellBio1997;29(1):63-78
[11]Ross,D,Simpson,M.Theneutrophilicleukocyteinwoundrepair-astudywithantineutrophilserum.JClinInvest2009;51(8):2009-2023
[12]Strbo,N,Yin,N,Stojadinovic,S.InnateandadaptiveimmuneresponsesinwoundEpithelialisation.AdvWoundCare2014;3(7):492-501
[13]Ross,S,Leibovich,R.Theroleofthemacrophageinwoundrepair:astudywithhydrocortisoneandantimacrophageserum.AmJPath1975;78(71):71-100
[14]Wilmink,J,Veenman,J,vandenBoom,R,Rutten,V,Niewold,T,Broekhuisen-Davies,J,etal.Differencesinpolymorphonuclearfunctionandlocalinflammatoryresponsebetweenhorsesandponies.EqVetJ2003;35(6):561-569
[16]Franz,M,Steed,D,Robson,M.OptimisinghealingoftheacutewoundbyminimisingComplications.CurrProbSurg2007;44(1):691-763
[17]Xue,M,Jackson,C.Extracellularmatrixreorganisationduringwoundhealinganditsimpactonabnormalscarring.AdvWoundCare2015;4(3):119-136
[18]Darby,I,Laverdet,Bonte,F,Desmouliere,A.Fibroblastandmyofibroblastsinwoundhealing.ClinCosmetInvestigDermatol2014;7:301-311
[19]Theoret,C,Barber,S,Moyana,T,Gordon,J.ExpressionofTransformingGrowthfactorB1,B3andbasicfibroblastgrowthfactorinfull-thicknessskinwoundsof equinelimbsandthorax.VetSurg2001;30(3):269-270
[20]Bischofberger,A,Dart,C,Horadagoda,N,Perkins,N,Jeffcott,L,Little,C,etal.EffectofManukahoneygelonthetransforminggrowthfactorB1andB3concentrations,bacterialcountsandhistomorphologyofcontaminatedfull-thicknessskinwounds
![Page 51: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/51.jpg)
51
inequinedistallimbs.AustVetJ2016;94(1-2):27-34
[21]Mertz,O,Eaglstein,P,Alvarez,W.Theeffectofocclusivedressingsoncollagensynthesisandre-epithelialisationinsuperficialwounds.JSurgRes1983;35(2):142-148
[22]Field,F,Kerstein,M.Overviewofwoundhealinginamoistenvironment.AmJSurg1994;167(1):S2-S6
[23]Seeger,M,Paller,A.Therolesofgrowthfactorsinkeratinocytemigration.AdvWoundCare2015;4(4):213-224
[24]O'Toole,E.Extracellularmatrixandkeratinocytemigration.ClinExpDermatol2001;26(6):523-530
[25]Eming,A,Martin,P,Tomic-Canic,M.Woundrepairandregeneration:mechanisms,signaling,andtranslation.SciTransMed2014;6(265):265
[26]Usui,M,Underwood,R,Mansbridge,J,Muffley,L,Carter,W,Olerud,J.Morphologicalevidencefortheroleofsuprabasalkeratinocytesinwound Reepitheliaisation.Woundrepairregen2005;13(5):468-479
[27]Vaughn,S,Kincaid,D,Morrison,S,Murray,N,Woodhead,S,Hoffma,etal.Effectsoflocallyinjectedmedicationsonhealingofpadwoundsindogs.AmJVet Res1996;57(3):394-399
[28]Eichler,M,Carlson,M.Modelingdermalgranulationtissuewiththelinearfibroblast-populatedcollagenmatrix:acomparisonwiththeroundmatrixmodel.JDermatol Sci2006;41(2):97-108
[29]DiPeitro,L,Burns,A.Woundhealingmethodsandprotocols.Totowa:Humana Press,2003.
[30]Medscape.Skinwoundhealing(Internet).America:Medscape,2010(citedJuly2020).Availablefromhttp://emedicine.medscape.com/article/884594-overview
[31]Theoret,C.Thepathophysiologyofwoundrepair.VetClinEq2005;21(1):1-13[32]Medscape.Woundhealingandrepair.America:Medscape,2019(citedJuly2020)
Availablefromhttp://emedicine.medscape.com/article/1298129-overview[33]Wilmink,JM,vanHerten,J,vanWeeren,P,Barnevald,A.Retrospectivestudyof
primaryintentionhealingandsequestrumformationinhorsescomparedtoponies underclinicalcircumstances.EqVetJ2002;34(3):270-273
[34]Wilmink,J,Stolk,P,vanWeeren,P,VanMil,F,Barneveld,A.Differencesinsecondintentionwoundhealingbetweenhorsesandponies:macroscopicaspects.Eq VetJ1999;31(1):61-67
[35]Jacobs,K,Leach,D,Fretx,P,Townsend,H.Comparativeaspectsofthehealingofexcisionalwoundsonthelegandbodyofthehorse.Vetsurg1984;13(2):83-90
[36]Sorenson,M,Peterson,L,Bundgaard,L,Toft,N,Jacobsen,S.Regionaldisturbancesinbloodflowandmetabolisminequinelimbwoundhealingwithformationof exuberantgranulationtissue.Woundregenrepair2014;22(5);647-653
[37]Wilmink,J.Differencesinwoundhealingbetweenhorsesandponies.Equinewoundmanagement.Ames:Wiley-Blackwell,2008.
[38]Lepault,E,Celeste,C,Dore,M,Martineau,D,Theoret,C.Comparativestudyonmicrovascularocclusionandapoptosisinbodyandlimbwoundsinthehorse. Woundrepairregen2005;13(5):520-529
[39]Ulrich,O,Gothen,A,Siggaard-Anderson,I.Classesoftissuehypoxia.ActaAnaesScan1995;39:137-142
![Page 52: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/52.jpg)
52
[40]Aslam,T,Beckert,R,Wagner,S,Ghani,S,Hussain,Q,Hunt,M.Aerobicallyderivedlactatestimulatesrevascularisationandtissuerepairviaredoxmechanisms.AntioxRedoxSign2007;9:1115-1124
[41]Feng,Z,Zabel,J,Zabel,D,Yuan,D,Suh,H,Hunt,D,etal.Lactateelicitsvascularendothelialgrowthfactorfrommacrophages:apossiblealternativetohypoxia.Woundregenandrepair2000;8(5):353-360
[42]Mustoe,A,Tandara,T.Oxygeninwoundhealing-morethananutrient.WorldJSurg2004;28:294-300
[43]Wagner,O,Wicke,S,Scheuenstuhl,H,Hussain,H,Rosen,M,Seremetiev,N,etal.Lactateandoxygenconstituteafundamentalregulatorymechanisminwoundhealing2003;11(6):504-509
[44]Dart,A,Perkins,N,Dart,C,Jeffcott,L,Canfield,P.Effectofbandagingonsecondintentionhealingwoundsofthedistallimbinhorses.AustVetJ2009;87(6)212-218
[45]Martin,P,Joacobs,K,McIllwraith,K,Fretz,C.Treatmentofexuberantgranulationtissueinthehorse:evaluationoffourmethods.VetSurg1983;12(3):137-140
[46]Barber,S.Secondintentionwoundhealinginthehorse:theeffectsofbandagesandtopicalcorticosteroids.In198935thAnnualMeetingoftheAmericanAssociation ofEquinePractitioners,1989,
[47]Chan,G,Bruce,R,Costeron,A,Reid,J.PreventionofurinarytractinfectioninratswithanindigenousLactobacilluscaseistrain1985;49:320-324
[48]Veeh,W,Shirtcliff,R,Pasmore,M,Post,M,Erlich,C,Costeron,G.Theapplicationofbiofilmsciencetothestudyandcontrolofchronicbacterialinfections.JClinInvest 2003;1466-1477
[49]Gompelman,M,vanAsten,S,Peters,G,Edgar,J.Updateontheroleofinfectionandbiofilmsinwoundhealing:pathophysiologyandtreatment.PlasticRecon Surg2016;183:61S-70S
[50]Geriner,A,Seth,M,Hong,A,Smeltzer,S,Gallano,M,Leung,R,etal.Developmentofanovel,highlyquantitativeinvivomodelforthestudyofbiofilm-impaired cutaneouswoundhealing.WoundRegenRepair2001;19(3):400-410
[51]Jorgensen,E,Bay,L,Bjarnsholt,T,Bundgaard,L.Theoccurenceofbiofilminanequineexperimentalwoundmodelofhealingbysecondaryintention.VetMicrobiol2017;204:90-95
[52]Bjarnsholt,M,Kirkketerp-Moller,T,Jorgensen,K,Anderson,B,Krogfelt,A,,Govskov,K.NonrandomdistributionofPseudomonasaeruginosaandStaphylococcusaureusinchronicwounds.JClinMicrobiol2009;47:4084-4089
[53]Jensen,T,Burmolle,P,Henzter,M,Haagensen,M,Hougen,JCalum,H,etal.Pseudomonasaeruginosatolerancetotobramycin,hydrogenperoxideandpolymorphonuclearleukocytesisquorum-sensingdependent.Microbiol 2005;151:373-383
[54]GeZhao,G,Usui,A,Underwood,M,Nguyen,R,Beyenal,H,deLanceyPulcini,H,etal.Microsensorandtranscriptomicsignaturesofoxygendepletioninbiofilmsassociatedwithchronicwounds.WoundRegenRepair2016;24:373-383
[55]Raw,R,Loinberger,A,Yu,R,Chang,L.Genericdevelopmentoftopicaldermatologicproducts:formulationdevelopment,processdevelopment,andtestingoftopicaldermatologicproducts.AAPSJ2012;15(1):41-52
![Page 53: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/53.jpg)
53
[56]Hubbell,J.Hydrogelsystemsforbarriersandlocaldrugdeliveryinthecontrolofwoundhealing.JControlRel1996;39:2-3
[57]Dart,A,Dart,C,Jeffcott,L,Tsang,A.Mechanismofactionofmanukahoneyinanequinemodelofsecondintentionwoundhealing:currentthoughtsandfuture directions.MedResArchives2018;6(7):1-14
[58]Carter,D,Blair,S,Cokcetin,N,Bouzo,D,Brooks,P,Scothauer,R,etal.Therapeuticmanukahoney:nolongersoalternative.FrontMicrobiol2016;7:569
[59]Fattu,L,Bolton,A.Topicalagentsandwoundhealing.ClinDermatol1994;12:95-120[60]Bischofberger,A,Dart,C,Perkins,N,Jeffcott,L,Dart,A.Theeffectofshort-and
long-termtreatmentwithManukahoneyonsecondintentionhealingof contaminatedandnoncontaminatedwoundsonthedistalaspectoftheforelimbs inhorses.VetSurg2013;42(2):154-160
[61]Holmes,STopicaldosageforms(online).CitedJuly2020.Hobart:UniversityofTasmania[Online].Availablefrom
https://www.utas.edu.au/__data/assets/pdf_file/0007/618613/CSA156-Topical-Dosage-Forms-for-UniView3.pdf
[62]Bolaji,O,Kolawole,B,Ige,I.Opioid-sparingeffectofbupivicainewoundinfiltrationafterlowerabdominaloperations.WestAfrJMed2011;1(3)
[63]Grafford,L,Evers,K,Ohlsen,H.EMLAcreamasatopicalanaestheticforulcerdebridementandsimultaneoussplit-skingrafting.EurJPlasticSurg1994;17: 277-282
[64]Tracey,T,Morris,J.Lignocaine:Itseffectsonwoundhealing.BritJSurg1977;64:902-903
[65]USFoodandDrugAdministration.(Online).America:USFoodandDrugAdministration,2009.CitedJuly2020.Availablefromhttps://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022122s006lbl.pdf
[66]Nakashani,I,Shono,H,Toda,Y,Tsuda,M,Arase,H,Shimoto,A.Angiostaticeffectsofcorticosteroidonwoundhealingoftherabbitear.JMedInvest2002;49(1-2):61-66
[67]Maida,V,Corban,J.Topicalmedicalcannabis:anewtreatmentforwoundpain–threecasesofpyodermagangrenosum.JPainSymptomManag2017;54(5):732-736
[68]Willix,D,Molan,P,Harfoot,C.Acomparisonofthesensitivityofwound-infectingspeciesofbacteriatotheantibacterialacivityofmanukahoneyandotherhoney. JAppBacteriol1992;73(5):388-394
[69]Molan,P.Theevidenceandtherationalefortheuseofhoneyasawounddressing.WoundPractRes2011;19:204-220
[70]Molan,P.Theroleofhoneyinthemanagementofwounds.JWoundCare1999;8:415-418
[71]Rondeau,R,Kang,D,SabDeBoard,S,Baj,A,McManus,J.EmergencymedicineClinicsofNorthAmerica2007;25(1):23-29
[72]White,R.Woundcolonizationandinfection:theroleoftopicalantimicrobials.BritJNur2001;10(9):563-578
[73]Cox,E,Jeffcott,L,Dart,A,Biasutti,S.Areviewofregionallimbperfusionfordistallimbinfectionsinthehorse.EqVetEduc2020:1-15
![Page 54: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/54.jpg)
54
[74]Drugandtherapeuticsbulletin.Localapplicationstowounds1:cleansers,antibacterials,debriders.Drugandtherapeuticsbulletin29(24):93-95
[75]Duerden,BP,Armstrong,I,Bowler,D.Woundmcirobiologyandassociatedapproachestowoundmanagement.ClinMicrobiolRev2001;14:244-269
[76]Heal,C,Banks,J,Lepper,P,Kontopantelis,E,vanDriel,M.Topicalantibioticsforpreventingsurgicalsiteinfectioninwoundshealingbyprimaryinetntion. CochraneDatabaseSystRev2016;11
[77]Shall,I,Dalziel,L,Zaki,K.Bacitracin:asignificantsensitiserinlegulcerpatients?.ContactDermatol1994;31:92-94
[78]BritishMedicalJournal.Topicalantibiotics(editorial).1977;1:494
[79]Kisner,A,Kerdel,R,Colsky,F.Analysisofsusceptibilitiesofskinflorainhospitaliseddermatologypaients.Thecrisisofantiboticresistancehascometothesurface.ArchDermatol1998;134:1006-1009
[80]Booth,L.Earlywoundmanagementinthehorse.EqPract1992;14(2)[81]Schultz,R,Tarnuzzer,G.Biochemicalanalysisofacuteandchronicwound
Environments.WoundRepairRegen1996;4:321-325
[82]HadagaliM,Chua,L.Theanti-inflammatoryandwoundhealingpropertiesofHoney.EurFoodResTechnol2014;239(6):1003-1014
[83]Hansen,M,Lu,E.Hydrogenperoxidewoundirrigationinorthopaedicsurgery.JBoneJtInfect2017;2(1):3-9
[84]R,Cooper.(Internet).America:WorldWideWounds(citedJuly2020).Availablefrom
http://www.worldwidewounds.com/2004/february/Cooper/Topical-Antimicrobial-Agents.html
[85]Appendino,G,Gibbons,S,Giana,A,Pagani,A,Grassi,G,etal.AntibacterialcannabinoidsfromCannabissativa:astructure-activitystudy.JNatProd2008;71(8):1427-1430
[86]Liu,J,Lin,T,Wang,Y,Peng,C.Effectoffloralsourcesonantioxidant,antimicrobial,andanti-inflammatoryactivitiesofhoneysinTaiwan.FoodChem 2013;139(1-4):938-942
[87]Cooper,R,Jenkins,L,Henriques,A,Duggan,R,Butron,N.Absenceofbacterialresistancetomedical-grademanukahoney.EurJClinMicrobiol2010;29(10): 1237-1241
[88]Mavric,E,Wittman,S,Barth,G,Henle,T.IdentificationandquantificationofmethylglyoxalasthedominantantibacterialconstituentofManuka (Leptospernumscoparium)honeysfromNewZealand.MolNutrFoodRes 2008;52(4):483-489
[89]Dart,A,Dowling,B,Smith,C,Dart,C.Topicaltreatmentsinequinewoundtherapy.VetClinNAm-Equine2005;21:77-89
[90]Tepper,R,Pelo,O,Bhatt,C,Challaghen,K,Bastidas,M,Bunting,N,etal.Topicalvascularendothelialgrowthfactoracceleratesdiabeticwoundhealingthrough increaesdangiogenesisandbymobilisngandrecruitingbonemarrow-derived cells.AmJPath2004;164(6):1935-1947
[91]Pertwee,R.Cannabinoidpharmacology:thefirst66years.BritJPharmacol2006;147:163-171
![Page 55: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/55.jpg)
55
[92]Andre,C,Hausman,J,Guerriero,G.Cannabissativa:theplantoftheonethousandandonemolecules.FrontPlantSci2016;7(9):19
[93]Borgelt,L,Franson,K,Nussbaum,A,Wang,G.Thepharmacologicandclinicaleffectsofmedicalcannabis.Pharmacol2013;33(2):195-209
[94]Pisanti,S,Malfitano,A,Ciaglia,E,Lamberti,A,Ranieri,R,Cuomo,G.Cannabidiol:Stateoftheartandnewchallengesfortherapeuticapplications.PharmacolTherapeut2017;175:133-150
[95]WorldHealthOrganisation:ExpertCommitteeonDrugDependence(online)Cannabidiol(CBD)Pre-ReviewReport[2017].Availablefromhttp://www.who.int/medicines/access/controlled-substances/5.2_CBD.pdf
[96]Hui-chen,L,Mackie,K.Anintroductiontotheendogenouscannabinoidsystem.BiolPsychiarty2016;79(7):516-525
[97]Pertwee,R,Howlett,A,Abood,M,Alexander,S,DiMarzo,V,Elphick,M,etal.Internationalunionofbasicandclinicalpharmacology.LXXIX.Cannabinoidreceptorsandtheirligands:beyondCBandCB.PharnmcolRev2010;62(4):588-631
[98]Pertwee,R.ThediverseCB1andCB2receptorpharmacologyofthreeplantcannabinoids:A9-tetrahydrocannabinol,cannibidiolandA9-tetrahydrocannabivarin. BritJPharmacol2008;152(2):199-215
[99]Thomas,A,Baillie,G,Phillips,A,Razdan,R,Ross,P,Pertwee,R.CannabidioldisplaysunexpectedlyhighpotentencyasanantagonistofCB1andCB2receptor agonistinvitro.BritJPharmacol2007;150(5):613-623
[100]Murillo-Rodriguez,E,Millan-Aldaco,D,Palomero-Rivero,M,Mechoulam,R,Drucker,C.Cannabidiol,aconstituentofCannabissativa,modulatessleepinrats.FEBSLetters2006;580(18):4337-4345
[101]Nicholson.A,Turner,C,Stone,B,Roboson,P.EffectofDelta-9-tetrahydrocannabinolandcannabidiolonnocturnalsleepandearly-morningbehaviourinyoungadults.JClinPsychopharmacol2004;24(3):305-313
[102]Zuardi,A,Hallak,J,Crippa,J.Interactionbetweencannabidiol(CBD)and(9)-tetrahydrocannabinol(THC):influenceofadministrationinetrvalanddoseratiobetweenthecannabinoids.Psychopharmacol(Berl)2012;219(1):247-249
[103]Finkelfarb,A,Bueno,E,Musty,O,Karniol,R,Zuadri,I.Characteristicsofthestimulusproducedbythemixtureofcanabidiolwithdelta9-tetrahydrocannabinol.Arch IntPharmacodynTher1981;249(1):137-146
[104]Wang,L-L,Zhao,R,Li,J-Y,Li,S,Liu,M,Wang,M,etal.Pharmacologicalactivationofcannabinoid2receptorattenuatesinflammation,fibrogenesis,andpromotes re-epithelializationduringskinwoundhealing.MollCellPharmacol2016; 786:128-136
[105]Baron,E.Medicinalpropertiesofcannabinoids,terpenes,andflavonoidsincannabis,andbenefitsinmirgraine,headache,andpain:anupdateoncurrentevidenceandcannabisscience.Headache2018;58(7):1139-1186
[106]Williamson,E,Evans,F.Cannabinoidsinclinicalpractice.Drugs2000;60:1303-1314
[107]Evans,F.Cannabinoids:theseparationofcentralfromperipheraleffectsonastructuralbasis.PlantaMed1991:57
[108]Ahrens,J,Demir,R,Leuwar,M,delaRoche,J,Krampfl,K,Foadi,N,etal.
![Page 56: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/56.jpg)
56
Thenonpsychotropiccannabinoidcannabidiolmodultesanddirectlyactivatesalpha-1andalpha-1-Betaglycinereceptorfunction.Pharmacol2009;83(4):217-222
[109]Pertwee,R.Cannabidiolasapotentialmedicine.CannabinoidsTher2005:47-65[110]Pertwee,R.Thepharmacologyandtherapeuticpotentialofcannabidiol.In2014
AmericanAssociationfortheAdvancementofScience[111]Mechoulam,M,Kwiatkowska,R.Cannabinoids:effectsonvomitingandnausea
inanimalsmodels.CannabinoidsTher2005:183-200
[112]Klein,M,deQuardosDeBortolli,J,SilvieraGuimaraesmF,GoncalvesSalum,F,Cherubini,K,ZancanarodeFigueiredo,M.Effectsofcannabidiol,aCannabissativaconstituent,onoralwoundhealingprocessinrats:clinicalandhistological evaluation.PhytotherRes2018;32(11):2275-2281
[113]Wang,L-L,Zhao,R,Ly,J-Y,Li,S-S,Liu,M,Wang,M,etal.Pharmacologicalactivationofcannabinoid2receptorattentuatesinflammation,fibrogensis,andpromotesre-epithelializationduringskinwoundhealing.EurJPharmcol2016;786:128-136
[114]Li,S-S,Wang,L-L,Liu,M,Jiang,S-S,Zhang,M,Tian,Z-L,etal.CannabinoidCB2receptorsareinvolvedintheregulationoffibrogenesisduringskinwoundrepairinmice.MolMedRep2016;13(4):3441-3450
[115]Younger,J,McCue,R,Mackey,S.Painoutcomes:abriefreviewoftehcniquesandinstruments.CurrPainHeadacheR2009;13(1):39-43
[116]Girling,S,Fraser,M.CannabisintoxicationinthreeGreeniguanas(Iguanaiguana).JSmallAnimPract2011;52(2):113-116
[117]Meola,S,Tearney,C,Haas,S,Hacket,T,Mazzaferro,E.Evaluationoftrendsinmarijuanatoxicosisindogslivinginastatewithlegalisedmedicalmarijuana:125dogs(2005-2010).JVetEmergCritCare2012;22(6):690-696
[118]Fitzgerald,K,Bronstein,A,Newquist,K.Marijuanapoisoning.TopCompanionAnimM2013;28(1):8-12
[119]Chien,F,Wang,R,Mittag,T,Podos,S.EffectofWIN55212-2,acannabinoidreceptoragonist,onaqueoushumordynamicsinmonkeys.ArchOphthalmol2003;121(1):87-90
[120]Pate,D,Jarvinen,K,Urtti,A,Mahadevan,V,Jarvinen,T.EffectoftheCB1receptorantagonist,SR141716A,oncannabinoid-inducedocularhypotensioninnormotensiverabbits.LifeSci1998;63(24):2181-2188
[121]Scarampella,F,Abramo,F,Noli,C.Clinicalandhistologicalevidenceofananalogueofpalmitoylethanolamide,PLR120(comicronisedPalmidrolINN)incatswitheosinophilicgranulonaandeosinophilicplaque:apilotstudy.VetDermatol2001;12(1):29-39
[122]Looney,A.Oncologypaininveterinarypatients.TopCompanionAnimM2010;32-44
[123]Sipis,P,Gyory,H,Hagymasi,K,Ondrejka,P,Blazovics,A.SpecialwoundhealingmethodsusedinancientEgyptandthemythologicalbackground.WorldJSurg2004;28(2):211-216
[124]Hippocrates,ThegenuineworksofHippocrates.London:SydenhamSociety,1849.[125]GMagno,Thehealinghand:manandthewoundintheancientworld.Cambridge:
![Page 57: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/57.jpg)
57
HarvardUniversityPress,1991.[126]SahihBukhari,Haddith#588.[127]Molan,P.Theevidencesupportingtheuseofhoneyasawounddressing.
IntJLowExtrWound2006;5(1):40-54[128]Jenkins,R,Cooper,L.Acomparisonbetweenmedicalgradehoneyandtable
honeysinrelationtoantimicrobialefficacy.Wounds2009;21:29-36[129]Jenkins,R,Hooper,L,Cooper,S.InhibitionofbiofilmsofPseudomonas
aureginosabyMedihoneyinvitro.JWoundCare2014;23:93-96[130]Molan,P.Theantibacterialacitivytofhoney.2.Variationinthepotencyofthe
antibacterialactivity.BeeWorld1992;63:59-76
[131]Henriques,A,Jenkins,R,Cooper,N,Butron,R.TheeffectofmanukahoneyonthestructureofPseudomonasaeruginosa.EurJClinMicrobiol2011;30(2):167-171
[132]Gethin,G.TheimpactofmanukahoneydressingonthesurfaceofchronicWounds.IntWoundJ2008;5:185-194
[133]Irish,J,Blair,S,Carter,D.TheantibacterialactivityofhoneyderivedfromAustralianflora.PLoSONE2011;6(3):18229
[134]Schepartz,J,Subers,A,White,M.Identificationofinhibine,theantibacterialfactorinhoney,ashydrogenperoxideanditsorigininahoneyglucose-oxidasesystem.BBA-GENSubjects1963;73:57-70
[135]Bang,L,Phil,M,Buntting,C,Molan,P.Theeffectofdilutionontherateofhydrogenperoxideproductioninhoneyanditsimplicationsforwound healing.JAlternComplemMed2003;92(2):267-273
[136]Fita,P,Loewen,I,Chelikani,P.Diversityofstructuresandpropertiesamongcatalases.CellMolLifeSci2004;61:192-208
[137]Chen,C,Campbell,L,Blair,S,Carter,D.Theeffectofstandardheatandfiltration processingproceduresonantimicrobialactivityandhydrogenperoxidelevels inhoneyialpropertiesofhoney.FrontMicrobiol2012;3:265
[138]Zaat,P,Kawkman,S.Antibacterialcomponentsofhoney,.Life2012;64:48-55[139]Majtan,J,Bohova,J,Garcia-Villalba,R,Tomas-Barberan,F,Madakova,Z,
Majtan,T,etal.FirhoneydewhoneyflavinoidsinhibitTNF-ainducedMMP-9expressioninhumankeratinocytes:anewactionofhoneyinwoundhealing.ArchDermatolRes2013;305(7):619-627
[140]Woo,K,Jeong,K,Inoue,H,Park,J,Kwon,T.Chrisinsuppresseslipopolysaccharide-inducedcyclooxygenase-2expressionthroughtheinhibitionofnuclearfactorforIL-6(NF-IL-6)DNA-bindingactivity.FEBSLet2005;579:705-711
[141]Kassim,M,Yusoff,K,Ong,G,Sekaran,S,Yusof,M,Mansor,M.Gelamhoneyinhibitslipopolysaccharide-inducedendotoxemiainratsthroughtheinductionofhemeoxygenase-1andtheinhibitionofcytokines,nitricoxideandhigh-mobilitygroupproteinB1.Fitoterapia2012;83(6):1054-1059
[142]Tonks,A,Cooper,R,Jones,K,Blair,S,Parton,J,Tonks,A.Honeystimulatesinflammatorycytokineproductionfrommonocytes.Cytokine2003;21(5):242-247
[143]Tonks,A,Cooper,R,Price,A,Molan,P,Jones,K.StimulationoftheTNF-areleaseinmonocytesbyhoney.Cytokine2001;14(4):24-242
[144]Yeung,A,Torfs,E,Jamshidi,F,Bains,M,Wiegand,I,Hancock,R,etal.SwarmingofPseudomonasaeruginosaiscontrolledbyabroadspectrumoftranscriptional
![Page 58: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/58.jpg)
58
regulatorsincludingMetR.JBacteriol2009;191(18):5592-5602
[145]Lu,J,Cokcetin,N,Bruke,C,Turnbull,L.HoneycanhinibitandeliminatebiofilmsproducedbyPseudomonasaeruginosa.SciRep2019;9(1):18160
[146]Carnwath,R,Graham,E,Reynolds,K,Pollock,P.Theantimicrobialactivityofhoneyagainstcommonequinewoundbacterialisolates.VetJ2014;199(1):110-114
[147]Molan,K,Reid,P,Allen,G.AsurveyoftheantibacterialactivityofsomeNewZealandhoneys.JPharmPharmacol1991;43:817-822
[148]Manley-Harris,M,Snow,M.Onthenatureofnon-peroxideantibacterialactivityinNewZealandmanukahoney.FoodChem2004;84:145-147
[149]Majtan,J,Bohova,J,Prochazka,E,Klaudiny,J.MethylglyoxalmayaffecthydrogenperoxideaccumulationinManukahoneytthroughinhibitionofglucoseoxidase.JMedFood2014;17(2):290-293
[150]Adams,C,Boult,C,Deadman,B,Farr,J,Grainger,M,Manley-Harris,M,etal.IsolationbyHPLCandcharacterisationofthebioactivefractionofNewZealandmanuka(Leptospermumscoparium)honey.CarbohydrRes2008;343(4):651-659
[151]Jenkins,R,Burton,N,Cooper,R.Proteonomicandgenomicanalysisofmethicillin-resistantStaphylococcusaureus(MRSA)exposedtomanukahoneyinvitrodemonstrateddownregulationofvirulencemarkers.JAntimicrobChemother2013;69(3):603-615
[152]Jenkins,A,Burton,R,Cooper,NF,Henriques,R.TheeffectofmanukahoneyonthestructureofPseudomonasaeruginosa.EurJClinMicrobiol2001;30:167-171
[153]Burton,R,Cooper,N,Jenkins,R.EffectofmanukahoneyonuniversalstressproteinAinmethicillinStaphylococcusaureus.IntJAntimicrobAgents2011a;37:373-376
[154]Molan,P.AnexplanationofwhytheMGOlevelinmanukahoneydoesnotshowtheantibacterialactivity.2008
[155]Manley-Harris,C,Molan,P,Adams,P.TheoriginofmethylglyoxalinNewZealandmanuka(Leptospermumscoparium)honey.CarbohydrRes2009;344:1050-1053
[156]Haberlau,J,Henle,S,Atrott,T.Studiesontheformationofmethylglyoxalfromdihydroxyacetoneinmanuka(Leptospermumscoparium)honey.CarbohydrRes2012;361:7-11
[157]Dart,A,Bischofeberger,A,Dart,C,Jeffcott,L.Areviewofresearchintosecondintentionequinewoundhealingusingmanukahoney:Currentrecommendationsandfutureapplications.EqVetEduc2015;27(12):658-664
[158]Stephens,J,Schlothaeuer,R,Morris,B,Yang,D,Fearnley,L,Greenwood,D,etal.PhenoliccompoundsandmethylglyoxalinsomeNewZealandmanukaandkanukahoneys.FoodChem2010;120(1):78-86
[159]Estevinho,L,Periera,A,Moreira,L,Dias,L,Periera,E.AntioxidantandantimicrobialeffectsofphenoliccompoundsextractsofNortheastPortugalhoney.FoodChemToxicol2008;46(12):3774-3779
[160]Cochrane,C,Freeman,K,Woods,E,Welbsy,S,Percival,S.Biofilmevidenceandthemicrobialdiversityofhorsewounds.CanJMicrobiol2009;55(2):197-202
[161]Lu,J,Turnbull,L,Burke,C,Liu,M,Carter,D,Schlothauer,R,etal.Manuka-typehoneyscaneradicatebiofilmsproducedbyStaphylococcusauereusstrains
![Page 59: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/59.jpg)
59
withdifferentbiofilm-formingabilities.PeerJ2014;2:e326[162]Schepartz,A.Theglucoseoxidaseofhoney.III.Kineticsandstoichiometryof
thereaction.BBA-GENSubjects1965;99(1):161-164
[163]Kawai,R,Kawasaki,T.Toll-likereceptorsignallingpathways.FrontiersImmunol2014;5:1-8
[164]Subrahmanyam,M.Honeydressingforburns:anappraisal.AnnalsBurnsFiresDisasters1996;9(1):33-35
[165]Cliver,J,Snowden,D.Microorganismsinhoney.InJFoodMicrobiol1996;31:1-26[166]Dudley,A,Porter,E,Parton,N,Razier,J,Smith,J,Tonks,E.A5.8-kDacomponent
ofmanukahoneystimulatesmmunecellsviaTLR4.JLeukocBio2007;82(5):1147-1155
[167]Kulakova,E.TheroleofManukahoneyinwoundhealingandinflammationusingIL-6andhumandermalfibroblastsasmdoelsystems.2007.
[168]Shah,S.Manukahoney:itsroleinwoundhealingandinflammation,2017.[169]Yussof,S,Hussein,M,Makpol,S,Yusof,Y.Gelamhoneyinhibitstheproduction
ofproinflammatory,mediatorsNO,PGE(2),TNF-aandIL-6incarrageenan-inducedacutepawodemainrats.Evid-basedComplAlt2012:109636
[170]El-Sitany,S,Abbas,N,Abdel-dayem,A,Ali,U,AlJauoni,S,Harakeh,S,etal.Antioxidant,anti-inflammatory,andantiulcerpotentialofmanukahoneyagainstgastriculcerinrats.Evid-basedComplAlt2017:1-12
[171]MelukaHoney.FAQ's.[Online].Availablefromhttps://www.melukahoney.com.au/pages/faq
[172]Halcon,L,Milkus,K.Staphylococcusaureusandwound:areviewofteatreeoilasapromisingantimicrobial.AmJInfectCont2004;32(7):402-408
[173]Thompson,G,Blackwood,B,McMullan,R,Alderdice,F,Trinder,T,Lavery,G,etal.Arandomisedcontrolledtrialofteatreeoil(5%)bodywashversusstandardbodywashtopreventcolonisationwithmethicillin-resistantStaphylococcusaureus(MRSA)incriticallyilladults:researchprotocol.BMCInfect2008;8:161-161
[174]DRudd.(2018,April)Shopify.[Online].Availablefromhttps://cdn.shopify.com/s/files/1/2809/0652/files/Chemical_profile_and_bioactive_properties_ of_Tea_Tree_Oct_2018_Final_2.pdf?13471794775953304683
[175]Cries,A,Jeffcott,L,Hodgson,L,Rose,R,Dart,A.Effectsof25%propyleneglycolhydrogel(Solugel)onsecondintentionwoundhealinginhorses.VetSurg2002;31:309-313
[176]Bischofberger,A,Dart,C,Perkins,N,Dart,A.Apreliminarystudyontheeffectofmanukahoneyonsecond-intentionhealingofcontaminatedwoundsonthe distalaspectoftheforelimbsofhorses.VetSurg2011;40(7):898-902
[177]Cries,A,Jeffcott,L,Hodgson,L,Rose,R,Dart,A.Theeffectofequinerecombinantgrowthhormoneonsecondintentionwoundhealinginhorses.VetSurg2002;31(4):314-319
[178]Tsang,A,Dart,A,Sole-Guitart,A,Dart,C,Perkins,N,Jeffcott,L.ComparisonoftheeffectsoftopicalapplicationofUMF20andUMF5manukahoneywithagenericmultifloralhoneyonwoundhealingvariablesinanuncontaminatedsurgicalequinedistallimbwoundmodel.AustVetJ2017;95(9):333-337
[179]Bebin,J,Szaflarski,E.Cannabis,cannabidiol,andepilepsy-fromreceptorsto
![Page 60: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/60.jpg)
60
clinicalresponse.EpilepsyBehav2014;41:277-282[180]Russo,E.TamingTHC:potentialcannabissynergyandphytocannabinoid-
terpenoidentourageeffects.BritJPharmacol2011;163(7):1344-1364
[181]Blasco-Benito,S,Seijo-Vila,M,Caro-Villalobos,M,Tundidor,I,Andradas,C,Garcia-Taboada,E,etal.Appraisingtheentourageeffect:antitumouractionofapurecannabinoidversusabotanicaldrufpreparationinpreclinicalmodels ofbreatcancer.BiochemPharmacol2018:157
[182]Santiago,M,Sachdev,S,Arnold,J,McGregor,I,Connor,M.Absenceofentourage:TerpenoidscommonlyfoundinCannabissativadonotmodulatethefunctionalactivityofdelta-9-THCathumanCB1andCB2receptors.BioRxiv2019;4(3):165-176
[183]Jerkovic,I,Kus,P.Terpenesinhoney:occurence,originandtheirroleaschemicalbiomarkers.RSCAdv2014;4(60):3170-31728
[184]Ali,E,Almagboul,A,Khogali,S,Gergier,U.AntimicrobialactivityofCannabissativaL.ChinMed2012;3(1):61-64
[185]Burstein,S.Cannabidiol(CBD)anditsanalogs:areviewoftheireffectsonInflammation.BioorganMedChem2015;23:1377-1385
[186]Colleoni,B,Conti,S,Paralaro,D,Franke,C,Trovato,A,Giagoni,G,etal.Oralanti-inflammatoryactivityofcannabidiol,anon-psychoactiveconstituentofcannabis,inacutecarrageenan-inducedinflammationintheratpaw.ArchPharm2004;369(3):294-299
[187]DiTommaso,N,Bari,M,Maccarone,M,Battista,M.Theendocannabinoidsystem:anoverview.FrontBehavNeurosci2012;14(6):9
[188]Reich,P,Szepietowshi,A,Kupczyk,J.Cannabinoidsystemintheskin–apossibletaregtforfuturethereapiesindermatology.ExpDermatol2009;18:669-679
[189]Thomas,S,Abu-Shar,K,Munro,M.Molecularcharacterisationofaperipheralreceptorforcannabinoids.Nature1993;365:61-65
[190]Meijerink,R,Witkamp,J.Theendocannbinoidsystem:anemergingkeyplayerininflammation.CurrOpinClinNutr2014;17:130-138
[191]Clark,A,Singer,R.Cutaneouswoundhealing.NEngJMed1999;341:738-746[192]Arany,K,Philip,P,Finnson,A.Transforminggrowthfactorbetasignalling
incutaneouswoundhealing:lessonslearnedfromanimalstudies.AdvWoundCare(NewRochelle)2013;2:225-237
[193]Kopp,M,Branton,J.TGF-betaandfibrosis.MicrobInfect1999;1:1349-1365[194]Barbem,C,Godron,S,Theoret,J.Temporallocalisationofimmunoreactive
transformindermalwoundsgrowthfactorbeta1innormalequineskinandinfull-thickness.VetSurg2002;31:274-280
[195]Barber,C,Moyana,S,Gordon,T,Theoret,J.Preliminaryobservationsonexpressionoftransforminggrowthfactorsbeta1andbeta3inequine full-thicknessskinwoundshealingnormallyorwithexuberantgranulation tissue.VetSurg2012;31(3):266-273
[196]Bischofberger,A,Dart,C,Perkins,N,Jeffcott,L,Dart,A.Theeffectofshort-andlong-termtreatmentwithManukahoneyonsecondintentionhealingof contaminatedandnoncontaminatedwoundsonthedistalaspectofthe forelimbsinhorses.VetSurg2013;42(2):154-160
![Page 61: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/61.jpg)
61
[197]Zhang,D,Ma,L,Abshire,F,McIllwraith,S,Stinchcomb,S,Westlund,A,etal.Transderamlcannabadiolreducedinflammationandpainrelatedbehavioursinaratmodelofarthitis.EurJPain2015;20(6):936-948
[198]Wallace,A,Eady,S,Miles,M,Martin,H,McLachlan,A,Rodier,M,etal.DemonstratingthesafetyofmanukahoneyUMF20+inahumanclinicaltrialwithhealthyindividuals.BritJNutr2010;103(7):1023-1028
[199]Schott,H.Pituitaryparsinetrmediadysfunction:equineCushing'sdisease.VetClinNAm:EqPract2002;18(2):237-270
[200]McGowan,T,Pinchbeck,G,McGowan,C.Prevalence,riskfactorsandclinicalsignspredictiveforequineparspituitaryintermediadysfunctoninagedhorses.EqVetJ2013;45(1):75-79
[201]Lobo,V,Patil,A,Phatak,A,Chandra,N.Freeradicals,antioxidantsandfunctionalfoods:impactonhumanhealth.PharmcognRev2010;4(8):118
[202]Rasik,A,Shukla,A.Antioxidantstatusindelayedhealingofwounds.IntJExpPathol2001;81(4):257-263
[203]VandenBoom,R,Wilmink,J,O’Kane,S,Wood,J,Ferguson,M.Transforminggrowthfactor-Blevelsduringsecondintentionhealingarerelatedtothedifferentcourseofwoundcontractioninhorsesandponies.WoundRepairRegen2002;10:188-194
[204]Comvita.(2016,September)Comvita.[Online]Availablefrom
https://www.comvita.com.au/blog-article/umf-means-quality-and-purity-in-every-drop/3200395
[205]sipos,.[206]magno,.[207]hippocrates,.[208]sahih,.[210]Nicholas,L(2019,June)Smallcaps.[Online].Availableonline
https://smallcaps.com.au/botanix-cbd-based-product-destroys-skin-superbug-infections/
[211]MedicinalHoneyCompany.TeatreesofAustraliaandNewZealand.[Online].Availablefromhttp://www.medicinalhoney.com.au/aboutteatrees.htm
[212]Ahmad,A,Khan,R,Mesaik,M.Anti-inflammatoryeffectofnaturalhoneyonbovinethrombin-inducedoxidativeburstinphagocytes.PhytotherRes2009;23(6):801-808
[213]Bracamonte,S,Hendrick,J,Carmalt,J,Wilson,D.Exvivocomparisonofburstingstrengthofventralmedialandrightventralparamedianceliotomiesinhorses.VetSurg2013;42(4):468-472
[214]Bisogno,T,Hanus,L,dePetrocellis,L,Tchilibon,S,Ponde,D,Brande,I.Moleculartargetsforcannbidiolanditssyntheticanalogues:EffectonvanilloidVR1receptorsandonthecellularuptakeandenzymatichydrolysisofanandamide.BritJofPharmcol2001;134(4):845-852
[215]Eteraf-Oskouei,T,Najafi,M.Traditionalandmodernusesofnaturalhoneyinhumandiseases:areview.IranJBasicMedSci2013;16(7):731-742
[216]Frank,S,Madlener,M,Werener,S.TransforminggrowthfactorsB1,B2,
![Page 62: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/62.jpg)
62
andB3andtheirreceptorsaredifferentiallyregulatedduringnormalandimpairedwoundhealing.JBiolChem1996;271(17):10188-10193
[217]Greenhalgh,D.Theroleofapoptosisinwoundhealing.IntJBiocehmCellBiol1998;30(9):1019-1030
[218]Grinnell,F.Fibroblastbiologyinthree-dimensionalcollagenmatrices.TrendsCellBiol2003;13(5):264-269
[219]Hinz,B,Mastrangelo,D,Iselin,C,Chaponnier,C,Gabbiani,G.Mechanicaltensioncontrolsgranulationtissuecontractileactivityandmyofibroblastdifferentiation.AmJPathol2001;159(3):1009-1020
[220]Ireland,J,McGowan,C.Epidemiologyofpituitaryparsintermediadysfunction:asystematicliteraturereviewofclinicalpresentation,diseaseprevalanceandriskfactors.VetJ2018;235:22-33
[221]Kato,Y,Umeda,N,Maeda,A,Matsumoto,D,Kitamoto,N,Kikuzaki,H.Identificationofanovelglycoside,Leptosin,asachemicalmarkerofmanukahoney.JAgricFoodChem2012;60(13):3418-3423
[222]Kessler,D,Dethlefsen,S,Haase,I,Plomann,M,Hirche,Krieg,T.Fibroblastsinmechanicallystressedcollagenlatticesassumea"synthetic"phenotype.JBiolChem2001;276(39):36575-36585
[223]Kwakman,P,teVelde,A,deBoer,L,Vandenbroucke-Grauls,C,Zaat,S.Twomajormedicinalhoneyshavedifferentmechanismsofbacteriocidialactivity.PLoSOne2011;6(3):17709
[224]Lee,T,Chin,G,Kim,W,Chau,D,Gittes,G,Longaker,M.ExpressionofTGF-B1,2and3proteinsinkeloids.AnnalsPlastSurg1999;34(2):179-184
[225]Leong,G,Herst,P,Harper,J.IndigienousNewZealandhoneysexhibitmultipleanti-inflammatoryactivities.InnateImmun2012;18(3):459-466
[226]Lusby,P,Coombes,A,Wilkinson,J.Honey:apotentagentforwoundhealing?JWoundOstomyCont2002;29(6):295-300
[227]Guy,E,Russo,G.Ataleoftwocannabinoids:thetherapeuticrationaleforcombiningtetrahydrocannabinolandcannabidiol.MedHypotheses2006;66(2):234-246
[228]Tonks,A,Cooper,R,Price,A,Jones,P,Molan,K.StimulationofTNF-alphareleaseinmonocytesbyhoney.Cytokine2001;14(4):240-242
[229]Wilmink,J,Nederbragt,H,vanWeeren,P,Stolk,W,Barnevald,A.Differencesinwoundcontractionbetweenhorsesandponies:theinvitrocontractoncapacityoffibroblasts.EqVetJ2001;33(5):499-505
[230]Hedayat,A,Zarei,A,Ahmadi,M.Studyonanti-inflammatoryeffectofsubcutaneoushoneybeevenominjectionanddermalapplicationofcreamcontaininghoneybeevenomonadjuvant-inducedarthriticrats.ArchRaziInst2007;223-227
[231]Zurier,B.Prospectsforcannabinoidsasanti-inflammatoryagents.JCellBiol2003;88(3):462-466
[232]Swogger,G,Wolcott,E,Pulcini,P,Secor,E,Sestrich,P,Costeron,J,etal.Biofilmsinchronicwounds.WoundRegenRepair2008;16(1):37-44
[233]Shirtliff,J,Costeron,M,Stoodley,J,Leid,A.Humanleukocytesadhereto,penetrateandrespondtoStaphylococcusaureusbiofilms.IneftcImmun
![Page 63: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/63.jpg)
63
2000;70:6339-6345[234]Goode,A.Infectedwounds.Care:SciPract1982;1:3-7[235]Kim,K,Brudzynski,L.Store-inducedchemicalchangesinactiecomponentsof
honeyde-regulateitsantibacterialactivity.FoodChem2011;126(3):1155-1163
![Page 64: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/64.jpg)
64
APPENDICESAppendix1:AnimalethicsANIMALRESEARCHETHICSCOMMITTEEAPPLICATIONFORMPleaseNote:ThisformwascreatedonlineinIRMAandtheinformationprovidedisrecordedintheUniversityResearchOfficedatabase.SignoffbyresearchersisprovidedonlineinIRMAandwillnotbedisplayedinthisdocument.ADMINISTRATIVEDETAILS
Title: Do the cannabinoids, cannabidiol (CBD) and tetrahydrocannabinol (THC),enhancesecondintentionhealingofcontaminateddistallimbwoundsinhorsesandaretheyaseffectiveasUMF20manukahoney.
ChiefInvestigator: ProfAndrewDartPrimaryFaculty/Department: Vet Science Faculty; Faculty of VeterinaryScience
Investigators: DartAndrew;TsangAlbert;
Grantslinked:ExternalAuthorities:
AdditionalInformation:Marijuana (Cannabis sativa) contains more than 60 biologically active chemicalagents thathavebeen shown tohavepotentantibacterial andanti-inflammatoryactivityaswellas theability to improveelementsofhealing inaratskinwoundhealingmodel.RecentstudiesbyourgrouphaveshownthatUMF20manukahoneyiseffectiveatstimulatingandimprovingtherateofwoundhealinginthedistallimbofhorses.Theaimofthisstudyistocomparewoundhealingvariablesfromwoundstreated with two active agents derived from marijuana, cannabidiol (CBD) andtetrahydrocannabinol(THC),UMF20manukahoneyanduntreatedcontrolwounds.
ANIMALNUMBERS
CountryJurisdiction InvasivenessLocation Classification1 Classification2 Common/strain AppliedRe-used
![Page 65: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/65.jpg)
65
AustraliaNSW 4.Minor
surgerywithrecovery
DomesticmammalsHorses Standardbred 12 0
QUESTIONNAIRE
1 - <div align="left">Welcome to the University of Sydney’s Animal EthicsApplicationQuestionnaire.Pleasebeawarethatthereisalimitoffifteenminutestocompleteeachindividualquestion.Ifyouexceedthistimethenyouranswermaynotbesavedbythesystem.Werecommendthatyoupreparelonganswersoutsideof IRMA before pasting it back into the report questionnaire and/or save youranswers regularly.If you choose to edit a previous question, your responses tosubsequentquestionswillbedeleted.Therestorebuttoncanbeusedtorefillyoursubsequent answers if this happens.For further information on the applicationprocedure, please consult our <ahref="http://sydney.edu.au/research_support/ethics/animal/">website</a> oremailtheAnimalEthicsteamatanimal.ethics@sydney.edu.auIfyouexperienceanytechnicaldifficulties,pleasedonothesitatetocontactResearchSupportusingthedetailsbelow:[email protected]</div>
Continue2-WhatistheChiefinvestigator'srelationshiptotheUniversityofSydney?Ifmorethan one applies, please select the option that is most relevant to this AECapplication.
Employee3-Pleaseindicatewhetherthisapplicationis fora:NewprotocolOrProjectwhichhas previously/simultaneously been submitted to this or another animal ethicscommittee
NewProtocol5-IsanyoftheworkforthisprotocolbeingundertakenataninstitutionotherthantheUniversityofSydney?No
7-DoestheprojectintendtouseSchedule8drugs?
Yes10-Pleaseselectallschedule8drugsthatyouintendtouse
Other11-Pleasespecifyanyotherschedule8drugsthatyouareusing(ifany)
![Page 66: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/66.jpg)
66
Ketamine:RoutineuseattheveterinaryhospitalforanaesthesiaTetrahydrocannabinol:hasrecentlybeenrescheduledtoaschedule8drug.Itwillonlybeusedatlowdosetopicallyonthewounds.(CBDisschdule4)
Asveterinarianswearelicensedtouseschedule8drugs9-<divalign="left">Whattypeofapplicationisthis?Pleasenote,breedingprotocolsmust be submitted as a separate application to experimental protocols.Privatelyownedanimalsincludeanyanimalsthatare:-notownedbytheresearcher,and/or-are not 'wild' animals. Examples include:-pets (e.g. cats, dogs, horses)-animalsownedbyaprivateentity(e.g.Acommercialfarm,azoo)</div>
Experimental(non-wildlife)12-Doesthisprotocolinvolvethedevelopmentofnewveterinaryoragriculturalchemicals?Thisincludestheunapproved('off-label')useofanexistingregisteredveterinary/agricultural chemical product; or the use of an unregisteredveterinary/agriculturalproduct(includingnaturalproducts).
No13-Isthisprojectcommerciallysponsoredand/orsupported?
No
15-AreanimalsusedinthisprotocollocatedinNewSouthWales?Yes19-Youhaveindicatedthatanimalsusedinthisprotocolwillbe locatedinNewSouthWales.Pleasechoose themostappropriateoption todescribe theprimarypurposeoftheprotocol.
Research:healthandwelfare20-WildlifeResearch:YoumayrequireascientificlicencefromtheNSWNationalParks andWildlife Service. This permit is obtained after AEC approval. Furtherdetails are available <ahref="http://sydney.edu.au/research_support/ethics/animal/">here</a> on theanimalethicswebsite.IconfirmthatIwillobtainallrequiredpermitsandapprovalspriortoundertakinganyresearch
18-AreanimalsusedinthisprotocollocatedoutsideofNewSouthWales?No21-Brieflydescribetheaimsoftheprotocolinscientificterms(notmorethan500words).
Marijuana (Cannabis sativa) contains more than 60 biologically active chemicalagents thathavebeen shown tohavepotentantibacterial andanti-inflammatoryactivityaswellas theability to improveelementsofhealing inaratskinwoundhealingmodel.RecentstudiesbyourgrouphaveshownthatUMF20manukahoneyiseffectiveatstimulatingandimprovingtherateofwoundhealinginthedistallimbofhorses.Theaimofthisstudyistocomparewoundhealingvariablesfromwoundstreated with two active agents derived from marijuana, cannabidiol (CBD) and
![Page 67: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/67.jpg)
67
tetrahydrocannabinol(THC),UMF20manukahoneyanduntreatedcontrolwounds.46- If theprotocolrepeatspreviouslyreportedexperiments,explainthereasonswhytheexperimentsneedtoberepeated.
No47-Whatspeciesofanimalwillbeusedinthisprotocolandwhy?
Equuscallabus:StandardbredhorsesHorsesareveryprone to traumaticandcontaminatedwoundsof thedistal limb.Theyareunique,withwoundhealingbeingmoreproblematicthaninotherspecies,includingponies.Woundsofthedistallimbsdonothealaswellasthoseofthebodyso there is a need for products that promote the healing of horse wounds,particularlythoseofthelowerleg.Manyproductsusedinotherspeciesdonothavethesameeffectinhorses.WehaveshownUMF20manukahoneypromoteslowerlimbwoundhealingindistallimbwoundsinhorses.Wehavedevelopedauniquecontaminated wound model which more closely replicates naturally createdwoundswithoutmany of the complications seen in naturally occurringwounds.Stadadrdbreds by virtue of their limited genetic diversity and temperament areidealforthismodelandhavebeenusedinallourpreviousstudiessoallowsomeintenrpetations and assumptions to be made between studies which reducenumbersofhorsesusedandrefinesthemodels.48-Pleaseprovideanexplanationofwhyanimalsareneededinthisprotocolandaclear description of the steps taken to consider and apply the 3Rs (Reduction,Refinement, Replacement). Please include a list of any potential alternatives toanimaluse,whetheranyof thesearebeingused in thisprotocol,and ifnot,whyalternativesareunsuitableforthisprotocol.Woundhealingisacomplexdynamicphysiologicalprocessthatistemporallyandspatiallyorchestratedandcanonlybestudiedinlivingtissues,Wehaveconductedmorethan5previousstudiesusingthismodelandwehavebeenabletoestablishthe numbers of horses needed to detect clinically relevant differences and haverefinedthemodeltousetheminimumnumberofhorsesandreduceanysideeffects.
49-Explainindetailhowyouhavedeterminedthenumberofanimalsnecessaryforthisprojectanddescribethewaysthatyouproposetominimisetheuseofanimals.Forexperimentalprotocols,includedetailsofstatisticalsignificance.Pleasedonotincludedetailsofmethodologyorimpactinthissection.Wehavefoundinpreviousexperiments6-8horsesaresufficienttodetectclinicallyrelevantdifferencesinwoundhealinginthismodel.Weaimtouse2groupsof6horses(12intotal).Thedoseofcannabinoidsweareusingtopicallyisconsideredtolowtohavesystemiceffectsbutitispossiblewemaygetlocaleffectsonadjacentwounds.Soweneed to test theCBDandTHC indifferenthorses.Ouraim isnotnecessarilytocompareTHCorCBDtoeachotherbuttocomparethemtoknowneffectivewoundhealingagent(UMF20manukahoney)andagainstasalinetreatedcontrolandthecarriervehiclefortheCBDandTHCgels.50 -Reuse:Does thisprotocol involve theuseofanyanimals thathavebeen thesubjectofpreviousresearch/teaching?
No
![Page 68: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/68.jpg)
68
51-Willanyanimaltissuebeavailabletobesharedwithotherinvestigators?Ifso,pleasespecifywhichtissuescanbeshared.Ifanimaltissuescannotbeshared,pleaseoutlinethereasonsforthis.No.Theseanimalswillnotbesacrificed.Thisisaminimallyinvasivestudy.WehaveworkedwiththeAECpreviouslytohavearesearchherdofhorsesheretoconductminimally invasive studies which results in using less horses while providingotherwiseunwantedhorsesaqualityoflife.Dependingontheprojectsplannedforthefuturewemayelecttokeepthesehorsesandrequesttheabilitytousethemforotherstudiesorifwehavenofurtherstudiesonthehorizonputthembackthroughthesales.53-Sequenceofevents:Giveaclearstepbystepdescriptionofwhathappenstoanimals from the time you obtain/encounter them until the time the project iscompleted. Where possible, please attach a flow chart in the documents tab todescribewhatwill happen to animals and their tissues.Youmust indicatewhichprocedures will be performed in sequence to the same animal(s).<fontcolor="red">Where appropriate, SOPs may be used - please attach them to thedocuments tab.</font>You may click on the documents tab now, upload thedocument,thenreturnbacktothistab.1.Horseswillbeacclimatedandquarantinedfor2weeksafterarrival2.Horseswillthenbebroughtuptoyardsclosertotheworkingareasandhousedincompatiblepairsinadjacentyards
3.Horseswillbeweighed,wormedandvaccinatedfortetanus
4.Ajugularcatheterwillbeplacedonthedayofsurgery5.Phenylbutasone2.2mg/kgwillbegivenorally6.Anaesthesiawillbeinducedusingxylazine(1,1mg/kg)diazepam(0.1mg/kg)andketamine(2.2mg/kg)
7.Metacarpiwillbeclippedandasepticallyprepared8.Twofullthicknessskinwounds(2.5cmx2.5cm)willbemadeoneachmetacarpusevenly spaced between the carpus and fetlock dorsomedially adjacent to theextensortendon.9.Freshfaecescollectedfromanotherhorsenotinthestudywillbeplacedonthewoundstocoverthemandthelegwillbebandagedovernight.10.Thedayaftersurgerybandageswillberemovedandthefaecesrinsedoffwithsterilesaline.
11.Digitalphotographswillbetakenofeachwoundwithastandardisedtemplateadjacenttothewoundtocontrolformagnification12.Woundsononelegofall12horseswillbetreatedwith2mlUMFmanukahoneyor2mlofsterilesaline.13.Woundsontheotherlegof6horseswillbetreatedwith2mlofTHCgelorthecarrierforTHC,whileintheother6horseswoundswillbetreatedwith2mlCBDgelorthecarrier.14. Bandages will be reapplied and changed and the wounds treated with theassignedtreatmentfor12days.
![Page 69: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/69.jpg)
69
15.Onday13bandageswillberemovedandthewoundleftopen.Dailytreatmentwiththeassignedmedicationwillcontinueuntilthewoundshavehealed.16.Woundswillbephotographedweeklyfor6weeksandthetotaltimetohealingwillberecorded.17.Woundswill bemeasured using a computer programwound size on day 1,wound size during the first 6 weeks of healing, total time to healing, and dailyhealingratewillberecordedandcomparedstatistically.54 - Impact: Identify all factors and procedures thatmay have an impact on ananimal's well-being. This may include handling, housing etc as well as specificexperimentalprocedures.Pleaserefertothechecklistavailablehereontheanimalethicswebsite, toensurealldetailshavebeenconsidered.Describeeachfactororproecedureandhowanyadverseimpactwillbeminimised.1.Horseswillbekeptasaherdandwheninseparateyardswillbeineyesightofeachother.2.Theywillbehandledandourexperienceisthattheyacclimatewelltothedailyroutines
3. Local anaestheticwill beused todesensitise the skin toplace the intravenouscatheter4.Horseswillbeanaesthetisedbyaveterinaryanaesthetistinapurposebuiltfaciiliy
5.Procedureswillbeperfromedunderanaesthesia6.Outexperienceisthatthesewoundsarenopainfulandhorsesarenotlameandlegsarenotswollen.
7.Apre-emptivedoseofphenylbutasoneisgivenpriortocreatingthewounds.8.Woundswillbecreatedbyanequinesurgeon9.Horseswillbesedatedifrequiredforanyofthebandagechangesorphotographysessionsiftheyareanxious
10Horsesarehousedandproceduresareperformedata24/7veterinaryfacility11.DrTsangandDrDartarelessthan15minutesawayandiftheyareunavailableornotcontactablethereisaveterinarianoncall24/7
55-Ifyouexpectanimalstodie(naturally/unassisted)duringthisprotocol,pleaseoutlinethepercentageofanimalsthatcouldbeaffected(i.e.theattritionrate)andexplainthelikelyreasonfortheanticipatedattritionrate.
Nodeathsareanticipated56-MonitoringPleaselistinvestigatorsresponsibleformonitoringoftheanimalsfor all of the following periods:-duringweekdays,-at night (if applicable)-duringweekends and holidays.-in an emergencyThis must include the methods andfrequencyofmonitoringoftheanimalspre,duringandpostprocedure.
DrDartandDrTsangwillmonitortheanimalsduringweekdaystwicedailyDrDartandDrTsangwillmonitor theanimalsduringweekendsandholidaysatleastoncedaily
DrDartandDrTsangwillbeavailableforemergencies
![Page 70: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/70.jpg)
70
The hospital is a 24/7 facility with a veterinarian always on call and final yearstudentsonovernightwatch.Horsesarefedbyexperiencedstablehandsallyeararoundtwicedaily.Allhorsesinhsoptialarecontinuouslymonitoredandwalkedby.57-Whatisexpectedtohappentotheanimalsatthecompletionoftheprotocol?
Reused58-Specifythescientificendpointsofthisprojectandstatethereasonforselectingthese.
Theexperimentwillbeoverwhenthelastwoundheals.Weareevaluatingwoundhealingandneedtotaltimetohealingasavariable.59-Otherthanscientificendpoints,whatfactorsaffectingthewell-beingofanimalswill lead topre-mature terminationof theexperiment (i.e.whatare thehumaneendpoints)? Please include clinical signs that may or may not be related to theprotocol.Pleaseuploadamonitoringsheetintothedocumentstab.Youmayclickonthe documents tab now, upload the document, then return back to this tab. Astandard monitoring sheet outlining humane end-point criteria is available <ahref="http://sydney.edu.au/research_support/ethics/animal/">here</a> on theanimalethicswebsite.Thereisnotexpectedtobeanyreasontoterminatethestudyforanyofthehorses.Anyhorsethatgetsinjuredorsickwillbeassessedthoroughly.Ifanyhorsecannotcontinue for veterinary reasons it will be removed from the study. Any horserequiringtreatmentwithdrugsthatmayaffect thestudywillberemoved. In thecase of a catastrophic injury such as a fracture or an illness that offers a poorprognosishorseswillbehumanelydestroyed.60 - Incaseofplannedorunplanned(emergency)euthanasia,pleaseoutline thefollowing: -Howwill this be done? -Whowill perform euthanasia?-Howwill thenominatedpersonbecontacted?-Wherewilleuthanasiabecarriedout?-Howwilldeathbeconfirmed?-Howwillthecarcassbedisposedof?Ifthehorsecanbemoveditwillbeperformedinarecoverystalloutofsight.Ifitcannotbemoveditwillbeperformedinthepaddockwiththeotherhorsesremoved.WewilluseanoverdoseofpentobarbitoneIVDrDartorDrTsang-bothperformeuthanasiaregularlyaspartoftheirjob
DrDartandDrTsangarecontactable24/7byphoneAsabove
Abscenceofaheartbeatusingastethoscope
Dismemberdandplacedinmedicalwastebinsthatareprofessionallyremoved61-WillanimalsbehousedinanLASmanagedfacility?LASmanagedfacilitiesare:-Bosch- Brain andMind Research Institute- The Cattery- Charles Perkins Centre-Gunn Building- McMaster Annexe- Medical Foundation Building-Psychology/Badham-SchoolofMolecularBioscience
No62-HousingandManagementPleaseprovidefurtherdetailonwhereanimalswill
![Page 71: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/71.jpg)
71
behoused/located.Pleaseincludethefollowing:-Describethetypeofhousingtobeprovided.-The maximum and minimum number of animals per cage/pen/tank.-Whattheanimalswillbefedandhowoftentheywillbefed.Horseswillbehousedinpairsinpurposefittedgrasspaddocksapproximately30metersby6metres
Theywillhaveaccesstograsssupplementedwithlucernehay2.5%bodyweightfedtwicedailyandhavefreeaccessotwater.72-Wherewillproceduresbeperformed?
Inapurposebuiltlargeanimalsurgicalcomplex.Thewoundswillbedressedandphotographedinthetreatmentareaofthehospitalcourtyard.
73-Willanimalsbeheldinaprocedureroomatanypointduringthisprotocol?No
74-Pleaseprovidedetailsofenvironmentalenrichmentsuppliedtoanimalsduringtheprotocol.Ifyouarenotusingenvironmentalenrichment,pleaseprovidereasons.Horsesareacclimatedandrunasaherdandkeptinpairs.Evenwhenkeptaspairstheywillalwaysbeinsightoftheotherhorses.77 - Have any researchers named on this application had their AEC approvalwithdrawn?
No78-PleasespecifytheroleoftheChiefInvestigatorinthisprotocol(e.g.supervisiononly,anaesthesia/surgicaltechniquesetc)DrDartwillperformthesurgeryandispresentandassistinginallprocedures.DrDartiscontactable24/7andisthefirstpointofcontactforanyissues80-PleaseprovidedetailonthelevelofexperienceoftheChiefInvestigatorwithtechniques to be performed on live animals in this protocol.For each techniquepleasespecifythelevelofexperience,stepstobetakentoincreaseexperience,andthe name of senior staff on the protocol who will supervise for unfamiliarprocedures.
Dr Dart has been an equine veterinarian for 32 years, a large animal surgicalspecialistfor23yearsandaclinicianandresearcherforhiswholecareer.Heisanexpertatalltheprocedures.
Heisthepointofcontactforanydecision
81-Forallinternalcoinvestigators,pleaseprovidedetailonthelevelofexperiencewithtechniquestobeperformedonliveanimalsinthisprotocol.Foreachtechniqueplease specify the level of experience of the investigator, steps to be taken toincreaseexperience,andthenameofseniorstaffontheprotocolwhowillsuperviseforunfamiliarprocedures.
DrTsanghasbeenaveterinarian for5yearsandworkedwithhorsesanddoingresearch for that time. He is training as a specialist and is competent in all
![Page 72: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/72.jpg)
72
proceduresperformed.82-Forallexternalcoinvestigators,pleaseprovidedetailonthelevelofexperiencewithtechniquestobeperformedonliveanimalsinthisprotocol.Foreachtechniqueplease specify the level of experience of the investigator, steps to be taken toincreaseexperience,andthenameofseniorstaffontheprotocolwhowillsuperviseforunfamiliarprocedures.
NA84-ExperimentalProtocol(non-wildlife)Wherewilltheanimalsbeobtainedfrom?
Saleyard86-Pleasespecifywhereanimalwillbeobtainedfrom(includingprotocolnumberifapplicable)
Thehorseswillbesourcedfromsaleyards87 -Will the protocol involve the use of geneticallymodified (gene knockout ortransgenic)animalsorgeneticallymodifiedmicro-organisms?
No88 - <div align="left">Thank you for completing the University of Sydney’sAnimalEthicsApplicationQuestionnaire.Afterselecting'Completed'below,pleaseremember to attach anydocuments relevant to your application in the next tab.After completing your application, return to the 'Coversheet' tab and press the'Submit' button. You will receive an email shortly after confirming yoursubmission.Once again, if you require further information on the applicationprocedure, please consult our <ahref="http://sydney.edu.au/research_support/ethics/animal/">website</a> oremailtheAnimalEthicsteamatanimal.ethics@sydney.edu.auIfyouexperienceanytechnicaldifficulties,pleasedonothesitatetocontactResearchSupportusingthedetailsbelow:[email protected]</div>
Completed
ATTACHEDDOCUMENTS
DateUploaded Type DocumentName11/10/2016 OtherHorseRecord
11/10/2016 OtherHorsewouldmeasurements
11/10/2016MonitoringSheet MonitoringSheet
![Page 73: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/73.jpg)
73
Appendix2:Anaestheticmonitoring
ISO
FLU
RA
NE 5%
4%
3%
2%
1%
Infusions
COMMENTS CODES
KEY:
HR •
RR SPONT O,
RR IPPV ∅,
Blood pressure:
Systolic V,
Diastolic ^,
Mean –,
Sp02 (%)ETC02 (mm Hg)TEMP (°C)
FLUIDS ml/hr
ET ANAE (%)
PRE- OXYGENATE !ET Size: mm Cu"ed ! BREATHING SYSTEM+ FGF:
! RBS ................ L/min
! NRBS ............. L/min
BODY POSITION:
! D ! LL ! RL ! S
MONITORING:
! PULSE OX
! ECG
! ETC02
! DOPPLER
! OSC
! IBP
! ET ANAES
! ABG
! TEMP
ANALGESIA
BP CUFF SIZE:
TEMP SUPPORT:
! AIRBED
! HEAT PAD
! WARM AIR BLANKET
! OTHER .....................
COMMENTS
IV FLUIDS
TYPE: ............................
Tot mls: .........................
TIME TO:
Start Proc. 1 ..................
Start Proc. 2 .................
End Surgery ..................
COMPLICATIONS:
! Hypotension
! Hypoventilation
! Hypoxaemia
! Hypothermia
! Bradycardia
! Arrhythmia
! Blood Loss
! Other
SA RECOVERY:Time In Recovery .........................................
Temp ..............................
Extubation Time.........................................
Recovery Quality:! Good
! Poor
! Satisfactory
230
220
200
180
160
140
120
100
80
60
50
40
30
20
10
8
6
4
2
230
220
200
180
160
140
120
100
80
60
50
40
30
20
10
8
6
4
2
PREMEDICATIONDrug Dose - mg/kg = Total mg = Total ml Route Time
SEDATIONQUALITY! Profound! Moderate! Poor
INDUCTIONDrug Total ml admln = Total mg = mg/kg Route Time
TIME :00 :15 :30 :45 :00 :15 :30 :45 :00
TEMP °C HR/PULSE RATE MM/CRT RR PCV PROTEIN USG
UREA CREAT PHYSICAL STATUS1 2 3 4 5 E
WEIGHT ABNORMAL LAB WORK
COMMENTS
THE UNIVERSITY OF SYDNEY VETERINARYTEACHING HOSPITAL CAMDEN
ANAESTHESIA RECORD
EQUINE RECOVERY:
Time In Recovery ....................
Extubation Time ......................
Time Sternal ............................
Drugs Administered ................ ...................................................
Time Standing .........................
Recovery Quality: A— B— C— D— E— F— G— H— Total:—
![Page 74: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/74.jpg)
74
Appendix3:Horserecords
HORSERECORD
TagNumber:Weight:DateofTetanusprophylaxis:DateofAnthelminticadministration:DateofSurgery:
WOUNDTEMPLATEWound LeftLeg RightLegWound1 Wound2 Abbreviations:UMF20–manukahoneyUMF20CBD–CannabidiolTHC-TetrahydrocannabinolCO–control(saline)
![Page 75: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/75.jpg)
75
Appendix4:Post-operativemonitoring
HORSEMONITORINGSHEETHorsetagnumber:Date Attitude Gait Swelling Comments Anyhorsesthatarenotbrightandalertwillbegivenafullclinicalexaminationandtreatedappropriately.Anyhorseswithlamenesswillbegivenafulllamenessexaminationandtreatedappropriately.Ifthereisexcessiveswellingandlamenesssuggestiveofcellulitishorseswillbegivenafullexaminationandtreatedappropriately.
![Page 76: Studies on the effect of various topical agents on second ...](https://reader033.fdocuments.us/reader033/viewer/2022041819/62547d98b908e450e5691233/html5/thumbnails/76.jpg)
76
HorseWoundMeasurementsHorseTagNumber
WoundSize(cm2)
LFUpper
LFLower RFUpper RFLower
Week1Day1
Week2
Week3
Week4
Week5
Week6
Week7
Totaldaystohealing